Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3028286	s-album	g/l (g/l)	9351	20970	0.00%
3028286	s-album	— (—)	1810	2379	100.00%	Distribution not available
3028286	s-alb-fr	g/l (—)	73	85	100.00%	Distribution not available
3028286	s-albumiini(valetietues-prot-fr)	g/l (—)	60	82	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

General symptoms and signs

2658

5617

2.42

317.78

2.4

1.9

37.23

38.52

g/l

17.10

2320

4791

Second line medication for Crohn's disease

1611

5863

2.85

313.43

4.7

1.7

36.99

38.12

g/l

10.70

1435

5039

L04AX Other immunosuppressants

1588

5757

2.86

311.37

4.7

1.7

36.98

38.10

g/l

10.41

1415

4946

Condition for Implicit Sepsis (Organ dysfunction codes)

2286

6943

2.46

310.74

2.3

2.1

36.36

38.31

g/l

34.84

1958

5940

Malaise and fatigue

1470

4056

3.14

307.65

2.2

2.0

35.89

38.27

g/l

32.23

1240

3399

Other and unspecified polyneuropathies, also in other diseases

972

2089

5.18

307.65

2.0

2.1

38.99

37.31

g/l

12.99

843

1769

Multiple myeloma and malignant plasma cell neoplasms

409

494

10.69

307.65

19.1

1.5

37.73

37.17

g/l

0.92

376

419

Heart failure, not strict

2238

6088

2.63

307.65

2.3

2.2

35.60

38.42

g/l

70.33

1959

5165

Primary_lymphoid and hematopoietic malignant neoplasms

1162

2596

4.91

307.65

8.5

1.5

37.28

37.60

g/l

0.90

1063

2180

Other bacterial diseases

2766

7253

2.72

307.65

2.7

2.0

35.57

38.63

g/l

95.14

2412

6174

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

3612

6870

3.95

307.65

2.5

2.0

37.08

38.09

g/l

14.65

3146

5844

Multiple myeloma and malignant plasma cell neoplasms

409

471

11.22

307.65

19.1

1.4

37.73

37.37

g/l

0.48

376

390

Fever of other and unknown origin

1569

4718

3.19

307.65

3.6

2.0

35.94

38.41

g/l

37.12

1402

3987

Renal failure

2021

4609

4.33

307.65

2.5

2.1

35.45

37.65

g/l

37.87

1796

3814

Tramadol

2165

5236

2.73

307.65

2.3

1.9

37.41

37.93

g/l

2.83

1885

4440

First line medication for Crohn's disease

2985

6134

2.72

307.65

2.8

1.6

37.23

38.40

g/l

16.62

2631

5194

Oral corticosteroids

2948

7006

2.62

307.65

2.0

2.2

36.88

38.25

g/l

22.66

2584

5957

Implicit Sepsis

2144

6531

2.64

307.65

2.4

2.1

35.95

38.19

g/l

41.57

1815

5564

Bacterial infection, other or unspecified

1752

5319

3.11

307.65

3.1

2.0

34.65

38.25

g/l

81.16

1515

4461

Other anaemias

1810

4568

4.11

307.65

2.6

2.1

36.40

37.38

g/l

7.87

1542

3811

Primary_lymphoid and hematopoietic malignant neoplasms

1162

2640

4.83

307.65

8.5

1.4

37.28

37.44

g/l

0.35

1063

2209

Other and unspecified anaemias

1800

4531

4.13

307.65

2.6

2.1

36.40

37.38

g/l

7.87

1534

3781

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

909

847

14.86

307.65

11.4

1.3

38.26

37.54

g/l

2.18

808

700

Renal tubulo-interstitial diseases

2763

7116

3.09

307.65

2.4

2.1

36.02

38.34

g/l

59.09

2423

6035

Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

598

461

19.55

307.65

7.6

1.3

38.60

37.31

g/l

3.57

523

381

Systemic connective tissue disorders

1297

3767

3.65

307.65

1.8

2.2

36.28

37.81

g/l

12.44

1116

3171

ILD medications

3257

6207

2.96

307.65

2.8

1.7

37.20

38.38

g/l

17.99

2860

5253

ILD medications: prednisolone, methylprednisolone, prednisone

3137

6183

2.95

307.65

2.1

1.7

37.09

38.36

g/l

20.03

2753

5230

Inflammatory bowel disease treatment related agents

3051

7057

2.52

307.65

2.0

2.2

37.05

38.28

g/l

18.97

2669

6003

Examination and observation for other reasons

1775

3669

3.03

307.65

2.3

2.1

37.87

37.59

g/l

0.95

1597

3206

Other systemic involvement of connective tissue (FG)

952

2332

4.31

307.65

1.7

2.4

36.89

37.97

g/l

5.06

808

1941

Aplastic and other anaemias

1896

4834

3.98

307.65

2.6

2.1

36.38

37.38

g/l

8.68

1619

4037

ILD medications: immunosuppressive drugs

1997

5249

3.81

307.65

4.1

1.7

36.82

38.55

g/l

25.75

1792

4469

Anaemias

792

530

10.46

307.65

2.4

1.3

37.08

40.00

g/l

17.14

708

469

Polyarthropathies

2094

4711

3.07

307.65

2.4

2.2

36.84

37.87

g/l

10.31

1863

4027

Chronic kidney disease

1451

3210

4.93

307.65

2.4

2.1

35.87

37.57

g/l

17.60

1299

2618

Multiple myeloma, excluding all cancers (controls excluding all cancers)

419

473

11.51

307.65

18.9

1.4

37.73

37.39

g/l

0.45

385

391

Polyneuropathies and other disorders of the peripheral nervous system

1048

2408

4.79

307.65

2.3

2.1

38.85

37.24

g/l

12.87

913

2039

Pain in limb

2072

6032

2.55

304.56

2.1

2.2

37.75

37.65

g/l

0.28

1814

5147

Metabolic disorders

2445

6572

2.37

295.50

2.5

2.0

37.36

38.03

g/l

5.19

2123

5625

Autoimmune diseases excluding thyroid diseases

2641

6496

2.31

292.38

2.0

2.3

37.19

38.06

g/l

8.78

2330

5528

Bacterial Sepsis

1457

4600

2.95

291.01

2.7

2.1

34.97

37.94

g/l

47.88

1234

3865

Autoimmune diseases excluding thyroid diseases, strict definition

2557

6297

2.31

285.14

2.0

2.3

37.21

38.06

g/l

8.06

2256

5353

Acute renal failure

821

2133

4.15

281.32

2.7

2.0

33.92

37.81

g/l

43.87

726

1760

Dialysis, with operation codes

578

1144

5.57

280.56

4.1

1.9

34.64

38.15

g/l

25.16

535

980

Other soft tissue disorders, not elsewhere classified

2293

6154

2.35

273.84

2.3

2.2

37.98

37.69

g/l

1.31

2010

5255

Glomerular diseases

742

1839

4.36

271.38

2.6

2.1

34.38

37.74

g/l

29.26

675

1584

Pneumonias (Asthma/COPD co-morbidities)

2452

7723

2.25

271.28

2.8

1.9

36.25

38.45

g/l

49.58

2153

6604

All pneumoniae

2462

7743

2.24

270.60

2.8

2.0

36.25

38.44

g/l

49.29

2160

6627

Other systemic involvement of connective tissue

974

2912

3.54

269.23

1.8

2.2

36.90

37.71

g/l

3.31

828

2457

Pneumonia, organism unspecified

2267

7329

2.29

264.17

2.8

2.0

36.13

38.40

g/l

49.20

1971

6265

2277

6298

2.32

263.48

2.8

1.9

36.28

38.37

g/l

41.31

1998

5374

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

2277

6298

2.32

263.48

2.8

1.9

36.28

38.37

g/l

41.31

1998

5374

Influenza and pneumonia

2511

7668

2.20

260.21

2.8

1.9

36.34

38.48

g/l

47.18

2196

6577

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

2393

7771

2.21

255.32

2.8

2.0

36.24

38.39

g/l

47.18

2097

6649

Implicit bacterial Sepsis

1279

4191

2.93

254.30

2.7

2.1

34.88

37.83

g/l

41.93

1080

3516

Finngen Rheumatological endpoints

2250

5692

2.30

250.03

2.0

2.3

37.76

38.28

g/l

3.18

1976

4889

Heart failure and antihypertensive medication

800

1385

4.00

235.01

2.0

2.3

35.11

38.83

g/l

38.88

700

1170

Codeine

2181

5389

2.27

232.66

2.1

1.8

38.13

38.01

g/l

0.36

1895

4578

Multiple myeloma

254

262

13.36

231.54

23.8

1.4

37.22

37.00

g/l

0.20

237

219

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

254

262

13.36

231.54

23.8

1.4

37.22

37.00

g/l

0.20

237

219

Gout

945

2796

3.25

223.15

3.0

2.3

36.25

37.33

g/l

5.70

839

2343

Disorders of lipoprotein metabolism and other lipidaemias

2110

6127

2.22

220.15

2.3

2.1

37.47

37.87

g/l

2.04

1823

5226

Nephropathy related operations

525

1190

4.83

216.66

4.3

2.1

34.51

37.75

g/l

20.16

487

1028

Opioids

2189

5418

2.16

205.58

2.4

1.8

37.98

38.02

g/l

0.12

1916

4604

Osteopathies and chondropathies

1460

5932

2.41

200.26

2.9

2.1

37.17

37.74

g/l

2.62

1203

5042

Exposure to unspecified factor

2224

8601

2.05

199.09

2.1

2.2

37.60

37.85

g/l

1.02

1906

7388

Hypertension, essential

1737

4343

2.33

199.08

2.0

2.1

37.49

38.65

g/l

10.40

1527

3735

Glomerular disorders in diseases classified elsewhere

489

1127

4.73

197.52

2.7

2.2

34.31

37.73

g/l

21.82

443

982

Codeine or tramadol medication

2644

7604

1.96

195.03

2.1

38.00

37.71

g/l

1.48

2298

6485

Infections, IBD-co-morbidities

427

576

5.61

194.35

3.5

2.1

36.47

38.20

g/l

4.48

363

504

Heart failure,strict

1499

4641

2.41

193.74

2.0

2.2

35.12

38.16

g/l

58.07

1319

3867

Persons encountering health services for specific procedures and health care

2420

7645

2.00

193.06

2.5

2.0

37.07

38.14

g/l

12.59

2142

6512

Certain infectious and parasitic diseases

2221

5389

2.10

192.08

2.4

1.8

37.11

38.79

g/l

25.57

1945

4575

Other heart diseases

982

2217

2.99

191.20

2.2

1.9

36.96

39.64

g/l

26.08

872

1931

Gout, FINNGEN

945

3392

2.93

190.85

3.0

2.2

36.25

37.44

g/l

7.14

839

2836

Unspecified kidney failure

436

944

5.07

190.69

2.6

2.0

35.22

37.70

g/l

10.87

390

776

Pain in joint

1403

3838

2.48

190.65

2.0

2.1

38.30

37.71

g/l

2.68

1224

3263

Oedema, not elsewhere classified

860

2912

3.05

189.71

2.3

2.0

36.04

38.16

g/l

16.51

746

2432

Hypertensive diseases (excluding secondary)

1081

2236

2.87

188.40

2.1

1.9

37.67

39.62

g/l

16.82

964

1939

Autoimmune diseases related-to ILD

1969

8505

2.08

188.30

2.0

2.2

37.04

38.00

g/l

8.18

1721

7259

Reimbursement for rheumatic diseases

1479

6561

2.31

187.54

1.7

2.3

36.90

37.97

g/l

8.67

1314

5550

Pure hypercholesterolaemia

1840

5824

2.17

185.37

2.3

2.1

37.32

37.74

g/l

1.92

1584

4949

Other and unspecified iron deficiency

947

3456

2.85

184.28

1.9

2.2

36.26

37.66

g/l

8.65

792

2906

Diseases of arteries, arterioles and capillaries (FINNGEN)

691

1379

3.64

183.43

2.2

2.0

35.94

39.33

g/l

28.04

618

1184

Nutritional anaemias

1322

5537

2.40

180.50

2.0

2.2

36.29

37.50

g/l

9.11

1102

4673

Abnormal findings on examination of blood, without diagnosis

1303

5217

2.42

179.44

2.6

2.2

36.62

37.51

g/l

5.27

1125

4468

Iron deficiency anaemia

1142

4585

2.55

178.97

1.9

2.2

36.21

37.65

g/l

10.85

944

3846

Asthma, unspecified (mode), excluding more controls

1166

3665

2.56

176.88

2.1

1.9

37.42

38.76

g/l

11.21

1021

3118

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

395

842

5.23

176.87

3.4

2.1

35.53

37.37

g/l

5.93

326

711

Cardiovascular diseases (excluding rheumatic etc)

1144

2504

2.68

176.87

2.1

1.9

37.83

39.76

g/l

16.96

1021

2179

Hypertensive diseases

1692

4385

2.23

174.54

2.0

2.1

37.51

38.68

g/l

10.34

1502

3768

Ulcer of lower limb, not elsewhere classified

556

1540

3.90

174.47

2.2

33.87

37.55

g/l

27.43

495

1286

Diverticular disease of intestine

1841

5909

2.12

174.08

2.4

2.2

37.39

37.66

g/l

1.02

1572

5054

Hypertension

1688

4383

2.22

173.24

2.0

2.1

37.52

38.68

g/l

10.23

1498

3766

Other diseases of blood and blood-forming organs, wide

711

2303

3.26

172.60

3.1

2.1

37.62

37.68

g/l

0.08

637

1971

Any gastric operation

1644

3721

2.25

169.14

2.1

1.8

37.84

38.56

g/l

3.95

1435

3183

GASTRO-related operations

1644

3721

2.25

169.14

2.1

1.8

37.84

38.56

g/l

3.95

1435

3183

Asthma, excluding more controls

1600

3898

2.23

162.87

2.0

1.8

37.82

38.82

g/l

8.37

1420

3333

Other specific joint derangements/joint disorders

1539

4764

2.21

162.66

1.9

2.2

38.36

38.08

g/l

0.95

1336

4113

Dental caries

697

2287

3.13

161.09

3.2

2.1

35.70

37.91

g/l

13.27

610

1969

Benign neoplasm of colon, rectum, anus and anal canal

1383

4432

2.29

160.36

2.3

1.4

37.27

37.76

g/l

2.00

1165

3754

Care involving dialysis

350

730

5.28

160.28

2.5

2.0

34.41

38.19

g/l

17.99

320

642

Dyspnoea

2051

8238

1.94

158.66

2.3

2.2

36.92

37.88

g/l

9.69

1769

7029

Explicit Sepsis

1106

4475

2.44

157.47

2.7

2.1

34.78

37.98

g/l

41.90

953

3769

Other arthritis (FG)

770

2733

2.91

157.34

2.1

2.5

37.01

38.25

g/l

6.64

683

2329

Asthma, unspecified (mode)

1195

4057

2.39

157.08

2.1

1.9

37.38

38.44

g/l

7.60

1042

3447

Fall on same level

2451

7456

1.86

156.95

2.2

37.40

38.08

g/l

5.24

2043

6548

Septicaemia

1078

4337

2.47

156.71

2.7

2.0

34.73

38.20

g/l

47.89

927

3621

Abnormalities of breathing

1890

5652

2.02

154.82

2.2

2.1

37.38

38.02

g/l

4.02

1639

4857

Heart failure, strict

1598

5567

2.13

154.29

1.9

2.3

35.09

37.72

g/l

47.59

1399

4637

Autoimmune diseases

2372

6517

1.89

154.03

2.0

2.3

37.53

38.06

g/l

3.34

2077

5546

Asthma

1682

4325

2.12

152.65

2.0

1.8

37.77

38.50

g/l

5.01

1487

3697

Medical observation and evaluation for suspected diseases and conditions

1562

3713

2.19

151.71

2.2

2.1

37.89

37.56

g/l

1.08

1315

3237

Used for control exclusion in common control thyroid runs

2238

6021

1.91

151.10

2.0

2.3

37.63

38.06

g/l

2.19

1960

5125

Diseases of oesophagus, stomach and duodenum

2335

7758

1.86

150.73

2.0

2.2

37.59

37.88

g/l

1.29

1973

6692

Osteoporosis

799

2841

2.82

148.70

2.2

2.1

37.33

37.08

g/l

0.47

621

2359

Acute tubulo-interstitial nephritis

1390

5840

2.16

146.93

2.0

2.1

36.00

38.18

g/l

27.72

1175

4898

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

321

441

5.63

146.28

2.4

2.1

36.11

37.86

g/l

3.71

292

377

Cerebrovascular diseases (FINNGEN)

718

1751

3.02

144.52

2.5

2.0

36.97

39.43

g/l

18.11

627

1507

Benign neoplasm: Colon

1236

4267

2.29

144.46

2.2

1.4

37.33

37.68

g/l

1.07

1031

3607

Dentinal caries

620

2047

3.13

143.24

3.2

2.1

35.55

37.92

g/l

13.44

539

1771

Cardiovascular diseases

972

2038

2.63

143.22

2.2

1.7

38.09

39.87

g/l

12.52

877

1786

Erysipelas

1330

5730

2.17

142.91

2.0

35.64

38.34

g/l

41.09

1159

4841

All-cause Heart Failure

1546

5483

2.09

142.82

1.9

2.3

35.11

37.70

g/l

45.50

1354

4563

Gout, idiopatic and unspecified

782

2966

2.77

142.48

2.1

2.3

36.14

37.41

g/l

6.75

692

2504

Asthma (mode)

1626

4357

2.08

141.96

2.0

1.8

37.87

38.50

g/l

3.83

1442

3726

Pain in throat and chest

1776

5575

1.98

138.54

2.2

2.1

37.92

37.97

g/l

0.13

1548

4785

Asthma (only as main-diagnosis), excluding more controls

1396

3898

2.17

137.88

2.0

1.8

37.72

38.82

g/l

9.09

1234

3333

Polymyalgia rheumatica

498

1501

3.57

137.35

1.7

2.2

35.66

37.23

g/l

5.50

405

1238

Other specified/unspecified arthritis

689

2497

2.86

135.62

2.1

2.3

37.10

37.96

g/l

3.24

606

2120

L04AA Selective immunosuppressants

599

2026

3.09

134.43

1.8

2.1

36.25

38.03

g/l

8.74

554

1756

Other heart diseases, wide

1845

6042

1.92

133.29

2.3

2.1

37.13

38.71

g/l

19.93

1618

5198

Continuous positive airway pressure

546

1487

3.30

132.54

2.3

35.89

38.72

g/l

17.94

462

1297

Disturbances of skin sensation

667

2409

2.86

132.14

1.8

2.1

39.84

37.96

g/l

14.36

595

2099

Disorders resulting from impaired renal tubular function

201

309

7.56

128.62

2.4

2.6

36.43

37.73

g/l

1.98

189

272

Other diseases of intestines

2139

6933

1.82

128.26

2.2

2.1

37.79

37.98

g/l

0.67

1843

5976

Diseases of the skin and subcutaneous tissue

2139

5928

1.83

127.23

2.2

2.1

37.57

38.05

g/l

2.63

1862

5046

Other septicaemia

932

3946

2.39

127.03

2.4

2.0

34.52

38.15

g/l

45.25

801

3284

Abnormalities of gait and mobility

438

1279

3.68

126.93

1.9

2.2

38.38

37.24

g/l

3.60

397

1087

Symptoms and signs involving cognition, perception, emotional state and behaviour

2074

8166

1.81

126.75

1.9

2.2

37.77

37.74

g/l

0.06

1749

7041

Complications of surgical and medical care, not elsewhere classified

2108

8553

1.80

126.43

2.2

37.18

37.86

g/l

4.96

1813

7313

L04AD Calcineurin inhibitors

351

880

4.26

126.24

2.4

35.81

38.20

g/l

8.31

335

770

Symptoms and signs involving the skin and subcutaneous tissue

1517

7879

1.96

125.08

2.1

2.2

38.57

37.64

g/l

7.67

1325

6703

Other disorders of skin and subcutaneous tissue

1587

7676

1.94

124.87

2.1

2.2

36.26

37.79

g/l

16.85

1367

6509

Gout, unspecified

641

2352

2.87

124.78

2.1

2.3

36.18

37.42

g/l

5.63

576

1973

Coagulation defects, purpura and other haemorrhagic conditions

550

1856

3.10

124.16

2.4

2.1

37.27

37.60

g/l

0.59

487

1594

Diseases of arteries, arterioles and capillaries

1647

6507

1.93

124.01

2.0

2.3

36.04

37.61

g/l

17.99

1433

5475

Neurological diseases, wide definition

504

697

3.69

123.06

2.2

2.0

38.54

38.52

g/l

0.02

446

606

Asthma (only as main-diagnosis)

1441

4325

2.04

122.46

2.0

1.8

37.63

38.50

g/l

6.00

1269

3697

Gout, strict definition

582

2058

3.00

121.71

2.0

2.3

35.75

37.39

g/l

8.12

515

1727

Low back pain

1538

6166

1.95

121.63

2.5

2.0

37.89

37.67

g/l

0.67

1335

5267

Syncope and collapse

998

3986

2.27

119.62

2.3

2.0

37.06

38.19

g/l

6.41

827

3340

Disorders of thyroid, IBD co-morbidities

346

596

4.34

119.49

1.9

2.1

37.85

38.44

g/l

0.89

301

516

Glomerulonephritis

356

941

4.05

119.25

2.8

2.2

34.43

37.74

g/l

12.73

328

817

Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)

455

1416

3.42

118.75

2.9

1.4

36.47

37.65

g/l

3.16

420

1176

Pain, not elsewhere classified

606

2199

2.84

118.72

2.5

1.9

37.54

38.65

g/l

3.96

532

1865

Diabetic nephropathy, excluding more controls

440

1091

3.56

117.57

1.7

2.0

34.63

37.58

g/l

15.49

392

915

Rheumatoid arthritis

812

3081

2.47

117.29

1.8

2.4

36.72

37.83

g/l

5.74

716

2595

Enlarged lymph nodes

420

1247

3.51

116.97

2.1

2.0

37.51

38.44

g/l

1.99

383

1064

Preparatory care for dialysis

220

409

6.14

115.91

2.1

2.6

35.50

37.69

g/l

4.65

205

359

Transplanted organ and tissue status

337

877

4.11

115.35

4.4

2.0

36.31

38.26

g/l

5.69

316

765

Persons encountering health services for other counselling and medical advice, not elsewhere classified

2319

7793

1.72

114.63

2.1

2.2

37.73

37.80

g/l

0.19

2068

6602

Covid-19 confirmed case

715

2874

2.57

114.55

2.8

2.0

35.67

37.82

g/l

13.57

610

2460

Benign neoplasm of colon, rectum, anus and anal canal

1500

7246

1.91

113.35

2.3

37.33

37.41

g/l

0.17

1268

6139

Spondylopathies

1778

5938

1.85

113.24

2.4

2.1

37.84

37.51

g/l

1.35

1548

5054

Heart failure and bmi 25plus

909

2727

2.38

112.92

1.9

2.4

35.28

37.63

g/l

22.36

792

2238

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

668

1195

2.84

110.20

2.2

1.7

37.91

38.85

g/l

2.74

598

1031

Persons encountering health services in other circumstances, wide

2501

7849

1.67

109.88

2.1

2.2

37.65

37.78

g/l

0.42

2219

6641

Codes for special purposes

950

4392

2.21

109.50

2.8

2.1

36.27

38.12

g/l

13.84

815

3775

Headache

1178

4871

2.05

109.22

2.1

1.9

38.60

38.65

g/l

0.09

1023

4143

Provisional assignment of new diseases of uncertain etiology

948

4384

2.21

109.19

2.8

2.0

36.26

38.12

g/l

13.84

814

3769

Type 2 diabetes, wide definition

1822

6705

1.80

108.35

1.9

2.4

36.47

37.97

g/l

18.41

1571

5704

Dorsalgia

2016

6272

1.76

107.72

2.3

2.0

38.10

37.65

g/l

2.36

1756

5356

Other necrotizing vasculopathies (FG)

236

500

5.14

105.94

1.5

2.6

33.44

37.99

g/l

16.01

205

422

Asthma (diagnoses ohter than nonallergic)

1773

8700

1.77

104.65

2.0

2.2

37.59

37.81

g/l

0.85

1553

7404

COPD/asthma/ILD related infections

2145

6300

1.73

104.58

2.8

1.9

37.01

38.37

g/l

17.84

1887

5376

COPD/asthma related infections

2145

6300

1.73

104.58

2.8

1.9

37.01

38.37

g/l

17.84

1887

5376

Hypertensive heart and/or renal disease

695

2175

2.56

104.53

1.9

2.2

36.05

37.83

g/l

9.90

611

1797

Other pulmonary diagnosis

1616

4368

1.88

103.63

2.4

1.8

37.48

38.50

g/l

7.92

1427

3735

Atrial fibrillation and flutter

662

1671

2.65

102.99

2.6

2.0

36.44

39.35

g/l

21.79

589

1434

Parasetamol

1516

4148

1.89

99.57

2.1

2.0

37.61

38.28

g/l

3.30

1315

3627

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)

166

275

7.08

99.17

2.1

1.3

39.24

37.30

g/l

3.07

156

227

Chronic lymphocytic leukaemia, helper endpoint

166

275

7.08

99.17

2.1

1.3

39.24

37.30

g/l

3.07

156

227

Nephrotic syndrome

157

244

7.29

98.92

2.5

2.8

31.96

38.16

g/l

13.70

149

212

Diaphragmatic hernia

921

4399

2.16

98.50

2.3

2.1

37.03

37.46

g/l

1.24

781

3716

Other disorders of fluid, electrolyte and acid-base balance

744

3137

2.36

98.26

2.5

2.0

35.53

37.45

g/l

11.70

633

2614

Excluding asthma or asthma-COPD overlap

1592

4368

1.85

97.50

2.3

1.8

37.47

38.50

g/l

7.98

1409

3735

Antihypertensive medication - note that there are other indications

923

2286

2.24

96.74

1.9

2.0

38.21

39.52

g/l

6.98

825

1977

Oxycodone

828

3681

2.23

96.69

4.6

2.0

35.93

37.47

g/l

9.30

702

3077

Viral Sepsis

512

1904

2.80

96.51

3.1

2.0

35.50

37.97

g/l

12.29

434

1603

Symptoms and signs involving the urinary system

1677

7468

1.77

96.30

2.1

2.2

37.25

37.65

g/l

1.74

1409

6375

Depression medications

409

584

3.57

96.12

1.6

1.3

38.78

40.25

g/l

3.85

378

514

Lower back pain or/and sciatica

2071

8714

1.67

95.96

2.4

2.1

37.87

37.76

g/l

0.36

1803

7450

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

784

2146

2.35

95.81

2.0

37.27

39.57

g/l

17.96

700

1864

Implicit viral Sepsis

510

1901

2.79

95.70

3.1

2.0

35.47

37.97

g/l

12.53

432

1601

Seropositive rheumatoid arthritis

610

2472

2.54

95.49

1.8

2.5

36.65

38.01

g/l

6.55

538

2063

Any reimbursement code in KELA

927

2097

2.24

95.31

2.3

1.5

38.07

39.66

g/l

9.99

842

1772

Other and unspecified dermatitis

1088

5581

1.99

94.80

2.0

2.2

37.78

37.74

g/l

0.09

948

4740

Adjustment and management of implanted device

559

2197

2.66

94.79

2.5

2.0

36.60

37.47

g/l

2.64

500

1798

COPD differential diagnosis

1577

4357

1.84

94.49

2.3

1.8

37.44

38.50

g/l

8.23

1399

3726

ILD differential diagnosis

1577

4357

1.84

94.48

2.3

1.8

37.44

38.50

g/l

8.23

1399

3726

Symptoms and signs involving the circulatory and respiratory systems

1928

5664

1.73

94.21

2.2

2.1

37.96

38.02

g/l

0.17

1691

4868

Asthma, hospital admission 2, infections

1209

6332

1.91

93.72

2.3

2.1

36.95

37.72

g/l

4.29

1066

5343

Asthma-related infections

1209

6332

1.91

93.72

2.3

2.1

36.95

37.72

g/l

4.29

1066

5343

Bleeding

1794

7701

1.72

93.44

2.2

36.38

37.81

g/l

16.81

1544

6547

Endocrine, nutritional and metabolic diseases

1454

3995

1.87

93.32

2.0

2.1

37.70

38.60

g/l

5.34

1277

3465

Other CVD (FINNGEN)

326

719

3.74

93.13

2.7

2.1

36.21

39.17

g/l

12.85

270

600

Chronic periodontitis

428

1479

3.03

92.90

3.1

2.0

36.04

37.65

g/l

5.50

382

1283

Other necrotizing vasculopathies

271

708

4.15

92.88

1.7

2.5

33.60

37.64

g/l

15.32

236

604

Benign neoplasm: Colon

1263

6723

1.89

92.47

2.3

2.2

37.36

37.34

g/l

0.03

1055

5716

Malignant immunoproliferative diseases

15.36

92.41

10.7

1.2

37.48

38.04

g/l

0.29

Symptoms and signs concerning food and fluid intake

294

809

3.82

92.23

2.0

2.1

38.15

38.02

g/l

0.12

255

676

Dermatitis and eczema

2150

8708

1.64

91.65

2.0

2.2

38.08

37.70

g/l

2.03

1872

7444

Other disorders of white blood cells

219

493

4.85

91.49

1.9

2.4

37.97

37.38

g/l

0.57

192

430

Small fibre neuropathy

153

253

7.05

91.47

2.2

2.5

38.88

36.84

g/l

2.91

130

214

Soft tissue disorders

1997

6205

1.69

91.44

2.3

2.2

38.19

37.69

g/l

2.66

1739

5294

Non-follicular lymphoma, hilmo, excluding all cancers

328

983

3.57

91.36

2.7

1.4

36.48

37.71

g/l

2.66

305

820

Lymphoid leukaemia

225

519

4.75

91.26

2.8

1.4

38.60

37.67

g/l

1.25

210

434

Other dorsopathies, not elsewhere classified

1988

6278

1.69

91.19

2.1

2.0

38.24

37.65

g/l

3.66

1715

5362

Chronic gastritis

746

3385

2.28

91.04

2.1

2.3

37.10

37.31

g/l

0.41

624

2862

Diseases of the musculoskeletal system and connective tissue

946

2208

2.18

90.70

2.2

2.1

38.07

38.14

g/l

0.12

837

1898

Constipation

1839

7891

1.69

90.17

2.6

2.1

37.70

37.61

g/l

0.23

1527

6784

Osteoporosis with pathological fracture (FG)

241

592

4.40

89.72

1.7

2.2

37.58

37.61

g/l

0.02

184

470

Chronic lymphocytic leukaemia

166

304

6.38

89.56

2.1

2.4

39.24

36.74

g/l

4.71

156

257

345

1072

3.35

89.55

2.2

37.15

38.07

g/l

1.62

308

922

Pain (limb, back, neck, head abdominally)

1480

4102

1.83

87.92

2.1

37.85

37.63

g/l

0.61

1286

3466

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

1427

7547

1.79

87.64

2.3

2.2

36.90

37.58

g/l

3.91

1243

6375

Parodontitis or operation codes

1867

8352

1.67

87.36

2.2

37.44

37.80

g/l

1.58

1593

7181

Non-ischemic cardiomyopathy

801

3076

2.21

87.34

2.0

2.2

34.98

37.75

g/l

25.04

691

2528

Parodontitis

1865

8353

1.67

87.15

2.2

37.44

37.80

g/l

1.59

1591

7183

Purpura and other haemorrhagic conditions

384

1296

3.11

87.05

2.4

2.2

37.43

37.55

g/l

0.14

338

1118

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma, excluding all cancers (controls excluding all cancers)

17.91

86.65

11.9

1.1

37.93

37.88

g/l

0.02

Chronic periodontitis, including avohilmo

1856

8353

1.67

86.43

2.2

37.45

37.80

g/l

1.52

1581

7184

Cardiomyopathy

479

1831

2.72

85.63

2.6

2.2

35.96

38.25

g/l

11.02

421

1527

Cardiac arrhythmias

1089

3716

1.96

85.43

2.3

2.1

37.40

39.07

g/l

14.05

962

3234

Disorders of mineral metabolism

265

720

3.92

85.39

3.7

2.0

36.44

37.90

g/l

2.47

217

622

Dermatitis

1243

6921

1.83

83.80

2.0

2.2

37.86

37.69

g/l

0.45

1075

5894

Neoplasms

1280

3701

1.87

83.56

2.6

1.2

38.22

38.20

g/l

0.02

1141

3188

Valvular heart disease excluding rheumatic fever

1061

4044

1.96

83.26

2.3

2.2

36.66

38.35

g/l

15.59

910

3411

Other antidepressants

2091

6781

1.63

82.86

2.1

2.2

38.01

37.64

g/l

1.75

1779

5839

Asthma, hospital admissions 3, pneumonia

832

4072

2.09

82.81

2.3

2.1

36.14

37.39

g/l

7.31

740

3376

Asthma-related pneumonia or sepsis

832

4072

2.09

82.81

2.3

2.1

36.14

37.39

g/l

7.31

740

3376

Diseases of pulp and periapical tissues

739

3460

2.18

82.76

3.1

2.0

36.61

37.81

g/l

4.89

636

2983

Lymphoid leukaemia

225

560

4.39

82.70

2.8

2.4

38.60

37.30

g/l

2.19

210

484

Diabetic nephropathy

443

1640

2.80

82.61

1.7

2.0

34.59

37.02

g/l

12.18

394

1398

Non-follicular lymphoma

328

1047

3.35

82.56

2.7

2.3

36.48

37.47

g/l

1.89

305

900

Asthma-related pneumonia

829

4063

2.09

82.21

2.3

2.1

36.14

37.38

g/l

7.22

737

3367

Non-rheumatic valve diseases

1055

4036

1.95

81.65

2.3

2.2

36.67

38.34

g/l

15.21

904

3404

Secondary hypertension

213

504

4.39

81.15

2.3

1.9

36.42

39.52

g/l

8.69

195

421

Atrial fibrillation and flutter with reimbursement

562

1450

2.55

80.62

2.7

2.1

35.95

39.23

g/l

22.79

493

1245

Follow-up examination after treatment for conditions other than malignant neoplasms

923

3007

2.04

80.50

2.1

37.82

37.65

g/l

0.33

809

2622

Arthropathies

1658

4965

1.72

80.24

1.9

2.2

38.06

38.01

g/l

0.09

1455

4265

Rheumatoid arthritis, including avohilmo

890

4524

2.02

80.11

1.8

2.2

36.86

37.64

g/l

3.50

781

3812

Gingivitis and periodontal diseases

1844

5780

1.67

80.00

2.3

2.0

37.78

37.56

g/l

0.75

1580

4921

Chronic lower respiratory diseases

2312

8051

1.57

79.66

2.0

2.2

37.45

37.96

g/l

3.51

2039

6862

Disorders of calcium metabolism

223

565

4.25

79.64

4.1

2.0

36.15

37.67

g/l

2.24

181

488

Hyperlipidaemia, other/unspecified

904

4373

2.01

79.38

2.4

2.1

37.14

37.46

g/l

0.85

770

3688

Haemorrhage from respiratory passages

800

3628

2.10

79.17

2.2

36.53

37.38

g/l

3.40

694

3046

Malignant immunoproliferative diseases

103

12.15

79.02

10.7

1.8

37.48

36.72

g/l

0.45

Complications of medical and surgical care

1495

8448

1.71

78.97

2.3

2.2

37.12

37.76

g/l

3.39

1294

7189

Complications of procedures, not elsewhere classified

1597

8328

1.68

78.72

2.0

2.2

37.26

37.84

g/l

3.02

1383

7118

Symptoms and signs involving the nervous and musculoskeletal systems

1200

6739

1.81

78.65

2.0

2.2

38.69

37.52

g/l

9.60

1059

5718

Diarrhoea and gastroenteritis of presumed infectious origin

1352

7106

1.75

78.50

2.6

2.0

36.92

37.94

g/l

7.31

1176

6047

Genitourinary diseases

1109

2905

1.94

78.43

2.0

2.1

37.53

38.58

g/l

5.13

992

2527

ILD medications: azathioprine

313

993

3.25

78.22

1.7

1.5

36.58

38.68

g/l

6.04

280

853

Fracture of lumbar spine and pelvis

566

2458

2.38

76.70

2.2

2.1

36.32

37.14

g/l

2.06

421

2035

Extracorporeal dialysis

217

556

4.22

76.46

2.5

2.4

33.91

37.76

g/l

11.31

194

488

Other diseases of urinary system

2002

7097

1.61

76.42

2.2

37.30

37.93

g/l

4.15

1715

6100

Other external causes of accidental injury

1616

4795

1.71

76.15

2.1

2.2

37.66

38.08

g/l

1.72

1376

4214

Intestinal infectious diseases

1789

8679

1.62

76.02

2.6

2.0

36.90

37.97

g/l

9.96

1553

7414

Parodontitis and operation codes

1727

8311

1.64

75.75

2.1

2.2

37.58

37.77

g/l

0.59

1470

7163

Chronic periapical parodontitis

491

2014

2.52

75.56

3.8

2.1

36.34

37.78

g/l

4.48

425

1740

Other and unspecified diseases of blood and blood-forming organs

132

228

6.62

75.29

5.2

2.6

37.91

37.49

g/l

0.29

123

202

Other and unspecified disorders of white blood cells

172

375

5.06

75.05

1.8

2.5

38.40

37.46

g/l

0.90

155

325

Hypothyroidism (congenital or acquired)

325

560

3.38

74.47

2.3

1.3

38.15

40.17

g/l

5.28

297

495

Accidents

1608

4795

1.70

74.42

2.1

2.2

37.61

38.08

g/l

2.06

1373

4214

Spinal stenosis

1159

5080

1.82

74.28

2.1

37.76

37.25

g/l

2.08

982

4275

Hypothyroidism and >3 levothyroxin purchases

324

560

3.37

74.07

2.3

1.3

38.31

40.17

g/l

4.71

296

495

Hypothyroidism, levothyroxine purchases

324

560

3.37

74.07

2.3

1.3

38.31

40.17

g/l

4.71

296

495

Falls/tendency to fall

2060

6556

1.59

73.70

2.1

2.2

37.62

38.10

g/l

2.56

1735

5768

Diseases of liver

759

3760

2.07

73.54

1.8

2.3

36.56

37.88

g/l

6.20

635

3249

Neurological diseases

1611

4850

1.69

73.41

2.0

2.2

38.50

37.43

g/l

8.47

1385

4196

Disorders of other endocrine glands

877

4485

1.96

73.40

2.5

2.1

37.42

37.74

g/l

0.81

757

3798

Injuries to the abdomen, lower back, lumbar spine and pelvis

838

4271

1.99

73.14

2.3

2.1

36.94

37.58

g/l

2.02

661

3622

Hypothyroidism, drug reimbursement

232

420

4.03

72.97

2.2

1.3

38.16

39.89

g/l

3.67

209

367

STROKE

1197

4679

1.81

72.86

2.5

2.3

37.08

38.27

g/l

8.65

1029

3992

838

4279

1.98

72.16

2.4

2.1

37.33

37.91

g/l

1.95

742

3620

Use of hypnotics and sedatives

2083

7783

1.56

71.86

2.3

2.2

37.66

37.83

g/l

0.52

1786

6697

Other disorders of urethra and urinary system

1357

5986

1.72

71.69

2.0

2.2

36.98

37.85

g/l

5.64

1170

5097

Amyloidosis, other/unspecified

107

160

7.97

70.78

8.3

2.1

35.97

37.21

g/l

0.91

137

Hypertensive Renal Disease

149

302

5.40

70.69

1.7

2.5

36.89

37.58

g/l

0.61

138

253

Statin medication

1258

4010

1.78

70.52

2.1

2.3

37.65

38.46

g/l

4.16

1116

3405

Asthma, including avohilmo

2229

8537

1.53

70.26

2.0

2.2

37.68

37.81

g/l

0.47

1960

7275

Cerebrovascular diseases

1604

7101

1.65

70.21

2.3

36.69

37.58

g/l

6.55

1340

6072

Need for other prophylactic measures

191

476

4.32

69.77

2.3

2.4

37.30

37.68

g/l

0.32

182

421

Diseases of oral cavity, salivary glands and jaws

1812

5820

1.61

69.56

2.2

2.0

37.77

37.54

g/l

0.78

1549

4951

Disorders of parathyroid gland

541

2379

2.33

69.23

2.4

2.1

37.39

37.24

g/l

0.23

457

1966

Other joint disorders

1543

4963

1.67

68.72

1.9

2.2

38.43

38.01

g/l

1.67

1344

4263

Dizziness and giddiness

1488

7397

1.66

68.69

2.0

2.3

37.86

37.62

g/l

0.78

1267

6334

Sulfasalazine

574

2622

2.24

68.49

1.7

2.3

37.45

38.31

g/l

2.75

507

2237

Other disorders of kidney and ureter

363

1356

2.81

68.44

2.5

2.2

37.01

37.52

g/l

0.93

337

1159

Sicca syndrome [Sjögren]

263

823

3.38

68.18

1.7

2.4

38.45

38.01

g/l

0.62

225

699

Infections of the skin and subcutaneous tissue

1068

6020

1.79

68.05

2.4

2.1

36.67

38.09

g/l

10.15

944

5188

Hypertensive Heart Disease

560

2053

2.30

67.66

2.0

2.2

35.85

37.82

g/l

9.97

482

1696

Injuries to the head

2050

8758

1.54

67.65

2.1

2.2

37.18

37.93

g/l

5.49

1723

7554

Dorsopathies

1926

6284

1.58

67.59

2.2

2.0

38.32

37.66

g/l

4.41

1668

5366

Venous thromboembolism

1183

6712

1.74

67.48

2.5

2.2

36.39

37.52

g/l

8.03

1022

5647

Benign neoplasms

1279

4189

1.75

67.39

2.1

1.4

37.99

38.25

g/l

0.70

1116

3619

Spondylosis

1121

5510

1.78

67.07

2.1

38.18

37.44

g/l

3.97

976

4687

Gastrointestinal diseases

1027

2769

1.88

66.56

2.3

1.9

37.82

38.36

g/l

1.70

904

2419

Bacterial pneumoniae

877

4148

1.91

66.52

3.3

1.9

36.00

38.19

g/l

20.73

797

3495

Amyloidosis

114

194

6.78

66.20

8.0

2.2

36.07

37.03

g/l

0.68

105

170

Unspecified privation

295

1004

3.08

66.00

1.9

2.1

36.05

37.71

g/l

3.98

262

871

Speech therapy

633

3060

2.13

65.80

2.3

2.1

37.14

37.68

g/l

1.45

588

2585

Kidney transplant status

170

407

4.48

65.46

1.7

2.4

35.27

38.61

g/l

7.81

162

360

Exposure to other specified factors

1334

7584

1.67

65.46

2.0

2.2

37.50

38.01

g/l

2.05

1125

6587

Care involving use of rehabilitation procedures

1225

6903

1.71

65.43

2.3

2.0

37.50

38.03

g/l

2.29

1119

5853

Bacterial pneumonia, not elsewhere classified

842

3951

1.92

65.41

3.3

1.9

35.96

38.16

g/l

20.08

773

3327

Certain disorders involving the immune mechanism

454

1928

2.43

64.92

2.8

2.1

37.96

37.86

g/l

0.13

415

1665

Azathioprine

313

1108

2.91

64.64

1.7

2.2

36.58

38.47

g/l

5.12

280

959

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

1795

7867

1.57

64.55

2.6

2.1

37.19

37.95

g/l

5.51

1534

6815

Other disorders of veins

826

4401

1.92

64.47

2.2

37.24

37.97

g/l

2.72

705

3742

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

1660

6180

1.61

64.31

3.6

1.4

37.84

38.00

g/l

0.47

1467

5291

Malignant neoplasm, wide definition for exclusion

1660

6180

1.61

64.30

3.6

1.4

37.84

38.00

g/l

0.47

1467

5291

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

1660

6180

1.61

64.30

3.6

1.4

37.84

38.00

g/l

0.47

1467

5291

Cystitis

1616

6203

1.61

63.85

2.1

2.2

37.53

37.91

g/l

1.53

1365

5292

Chronic rhinitis, nasopharyngitis and pharyngitis

644

3168

2.08

63.46

1.9

2.2

38.31

37.93

g/l

0.89

554

2737

Glucagon-like peptide-1 (GLP-1) analogues

1243

6120

1.70

63.42

2.1

2.4

36.55

37.55

g/l

6.72

1063

5177

Benign neoplasms

1802

6462

1.57

63.29

2.3

2.1

37.83

37.82

g/l

0.01

1557

5585

SLE (Finngen)

129

254

5.51

63.12

1.8

2.1

35.67

38.47

g/l

4.06

118

225

Disorders of eyelid, lacrimal system and orbit

1658

8340

1.58

62.86

2.4

2.1

38.08

37.57

g/l

2.87

1400

7130

Other diseases of blood and blood-forming organs

218

641

3.62

62.62

4.3

2.3

38.32

37.67

g/l

0.82

195

560

Other diseases of pleura

1026

5212

1.78

62.05

2.3

2.2

35.84

37.36

g/l

11.37

891

4385

Mixed connective tissue disease

205

586

3.72

61.45

1.7

2.4

37.11

37.98

g/l

1.09

187

509

Persons encountering health services for examination and investigation

1261

3713

1.72

61.45

2.0

2.1

37.89

37.56

g/l

0.92

1084

3237

Cough

795

4070

1.91

61.27

2.3

2.1

37.91

37.83

g/l

0.13

683

3448

Diseases of the eye and adnexa

1405

4265

1.67

60.86

2.1

2.0

38.26

38.09

g/l

0.41

1227

3749

Isolated proteinuria

120

230

5.76

60.83

3.1

2.7

35.73

37.89

g/l

2.75

111

197

Viral hepatitis, IBD co-morbidity

104

171

6.29

60.75

1.5

1.7

37.85

38.76

g/l

0.51

153

Seronegative rheumatoid arthritis

283

988

2.97

60.27

2.0

2.7

36.78

37.96

g/l

2.46

250

834

Peripheral artery disease

1030

4782

1.77

60.06

1.9

2.3

35.22

37.32

g/l

19.85

902

3990

Persons encountering health services for specific procedures, not carried out

202

582

3.64

59.45

2.2

2.0

38.13

38.48

g/l

0.35

184

512

Other specified/unspecified systemic involvement of connective tissue

184

501

3.91

59.27

1.8

2.6

37.42

38.13

g/l

0.75

172

433

Injuries to the hip and thigh

992

5241

1.76

58.68

2.0

2.2

36.59

37.39

g/l

3.20

754

4447

Abnormal findings on diagnostic imaging of lung

1052

6033

1.73

58.61

2.3

36.55

37.43

g/l

4.60

908

5098

Explicit bacterial Sepsis

267

921

3.02

58.26

3.6

2.0

35.44

38.18

g/l

8.43

230

792

Thrombocytopenia, unspecified

216

661

3.47

58.24

2.0

2.4

37.01

37.58

g/l

0.60

186

576

DVT of lower extremities and pulmonary embolism

920

5222

1.79

58.02

2.5

2.2

36.48

37.43

g/l

4.70

790

4390

Benign neoplasm: Colon, unspecified

561

2706

2.12

58.01

2.3

1.4

37.63

37.53

g/l

0.15

454

2274

COPD (mode)

675

2731

2.01

57.90

1.9

35.54

38.02

g/l

19.82

580

2277

2165

7776

1.48

57.67

2.9

1.9

37.45

37.89

g/l

2.49

1886

6617

Malignant neoplasm

1678

6451

1.56

57.62

3.8

1.4

37.93

g/l

0.01

1471

5529

Pruritus

279

994

2.92

57.41

1.9

2.3

38.78

37.66

g/l

2.54

248

853

Hernia

1775

7954

1.53

57.31

2.4

2.1

37.60

37.78

g/l

0.54

1515

6790

Intracranial trauma

949

4022

1.78

57.06

2.2

2.1

37.71

37.64

g/l

0.11

796

3487

Acquired haemolytic anaemia

113

219

5.81

56.94

4.0

2.2

38.08

37.57

g/l

0.35

103

187

Weight loss

270

954

2.97

56.69

2.2

38.06

37.57

g/l

0.60

234

819

Systemic lupus erythematosus

129

279

5.00

56.63

1.8

1.9

35.67

38.23

g/l

3.50

118

247

Polyuria

533

2561

2.14

56.50

2.0

2.2

37.81

37.48

g/l

0.61

459

2191

Disorders of choroid and retina

1624

7716

1.55

56.46

2.3

2.2

36.92

37.60

g/l

4.40

1354

6591

Streptococcal septicaemia

228

736

3.25

56.04

3.5

2.1

35.23

38.43

g/l

9.39

195

628

Diabetes, varying definitions

1880

7513

1.51

55.83

1.9

2.3

36.93

38.16

g/l

13.28

1611

6426

Idiopathic gout

270

964

2.96

55.83

2.0

2.2

35.75

37.47

g/l

3.85

230

823

Myalgia

439

1958

2.29

55.71

1.8

2.0

38.50

37.76

g/l

1.63

374

1681

Mood disorders, excluding more controls

1761

7078

1.53

55.70

2.0

2.2

38.25

37.78

g/l

2.36

1504

6140

Giant cell arteritis

160

416

4.21

55.66

1.5

2.5

33.24

37.49

g/l

10.80

134

350

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1204

7415

1.64

55.52

2.1

2.2

37.06

37.70

g/l

2.78

1043

6298

Pulmonary heart disease, diseases of pulmonary circulation

724

3890

1.91

55.45

2.4

2.2

36.36

37.37

g/l

4.29

627

3264

Diabetes mellitus

1883

7533

1.51

55.29

1.9

2.3

36.94

38.17

g/l

13.37

1613

6443

Depression or dysthymia

1386

4844

1.62

55.06

2.1

2.2

37.90

37.59

g/l

0.99

1165

4235

Other intervertebral disc disorders

1550

6113

1.57

54.99

2.1

2.0

38.24

37.57

g/l

4.05

1349

5209

Other/unspecified dorsalgia

720

3844

1.90

54.92

2.7

2.0

37.61

37.56

g/l

0.07

619

3245

Disorders of lens

1398

5563

1.61

54.92

2.4

2.3

37.11

37.80

g/l

3.82

1175

4879

Asthma, hospital admissions , main diagnosis only

1499

8714

1.56

54.90

2.0

2.2

37.63

37.84

g/l

0.70

1315

7426

Diseases of the respiratory system

1228

3705

1.68

54.73

2.4

1.9

37.48

38.39

g/l

5.30

1085

3150

Unspecified haematuria

901

4419

1.78

54.44

2.2

2.3

36.83

37.44

g/l

2.15

767

3768

Haemolytic anaemias

130

293

4.83

54.40

3.7

2.0

38.42

37.53

g/l

0.81

118

249

Coxarthrosis [arthrosis of hip](FG)

1053

4519

1.71

54.01

2.0

2.5

37.71

37.91

g/l

0.49

890

3828

Other special examinations and investigations of persons without complaint or reported diagnosis

1216

3713

1.67

53.89

2.1

38.07

37.56

g/l

1.92

1039

3237

Other arthrosis

1013

4265

1.72

53.40

2.1

2.3

38.18

37.80

g/l

1.21

883

3648

Bacterial pneumonia (organism specified)

933

4951

1.75

53.38

3.5

2.0

35.90

37.67

g/l

15.05

850

4134

Other symptoms and signs involving cognitive functions and awareness

936

5129

1.74

53.37

1.9

2.3

37.32

37.29

g/l

0.05

753

4359

Paroxysmal tachycardia

387

1387

2.40

53.26

1.8

2.0

37.46

39.39

g/l

8.10

335

1194

Gonarthrosis [arthrosis of knee](FG)

1384

5146

1.60

53.06

1.9

2.4

37.42

38.06

g/l

3.22

1192

4398

Abnormal weight loss

253

896

2.97

53.02

2.0

2.2

38.22

37.62

g/l

0.77

219

772

Other arrhythmias

1141

5333

1.66

52.90

2.1

2.2

37.54

38.59

g/l

6.80

965

4561

Dialysis

131

303

4.65

52.84

2.3

1.9

34.66

38.80

g/l

8.65

123

268

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

1796

7360

1.51

52.81

1.9

2.3

36.81

38.12

g/l

14.41

1552

6293

Chronic periodontitis, complicated

262

948

2.90

52.70

3.7

2.2

35.88

37.69

g/l

4.64

237

827

Seropositive rheumatoid arthritis, wide

610

3153

1.98

52.65

1.8

2.2

36.65

37.64

g/l

3.93

538

2657

Nerve, nerve root and plexus disorders

1994

8603

1.47

52.50

2.1

2.2

37.93

37.66

g/l

1.11

1723

7347

Other/unspecified seropositive rheumatoid arthritis

605

3122

1.99

52.49

1.8

2.2

36.65

37.66

g/l

4.01

533

2634

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

597

3069

2.00

52.39

1.8

2.2

36.65

37.66

g/l

3.94

526

2589

Gastro-oesophageal reflux disease

1274

7145

1.60

52.18

1.8

2.3

38.04

37.81

g/l

0.63

1035

6175

Benzodiazepine use

1842

8932

1.48

51.60

2.1

2.2

37.81

37.75

g/l

0.14

1532

7702

External causes of morbidity and mortality

1237

3798

1.65

51.55

2.1

37.70

38.13

g/l

1.49

1063

3332

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

1833

8104

1.49

51.54

2.2

36.95

37.87

g/l

7.72

1580

6955

Atherosclerosis, excluding cerebral and coronary sclerosis

958

4528

1.73

51.13

1.9

2.3

35.17

37.27

g/l

18.40

837

3763

Other disorders involving the immune mechanism, not elsewhere classified

114

243

5.10

51.04

2.0

2.6

35.95

37.96

g/l

2.07

105

214

Other cataract

944

4301

1.73

50.86

2.4

2.3

37.15

37.65

g/l

1.77

801

3754

Hyperparathyroidism

454

2113

2.19

50.76

2.6

2.1

37.43

37.18

g/l

0.37

385

1739

Cardiomyopathy, other and unspecified

222

749

3.11

50.67

2.3

2.1

36.75

38.40

g/l

3.48

197

627

Type 2 diabetes

1826

7377

1.48

49.90

1.9

2.3

36.91

38.12

g/l

12.45

1565

6305

Pulmonary embolism

654

3523

1.90

49.77

2.4

2.2

36.31

37.38

g/l

4.27

566

2960

Non-allergic asthma (mode), excluding more controls

374

1621

2.34

49.61

1.8

37.57

38.72

g/l

3.62

328

1354

Other nutritional deficiencies

1094

6630

1.63

49.56

1.9

2.2

36.68

38.25

g/l

13.67

945

5761

Pulmonary heart disease

654

3529

1.90

49.51

2.4

2.2

36.31

37.38

g/l

4.24

566

2965

Injuries to the thorax

894

5287

1.72

49.18

2.3

2.2

37.02

37.61

g/l

1.95

743

4522

Other gastritis (incl. Duodenitis)

516

2580

2.05

49.05

2.2

36.53

37.54

g/l

3.05

434

2206

SLE, strict definition

123

288

4.62

49.00

1.8

35.81

38.31

g/l

3.34

112

253

SLE, ICD10

123

288

4.62

49.00

1.8

35.81

38.31

g/l

3.34

112

253

Fracture of rib(s), sternum and thoracic spine

638

3435

1.90

48.64

2.6

2.2

37.09

37.52

g/l

0.93

530

2922

Vasculitis limited to skin, not elsewhere classified

108

231

5.17

48.43

2.5

2.6

37.15

37.44

g/l

0.17

102

199

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma

16.03

48.06

14.2

1.4

37.75

37.20

g/l

0.23

Obesity related asthma

640

3466

1.88

47.73

1.9

2.3

37.78

37.93

g/l

0.26

548

2989

Arthrosis

1319

4638

1.58

47.32

2.0

2.3

37.85

37.84

g/l

0.03

1144

3968

Other acute lower respiratory infections

986

5753

1.66

47.24

3.1

2.1

36.82

37.65

g/l

3.94

870

4848

Symptoms and signs involving the digestive system and abdomen

1894

6531

1.47

47.10

2.2

2.1

37.84

37.80

g/l

0.09

1642

5573

Temporal arteritis

139

369

4.11

47.03

1.5

2.7

32.89

37.47

g/l

11.08

117

309

Parodontitis or/and operation codes

1151

4267

1.62

46.88

2.1

2.3

37.77

38.19

g/l

1.34

982

3675

Insulin medication

1148

6218

1.60

46.80

2.0

2.3

35.69

37.80

g/l

23.83

989

5294

Acute bronchitis

799

4547

1.75

46.79

3.3

2.0

36.81

37.60

g/l

3.02

710

3801

Any mental disorder

2089

7343

1.44

46.77

2.0

2.2

37.85

37.73

g/l

0.38

1764

6361

Fibromyalgia

184

581

3.28

46.70

2.3

1.8

39.19

38.17

g/l

1.63

165

512

Mood [affective] disorders

1814

8247

1.46

46.61

2.0

2.2

38.30

37.82

g/l

2.49

1555

7095

IgA nephropathy (IgA glomerulonephritis)

184

5.61

46.58

1.8

2.6

35.47

38.32

g/l

3.27

159

Viral pneumonia

277

1094

2.61

46.49

3.1

1.9

35.98

38.31

g/l

6.61

247

922

Diabetes, insulin treatment (Kela reimbursement)

1874

7963

1.45

46.33

1.9

2.3

36.74

38.02

g/l

14.52

1626

6794

Mood disorders

1818

8269

1.46

46.24

2.0

2.2

38.29

37.81

g/l

2.51

1559

7113

Acute myeloid leukaemia and myelodysplastic syndromes, excluding all cancers (controls excluding all cancers)

132

341

4.19

46.24

2.1

1.4

37.11

36.99

g/l

0.07

116

282

Symptoms and signs involving speech and voice

663

3673

1.84

46.06

2.5

2.1

38.09

37.59

g/l

1.45

565

3118

Shoulder lesions

1431

5775

1.53

46.00

2.2

37.92

37.58

g/l

1.20

1231

4929

Anxiety disorders, excluding more controls

1428

6256

1.53

45.95

2.1

2.2

38.85

37.92

g/l

6.96

1245

5442

Direct fill therapy

288

1165

2.55

45.93

3.5

2.1

36.03

37.93

g/l

5.37

257

1022

Vocal cord dysfunction

237

799

2.81

45.93

2.5

2.4

38.00

39.11

g/l

1.73

193

720

ILD, hospital admission 2, with pulmonary infections

252

960

2.74

45.86

2.3

1.8

35.61

37.99

g/l

6.79

227

794

Sciatica+with lumbago

909

5207

1.68

45.85

2.0

2.1

38.00

37.73

g/l

0.70

804

4456

Diabetes medication

1854

7825

1.45

45.83

1.9

2.3

36.89

38.10

g/l

12.87

1584

6690

Factors influencing health status and contact with health services

616

1592

1.97

45.76

2.3

1.8

37.66

37.70

g/l

0.06

540

1385

Dental pulpitis 2

1425

4773

1.55

45.66

2.1

2.2

37.38

37.46

g/l

0.17

1207

4043

Dental caries 1

1565

5340

1.51

45.61

2.0

2.2

37.48

37.51

g/l

0.06

1332

4542

Episodal and paroxysmal disorders

2000

7180

1.44

45.48

1.9

2.2

38.26

37.62

g/l

4.55

1705

6164

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1099

6980

1.60

45.34

2.0

2.2

37.10

37.65

g/l

2.04

947

5932

Abnormal findings on examination of urine, without diagnosis

143

395

3.87

45.34

3.5

2.6

35.91

37.45

g/l

1.99

129

344

Dental caries, including avohilmo

1562

5337

1.51

45.27

2.1

2.2

37.48

37.51

g/l

0.05

1329

4539

Anxiety (asthma-related co-morbidities)

905

4277

1.69

45.23

1.8

2.2

38.87

38.34

g/l

1.74

795

3739

Bronchitis

1913

8808

1.44

45.17

3.0

2.0

37.32

37.86

g/l

3.20

1663

7521

Hypo-osmolality and hyponatraemia

386

1783

2.22

45.03

2.5

1.9

35.81

37.32

g/l

4.41

333

1463

Any event in cancer register

1636

6598

1.48

44.90

3.5

1.6

37.97

g/l

0.01

1428

5668

Diseases of pulp and periapical tissues, including avohilmo

2004

7319

1.43

44.87

2.1

2.2

37.62

37.79

g/l

0.54

1726

6253

Any operation in hilmo

17.62

44.53

1.7

1.4

39.85

38.76

g/l

0.21

Visual disturbances and blindness

954

5889

1.64

44.48

2.2

2.1

37.99

37.59

g/l

1.27

805

5001

Myelodysplastic syndrome, excluding all cancers (controls excluding all cancers)

115

277

4.55

44.45

2.1

1.4

37.29

36.71

g/l

0.36

100

227

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

102

223

4.96

44.31

1.8

2.7

35.46

38.27

g/l

3.33

195

Dental pulpitis 4

2002

7331

1.43

44.18

2.1

2.2

37.61

37.78

g/l

0.52

1724

6268

Dental pulpitis 1

2001

7336

1.43

43.92

2.1

2.2

37.61

37.78

g/l

0.54

1724

6271

Psychiatric diseases

2020

7141

1.43

43.90

2.0

2.2

37.90

37.74

g/l

0.49

1712

6199

Dental pulpitis 2, only avohilmo

1446

4902

1.53

43.77

2.1

2.2

37.44

g/l

0.01

1218

4155

Depression

1636

7743

1.47

43.64

2.0

2.2

38.34

37.89

g/l

2.11

1402

6686

Other anxiety disorders

660

3262

1.81

43.62

1.8

2.1

39.00

38.32

g/l

2.04

582

2859

Senile cataract

1287

5214

1.55

43.48

2.5

2.3

37.10

37.73

g/l

3.02

1074

4562

Obesity, other/unspecified

570

3067

1.89

43.30

1.6

2.1

36.93

38.35

g/l

6.86

504

2673

Abdominal and pelvic pain

1862

6531

1.44

43.16

2.2

2.1

37.92

37.80

g/l

0.31

1613

5573

Fracture of shoulder and upper arm

698

3998

1.78

43.14

2.4

2.2

37.31

37.62

g/l

0.59

565

3393

Prurigo nodularis

217

5.02

43.11

1.7

3.3

38.46

37.85

g/l

0.46

183

Asthma/COPD (KELA code 203)

1651

8038

1.46

43.10

2.0

2.2

37.53

37.96

g/l

2.10

1427

6851

Non-allergic asthma (mode)

374

1720

2.20

43.06

1.8

37.57

38.46

g/l

2.35

328

1446

Visual disturbances

878

5364

1.66

42.72

2.2

38.07

37.68

g/l

1.17

758

4572

Hard cardiovascular diseases

1534

6710

1.48

42.52

2.4

2.3

36.65

37.87

g/l

10.91

1314

5741

Subjective visual disturbances

485

2496

1.99

42.45

2.2

2.1

38.44

37.68

g/l

2.24

423

2136

All anxiety disorders

913

4495

1.65

42.39

1.8

2.1

38.87

38.22

g/l

2.44

802

3919

Benign neoplasm: Colon, unspecified

561

3036

1.90

42.39

2.3

2.2

37.63

37.34

g/l

0.53

454

2569

Dental caries 1 and operation codes

1689

5965

1.47

42.32

2.1

2.2

37.58

37.53

g/l

0.11

1431

5087

Conjunctivitis

1214

6945

1.54

42.22

2.1

38.43

37.99

g/l

1.86

1058

5952

Giant cell arteritis with polymyalgia rheumatica

139

398

3.80

42.19

1.5

2.5

32.89

37.44

g/l

11.03

117

336

Chronic nephritic syndrome

130

354

3.93

42.13

2.6

36.34

37.67

g/l

1.40

121

309

Obesity

1017

6390

1.59

42.08

1.8

2.2

36.67

38.22

g/l

12.71

884

5544

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

871

5231

1.66

42.03

1.9

2.0

38.59

38.12

g/l

1.55

760

4489

Coxibs

555

1524

1.97

41.90

2.0

2.1

38.13

36.91

g/l

3.88

482

1306

Systemic lupus erythematosus, unspecified

105

246

4.61

41.85

1.8

1.9

36.01

38.20

g/l

2.43

217

Obesity and other hyperalimentation

1021

6426

1.59

41.81

1.8

2.2

36.67

38.22

g/l

12.78

886

5576

Other and unspecified vasculitis limited to skin

215

4.98

41.72

2.7

37.06

37.43

g/l

0.20

185

Hernia of abdominal wall, postoperative

323

1441

2.29

41.15

1.9

2.0

37.50

38.26

g/l

1.39

286

1242

Cardiomyopathies, Primary/intrinsic

289

1235

2.42

41.04

1.9

2.1

35.60

38.46

g/l

10.12

250

1028

Allergic conjunctivitis

898

5474

1.63

41.03

1.9

2.0

38.57

38.14

g/l

1.39

783

4702

Insulin, intermediate and long-acting

1052

6642

1.57

40.97

1.9

2.2

35.89

37.71

g/l

17.57

904

5656

Other coagulation defects

175

582

3.14

40.95

2.4

36.96

37.61

g/l

0.72

157

511

Coxarthrosis

969

4092

1.63

40.92

2.0

2.4

37.75

37.63

g/l

0.23

822

3478

Hyperkalaemia

158

497

3.36

40.86

2.5

2.0

34.65

37.28

g/l

4.72

135

423

Diseases of the digestive system

898

5573

1.63

40.66

2.2

36.14

37.47

g/l

7.48

772

4696

Secondary right heart disease

142

422

3.61

40.49

2.1

2.4

37.54

36.76

g/l

0.88

129

361

Immunodeficiencies

137

398

3.64

40.18

4.5

2.3

38.92

37.94

g/l

1.13

127

353

Cardiomyopathy (excluding other)

296

1291

2.37

40.11

1.9

2.0

35.67

38.49

g/l

10.14

256

1069

Osteonecrosis

162

526

3.25

39.75

6.6

1.9

36.56

37.90

g/l

1.84

142

465

Immunodeficiency with predominantly antibody defects

207

4.87

39.58

5.3

2.1

38.97

38.51

g/l

0.32

188

Other disorders of lacrimal gland

638

3657

1.78

39.52

2.7

2.1

38.35

37.57

g/l

2.61

536

3125

Voice disturbances

523

2827

1.89

39.47

2.6

2.2

38.24

37.71

g/l

1.40

454

2414

Other and unspecified coagulation defects

131

374

3.69

39.40

2.5

2.3

37.12

38.00

g/l

0.91

117

328

All influenza

467

2434

1.96

39.28

4.5

1.9

36.74

38.42

g/l

6.43

394

2065

Dental caries 1, only avohilmo

1580

5573

1.46

39.27

2.1

2.3

37.58

37.41

g/l

0.45

1346

4743

Sleep disorders (combined)

1769

8237

1.42

39.26

1.9

2.2

38.02

37.75

g/l

1.09

1521

7104

Cutaneous abscess, furuncle and carbuncle

465

2428

1.95

38.92

1.9

2.1

36.66

38.10

g/l

4.84

418

2117

Disorders of gallbladder, biliary tract and pancreas

1811

8338

1.41

38.82

2.1

2.2

37.05

37.80

g/l

5.40

1548

7144

Acetic acid derivatives and related substances

553

1523

1.92

38.70

2.1

38.05

36.91

g/l

3.70

486

1305

Conduction disorders

593

2760

1.82

38.64

2.2

2.1

36.52

38.14

g/l

8.22

501

2288

Early onset COPD, excluding more controls

390

1920

2.07

38.60

2.1

1.8

36.23

38.39

g/l

9.28

343

1644

Postmenopausal osteoporosis with pathological fracture

188

678

2.95

38.54

1.7

2.1

38.40

37.05

g/l

2.46

140

561

Other functional intestinal disorders

792

4599

1.66

38.50

2.4

2.1

37.49

37.62

g/l

0.23

658

3899

Overexertion and strenuous or repetitive movements

220

854

2.66

38.43

2.5

2.2

36.90

37.90

g/l

1.46

191

755

Disorders of conjunctiva

1349

7724

1.48

38.28

2.2

2.1

38.40

37.91

g/l

2.33

1171

6610

Fracture of femur

577

2951

1.82

38.28

2.2

2.1

35.57

36.95

g/l

4.62

399

2439

In situ neoplasms

657

3650

1.75

38.14

2.2

1.4

37.10

37.65

g/l

1.46

560

3039

Amputation

256

1075

2.48

38.00

1.6

2.2

33.39

37.27

g/l

15.46

232

900

Neurotic, stress-related and somatoform disorders

1451

7128

1.46

37.97

2.1

2.2

38.84

37.92

g/l

6.85

1270

6153

Other autoimmune haemolytic anaemias

114

6.72

37.95

2.9

2.3

39.90

37.13

g/l

3.16

Urticaria and erythema

604

3445

1.78

37.90

2.2

2.1

38.14

37.99

g/l

0.23

531

2969

Adverse effects, not elsewhere classified

351

1676

2.14

37.79

2.1

38.43

38.14

g/l

0.43

325

1467

Methotrexate

290

1284

2.32

37.77

1.6

2.4

36.77

38.17

g/l

3.53

259

1091

Selective serotonin reuptake inhibitors

1807

6781

1.41

37.67

2.2

37.86

37.64

g/l

0.73

1563

5839

Other retinal disorders

1235

6691

1.50

37.65

2.2

36.82

37.44

g/l

3.04

1008

5674

Soft tissue disorders related to use, overuse and pressure

504

2736

1.88

37.46

2.1

2.2

37.98

37.61

g/l

0.70

434

2340

Retention of urine

704

3536

1.71

37.40

1.9

2.3

36.31

37.30

g/l

3.71

598

3013

Atopic dermatitis

798

4168

1.65

37.37

1.8

2.1

38.38

38.33

g/l

0.08

697

3609

Dental caries 3

1591

5675

1.45

37.19

2.1

2.2

37.54

37.56

g/l

0.04

1354

4837

ILD, hospital admissions 3, with pneumonia sepsis

217

854

2.66

37.15

2.2

1.9

35.55

37.87

g/l

6.09

196

710

Endocarditis

108

282

4.08

37.13

1.4

2.2

32.70

38.02

g/l

10.72

243

Seropositive rheumatoid arthritis, strict definition

339

1613

2.16

37.13

1.6

2.2

36.76

37.81

g/l

2.56

300

1385

Anxiety disorders

1465

7223

1.45

36.99

2.1

2.2

38.84

37.92

g/l

7.00

1281

6230

Other diseases of liver

357

1734

2.11

36.91

2.1

37.68

37.90

g/l

0.26

304

1513

Secondary and unspecified malignant neoplasm of lymph nodes

219

869

2.63

36.85

1.8

2.3

35.86

37.66

g/l

3.61

202

752

Other dialysis

102

259

4.25

36.64

2.5

2.8

34.57

37.69

g/l

4.85

224

Injuries to the shoulder and upper arm

1485

8748

1.44

36.57

2.4

2.2

37.53

37.71

g/l

0.52

1246

7514

Disorder of lipoprotein metabolism, unspecified

310

1434

2.23

36.53

1.7

2.0

36.66

37.40

g/l

1.15

269

1197

Other CVD

436

2285

1.96

36.45

2.4

2.1

36.13

37.04

g/l

2.36

357

1880

Insulin, combination of fast acting with intermediate-acting or long-acting

1148

7107

1.51

36.40

2.0

2.2

35.69

37.67

g/l

21.43

989

6051

Other abnormal findings of blood chemistry

124

361

3.64

36.34

3.5

2.3

37.66

37.96

g/l

0.20

118

315

Dysphagia

501

2745

1.86

36.28

2.2

37.69

37.49

g/l

0.32

423

2308

Unspecified fall

880

5555

1.59

36.18

2.2

2.1

36.84

37.64

g/l

3.04

720

4729

Injury, poisoning and certain other consequences of external causes

970

3069

1.60

36.11

2.1

2.2

37.72

38.14

g/l

1.20

832

2680

Other respiratory diseases principally affecting the interstitium

411

2121

1.99

36.04

2.3

2.1

35.83

37.30

g/l

5.02

371

1776

Abnormal involuntary movements

288

1300

2.28

36.02

2.0

2.2

38.77

37.38

g/l

3.23

250

1118

Irritable bowel syndrome

466

2498

1.90

35.95

2.3

2.1

39.02

37.93

g/l

3.47

392

2151

Superficial injury of head

425

2219

1.95

35.64

1.9

2.1

36.59

37.69

g/l

2.75

359

1877

Gonarthrosis

1172

4477

1.52

35.61

1.9

2.3

37.53

37.77

g/l

0.63

1016

3822

Convulsions, not elsewhere classified

357

1732

2.07

35.36

1.7

2.0

36.64

38.71

g/l

6.40

313

1479

COPD

921

4888

1.58

35.26

1.9

2.3

35.75

37.46

g/l

14.12

795

4107

Viral infections characterized by skin and mucous membrane lesions

714

4345

1.66

35.25

3.2

2.1

37.59

37.86

g/l

0.56

626

3720

Other and unspecified effects of external causes

440

2331

1.92

35.21

2.0

2.1

38.40

38.13

g/l

0.42

401

2036

Peripheral artery operations in Hilmo

307

1437

2.20

35.10

1.7

2.2

34.23

37.37

g/l

12.19

274

1195

Presence of cardiac and vascular implants and grafts

985

4863

1.56

35.05

1.7

2.2

36.45

37.29

g/l

3.78

802

4147

Other and unspecified immunodeficiencies with predominantly antibody defects

6.80

35.03

5.2

2.4

38.83

38.70

g/l

0.06

Dental caries 3 and operation codes

1703

6242

1.41

35.00

2.1

2.2

37.60

37.59

g/l

0.02

1447

5330

Polyarthrosis

405

2008

1.98

34.85

2.2

2.4

36.70

37.59

g/l

1.88

329

1667

Other diseases of pericardium

123

366

3.55

34.82

1.6

2.3

33.97

38.25

g/l

8.00

104

311

Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)

1053

4744

1.54

34.82

2.5

1.5

37.63

37.58

g/l

0.08

886

4002

Concussion

743

3943

1.65

34.70

2.0

2.1

37.83

37.62

g/l

0.38

622

3414

Special screening examination for infectious and parasitic diseases

332

1169

2.15

34.70

2.3

2.1

39.50

38.64

g/l

1.72

290

1058

Other (not insulin) diabetes medications

1742

7585

1.40

34.69

1.9

2.3

36.98

38.02

g/l

9.02

1484

6477

Hypotension

383

1956

2.02

34.65

2.5

2.1

36.09

37.08

g/l

2.48

307

1603

Other pulmonary heart/vessel disease

144

477

3.21

34.36

2.1

2.3

37.54

36.87

g/l

0.74

129

413

Biological medication for rheuma

269

1202

2.29

34.27

1.4

2.2

37.25

38.32

g/l

1.89

244

1063

Other (seronegative) rheumatoid arthritis, wide

406

2124

1.96

34.09

2.0

2.2

36.71

37.57

g/l

2.09

357

1792

Type 2 diabetes, definitions combined

1686

7251

1.40

33.95

1.9

2.3

37.11

38.07

g/l

7.66

1429

6196

Diabetic retinopathy, excluding more controls

477

1429

1.92

33.88

1.7

2.0

35.99

37.61

g/l

6.18

411

1205

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

322

1559

2.13

33.81

1.5

2.1

34.92

37.50

g/l

9.11

275

1351

GI-bleeding

654

3948

1.69

33.63

2.1

35.51

37.23

g/l

8.50

561

3303

Personality disorders, excluding more controls

361

1815

2.02

33.62

1.6

2.1

38.59

38.52

g/l

0.08

321

1618

Rash and other nonspecific skin eruption

224

936

2.48

33.60

2.0

2.2

38.41

37.57

g/l

1.37

202

803

Diseases of the myoneural junction and muscle

272

1236

2.27

33.58

1.6

2.1

36.77

37.42

g/l

0.83

223

1057

Other headache syndromes

699

4294

1.65

33.31

1.8

2.3

39.06

37.91

g/l

5.89

609

3693

Benign neoplasm of other and ill-defined parts of digestive system

359

1817

2.03

33.24

2.1

1.4

37.41

37.70

g/l

0.41

314

1516

Type 2 diabetes, strict (exclude DM1)

1690

7302

1.39

33.21

1.9

2.3

37.10

38.07

g/l

7.87

1434

6241

Noninfective enteritis and colitis

783

4943

1.60

33.17

2.4

2.1

37.45

37.92

g/l

1.26

667

4243

Substance abuse, excluding more controls

940

5392

1.54

33.17

1.6

2.3

37.14

37.77

g/l

1.91

789

4721

Other bacterial intestinal infections

367

1873

2.01

33.11

3.0

2.0

35.97

37.47

g/l

3.85

306

1571

ILD, hospital admissions

349

1759

2.05

32.90

2.4

2.2

35.88

37.38

g/l

4.38

316

1475

Amputation of toe

191

751

2.67

32.90

1.6

2.4

33.08

37.42

g/l

14.68

174

640

Dental operations, only avohilmo

1397

4992

1.45

32.88

2.1

2.2

37.46

37.30

g/l

0.39

1180

4265

Reactive arthropathies, FINNGEN

145

491

3.05

32.83

2.4

2.5

37.77

38.19

g/l

0.32

125

422

Other diseases of the digestive system

648

3931

1.68

32.72

2.1

2.2

35.52

37.26

g/l

8.67

553

3297

Arthropathies in other diseases classified elsewhere

102

280

3.85

32.64

2.5

2.2

36.14

37.85

g/l

1.74

240

Undetermined asthma, excluding more controls

228

969

2.40

32.61

2.1

1.6

37.43

38.77

g/l

2.92

196

816

Open wound of lower leg

293

1387

2.17

32.49

2.0

35.81

37.61

g/l

5.07

250

1190

Stroke, excluding SAH

1208

6195

1.47

32.49

2.3

2.2

36.29

37.39

g/l

7.91

1014

5250

Other interstitial pulmonary diseases

352

1788

2.03

32.45

2.4

2.1

35.87

37.40

g/l

4.58

319

1497

Abnormalities of heart beat

600

3539

1.70

32.35

2.1

37.84

37.77

g/l

0.10

507

2973

Agranulocytosis

244

1078

2.34

32.25

3.4

2.1

37.02

37.61

g/l

0.76

228

931

Stroke, including SAH

1252

6447

1.45

32.21

2.4

2.3

36.39

37.44

g/l

7.55

1049

5480

Interstitial lung disease endpoints

352

1793

2.02

32.20

2.4

2.1

35.87

37.39

g/l

4.53

319

1503

Interstitial lung disease

352

1793

2.02

32.20

2.4

2.1

35.87

37.39

g/l

4.53

319

1503

Pericarditis

100

275

3.84

31.90

1.7

2.1

34.50

38.34

g/l

6.72

237

Other diseases of anus and rectum

552

3228

1.74

31.82

2.3

2.2

37.31

37.47

g/l

0.22

442

2742

Other reaction to severe stress, and adjustment disorders

512

2931

1.77

31.73

2.3

2.0

39.28

38.31

g/l

3.30

461

2568

Open wound of head

913

5940

1.53

31.72

2.0

2.1

36.56

37.66

g/l

5.49

764

5096

Pleural effusion

353

1811

2.01

31.58

2.7

2.1

34.80

37.47

g/l

11.17

318

1515

Lumbar disc prolapse

1069

5763

1.49

31.54

2.2

2.1

38.51

37.67

g/l

4.91

941

4943

Nausea and vomiting

479

2652

1.80

31.54

2.7

2.1

36.57

37.49

g/l

2.42

413

2213

Cellulitis

407

2188

1.90

31.37

2.7

2.1

36.10

37.85

g/l

5.83

358

1887

Artrosis, including avohilmo

1512

5934

1.41

31.36

2.0

2.3

38.03

37.74

g/l

1.01

1289

5142

Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)

131

434

3.21

31.30

1.7

1.3

34.39

37.48

g/l

5.15

122

365

Diffuse large B-cell lymphoma, helper endpoint

131

434

3.21

31.30

1.7

1.3

34.39

37.48

g/l

5.15

122

365

Volume depletion

206

856

2.49

31.29

2.0

34.63

37.24

g/l

6.08

166

705

Dental pulpitis 4, only avohilmo

1962

7633

1.35

31.24

2.0

2.2

37.72

g/l

0.01

1702

6519

Ischaemic Stroke, excluding all haemorrhages

1146

5971

1.47

31.19

2.3

2.2

36.34

37.32

g/l

6.13

958

5047

Other disorders of teeth and supporting structures

392

2086

1.92

31.15

2.8

2.1

37.02

37.65

g/l

1.12

330

1783

Rotator cuff syndrome

1095

5550

1.48

31.09

2.2

37.86

37.53

g/l

0.99

943

4740

Asthma and allergy, excluding more controls

176

668

2.64

31.03

1.8

1.6

38.99

39.59

g/l

0.62

152

577

Cardiodefibrillation

768

4928

1.58

30.68

2.2

36.12

37.30

g/l

5.94

682

4151

Other inflammation of eyelid

272

1284

2.18

30.50

2.7

2.2

38.44

37.52

g/l

1.81

222

1107

Other noninfective gastroenteritis and colitis

437

2420

1.84

30.47

2.7

2.1

37.17

37.69

g/l

0.98

375

2057

Injuries to the knee and lower leg

2020

8715

1.34

30.32

2.0

2.2

37.63

37.83

g/l

0.75

1705

7507

Recurrent or chronic depression

612

2653

1.68

30.26

1.9

2.1

38.53

38.22

g/l

0.56

537

2360

Biguanides

1702

7727

1.37

30.22

1.9

2.3

36.90

37.94

g/l

8.82

1459

6607

Alcohol use disorder, Swedish definition

954

5960

1.50

30.06

1.6

2.3

36.77

37.84

g/l

4.80

811

5205

Type 2 diabetes, definitions combined, including avohilmo

1665

7233

1.37

30.05

1.8

2.3

37.14

38.08

g/l

7.33

1420

6184

Dental caries 3, only avohilmo

1590

5897

1.39

30.01

2.1

2.3

37.61

37.47

g/l

0.38

1354

5029

Later onset COPD, excluding more controls

446

1928

1.84

29.99

1.6

1.9

35.13

37.86

g/l

16.57

379

1557

992

6179

1.49

29.98

1.6

2.3

36.71

37.88

g/l

5.78

847

5394

Disorders of lacrimal system

740

4736

1.58

29.90

2.6

2.1

38.36

37.55

g/l

3.21

618

4015

Benign neoplasm: Sigmoid colon

366

1935

1.94

29.89

2.3

1.4

37.55

37.66

g/l

0.13

318

1612

AV-block

369

1765

1.94

29.88

2.1

2.0

36.66

38.07

g/l

4.31

309

1426

Dental operations

1302

4689

1.44

29.75

2.2

2.1

37.41

37.35

g/l

0.12

1095

4001

Fibrosis and cirrhosis of liver

185

753

2.56

29.63

1.5

2.4

34.96

37.78

g/l

6.67

159

650

Other medical care

742

4649

1.58

29.55

3.5

2.1

35.81

37.63

g/l

12.75

665

3890

Basal cell carcinoma, excluding all cancers (controls excluding all cancers)

930

4275

1.52

29.53

2.5

1.4

37.33

37.51

g/l

0.38

780

3585

Hypertrophic cardiomyopathy

120

391

3.26

29.51

2.8

35.96

37.32

g/l

1.38

108

341

Urticaria

459

2604

1.79

29.50

2.2

2.0

38.35

38.07

g/l

0.43

404

2255

Migraine with aura

337

1734

1.97

29.46

1.5

2.1

39.44

38.31

g/l

3.17

298

1515

Chronic sinusitis

720

4589

1.59

29.45

2.2

38.22

37.89

g/l

0.73

636

3956

1029

6326

1.47

29.18

1.6

2.3

36.86

37.89

g/l

4.85

878

5525

Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)

955

4399

1.51

29.14

2.6

1.5

37.43

37.54

g/l

0.22

805

3695

Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers

121

400

3.20

29.01

3.2

1.4

35.59

37.52

g/l

2.33

110

336

Asthma and allergy

176

691

2.55

28.99

1.8

1.6

38.99

39.30

g/l

0.26

152

593

Bacterial intestinal infections, IBD co-morbidities

369

1975

1.91

28.96

3.1

2.1

36.00

37.37

g/l

3.37

309

1666

Other chronic obstructive pulmonary disease

867

4786

1.53

28.93

1.9

2.3

35.69

37.45

g/l

13.98

746

4015

Dental pulpitis 1, only avohilmo

1951

7677

1.34

28.86

2.0

2.2

37.74

37.71

g/l

0.07

1690

6555

Need for immunization against other single viral diseases

148

4.89

28.86

2.8

2.2

36.47

38.09

g/l

1.20

129

Type 1 diabetes

422

2349

1.82

28.82

1.8

2.2

35.81

38.27

g/l

13.44

378

2042

Migraine

667

3551

1.61

28.71

1.8

2.1

39.22

38.16

g/l

5.22

584

3107

Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)

937

4328

1.51

28.70

2.5

1.4

37.36

37.52

g/l

0.36

784

3629

Trochanteric bursitis

272

1316

2.12

28.58

2.2

2.1

38.20

37.53

g/l

1.05

229

1115

Other diseases of upper respiratory tract

1981

7815

1.33

28.52

2.1

2.2

37.92

37.59

g/l

1.51

1703

6673

Undetermined asthma

228

1029

2.26

28.41

2.1

1.6

37.43

38.45

g/l

1.86

196

862

Heart failure and hypertrophic cardiomyopathy

168

4.67

28.31

2.9

2.4

34.76

37.17

g/l

1.92

139

Progressive vascular leukoencephalopathy

108

340

3.41

28.27

2.4

2.3

37.05

36.73

g/l

0.20

283

Nonalcoholic fatty liver disease

190

800

2.45

28.09

2.2

2.4

38.31

38.07

g/l

0.19

162

699

Lichen simplex chronicus and prurigo

155

594

2.72

28.09

1.8

2.6

37.93

37.69

g/l

0.20

135

511

Cardiomyopathy in other diseases

8.81

28.01

9.0

2.2

36.65

37.52

g/l

0.30

Benign neoplasm: Ascending colon

277

1368

2.09

27.70

2.1

1.4

36.88

37.60

g/l

1.03

231

1134

Deposits [accretions] on teeth

139

487

2.84

27.62

4.8

1.9

36.14

38.03

g/l

2.52

127

427

Benign neoplasm: Transverse colon

226

1035

2.26

27.58

2.5

1.4

36.98

37.73

g/l

1.11

187

857

ILD, hospital admissions 1, main diag only

308

1585

2.00

27.48

2.4

2.2

35.84

37.39

g/l

4.26

280

1337

Insulin, fast-acting

632

3985

1.61

27.19

1.8

2.2

35.70

37.97

g/l

15.92

552

3411

Sequelae of external causes of morbidity and mortality

477

2808

1.73

27.15

2.5

2.2

36.58

37.57

g/l

2.70

435

2391

Other and unspecified types of non-Hodgkin lymphoma, hilmo

121

416

3.08

27.13

3.2

2.4

35.59

37.06

g/l

1.53

110

358

Other neurological diseases

1321

7707

1.39

27.11

2.2

37.69

37.42

g/l

0.89

1106

6543

Injuries to the ankle and foot

1008

6377

1.45

26.89

2.0

2.1

37.90

38.20

g/l

0.84

874

5573

Mixed and other personality disorders

138

509

2.78

26.71

1.6

2.1

38.77

38.56

g/l

0.14

128

457

Sleep apnoea

1594

8065

1.35

26.63

2.0

2.2

37.85

37.77

g/l

0.22

1368

6977

Phobic anxiety disorders

168

682

2.50

26.58

1.9

2.0

38.42

38.59

g/l

0.11

154

606

Diffuse large B-cell lymphoma

131

478

2.90

26.40

1.7

2.6

34.39

37.24

g/l

4.53

122

412

Reactive arthropathies

169

694

2.50

26.33

2.3

37.79

37.93

g/l

0.11

145

606

Allergic asthma (mode), excluding more controls

311

1591

1.94

26.11

1.9

1.7

38.43

39.30

g/l

1.75

279

1363

Cerebral palsy and other paralytic syndromes

226

1057

2.19

25.99

1.9

2.2

37.49

37.81

g/l

0.30

196

919

In situ neoplasms

657

4239

1.57

25.78

2.2

37.10

37.42

g/l

0.67

560

3539

Osteomyelitis

149

586

2.64

25.66

2.1

1.9

34.27

37.57

g/l

6.52

132

515

Somatoform disorder

283

1444

2.00

25.61

2.4

2.2

38.81

37.79

g/l

2.20

244

1256

Fungal Sepsis

100

319

3.31

25.47

3.0

2.3

33.71

37.97

g/l

5.97

279

Other chronic obstructive pulmonary disease, including avohilmo

1031

6042

1.44

25.41

1.8

2.3

35.98

37.50

g/l

12.63

887

5129

Other disorders of eye and adnexa

250

1227

2.08

25.29

2.0

2.2

38.18

37.85

g/l

0.40

225

1060

Other abnormalities of plasma proteins

132

4.93

25.23

5.2

3.1

34.31

38.16

g/l

3.14

112

Sleep apnoea, including avohilmo

1661

8147

1.33

25.20

1.9

2.3

37.91

37.76

g/l

0.48

1426

7042

Calcific aortic valvular stenosis

620

3892

1.59

25.05

2.2

2.1

35.93

36.95

g/l

3.98

530

3210

Calcific aortic valvular stenosis, operated

620

3892

1.59

25.05

2.2

2.1

35.93

36.95

g/l

3.98

530

3210

Essential (haemorrhagic) thrombocythaemia

105

350

3.17

24.88

2.3

1.4

38.85

37.84

g/l

0.94

294

Calcific aortic valvular stenosis, diagnosis (helper)

619

3891

1.58

24.87

2.2

2.1

35.93

36.95

g/l

3.94

529

3209

Operations 2 for CAVS

619

3891

1.58

24.87

2.2

2.1

35.93

36.95

g/l

3.94

529

3209

Other diseases of arteries and capillaries

195

877

2.29

24.83

1.9

2.3

35.89

37.66

g/l

3.02

163

746

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

253

3.56

24.82

1.5

2.0

38.99

38.22

g/l

0.62

229

Injuries to the elbow and forearm

1116

7240

1.40

24.80

2.0

2.2

37.75

37.87

g/l

0.26

926

6203

Zoster [herpes zoster]

357

1989

1.84

24.77

3.6

2.1

37.35

37.38

g/l

0.02

299

1672

Calcific aortic valvular stenosis, including rheumatic fever

621

3909

1.58

24.70

2.2

2.1

35.93

36.94

g/l

3.91

531

3224

Phlebitis and thrombophlebitis (not including DVT)

417

2432

1.75

24.60

2.4

2.1

36.91

37.80

g/l

2.15

364

2076

Sequelae of cerebrovascular disease

696

4024

1.54

24.46

2.0

2.2

36.55

37.21

g/l

2.01

548

3398

Diabetic neuropathy

245

1206

2.09

24.45

2.0

36.38

37.00

g/l

0.73

213

1028

Tumor necrosis factor alpha inhibitors

220

1044

2.15

24.28

1.4

2.3

37.20

38.30

g/l

1.65

199

930

Non-Hodgkin lymphoma, all

118

426

2.93

24.28

3.5

2.5

35.15

36.89

g/l

1.92

110

365

Ischaemic heart disease, wide definition

1425

6633

1.36

24.11

2.4

2.3

37.00

37.75

g/l

4.49

1248

5625

Substance abuse

940

6299

1.44

24.11

1.6

2.3

37.14

37.90

g/l

2.67

789

5499

Other diseases of intestine

249

1244

2.05

24.11

2.7

2.0

35.91

37.50

g/l

3.02

219

1060

Obesity due to excess calories

690

4562

1.53

24.08

1.8

2.3

36.46

38.27

g/l

11.09

598

3969

Iron deficiency anaemia secondary to blood loss (chronic)

314

1696

1.89

24.08

2.0

2.2

35.83

37.44

g/l

4.22

244

1428

Myeloproliferative diseases

197

905

2.25

23.95

2.9

2.2

38.57

37.60

g/l

1.42

168

781

Ischemic heart diseases

1434

6694

1.35

23.91

2.3

37.07

37.75

g/l

3.76

1257

5677

Acute sinusitis

771

4858

1.49

23.87

3.1

2.0

38.24

38.09

g/l

0.31

675

4198

Hypokalaemia

226

1095

2.12

23.78

2.8

2.0

35.80

37.59

g/l

3.82

188

911

Mental and behavioural disorders due to psychoactive substance use

964

6425

1.43

23.71

1.6

2.3

37.18

37.90

g/l

2.51

811

5604

Disorders of adult personality and behaviour

382

2192

1.76

23.68

1.7

2.0

38.74

38.52

g/l

0.28

340

1946

DVT of lower extremities

375

2148

1.78

23.67

2.5

2.1

36.80

37.57

g/l

1.55

318

1824

Other specified and unspecified disorders of eye and adnexa

103

349

3.10

23.66

2.3

2.4

38.31

38.11

g/l

0.13

304

Invasive ventilation

166

714

2.41

23.58

2.3

2.2

34.67

37.68

g/l

6.37

147

615

Superficial injury of lower leg

392

2272

1.75

23.56

1.8

2.1

37.78

38.03

g/l

0.34

320

1949

Peripheral arterial reconstruction

367

2096

1.79

23.51

1.7

2.2

34.92

37.12

g/l

8.13

317

1733

Drug-induced osteoporosis with pathological fracture

162

4.38

23.47

1.6

2.3

35.25

37.19

g/l

1.57

137

Viral pneumonia (unknown virus, not influenza)

134

522

2.65

23.46

2.2

2.4

36.32

37.83

g/l

1.68

122

458

Memory loss

223

1085

2.13

23.43

2.0

2.3

37.15

37.26

g/l

0.10

187

933

Benign neoplasm of other and ill-defined parts of digestive system

359

2040

1.80

23.37

2.1

2.2

37.41

37.48

g/l

0.08

314

1734

Oter anti-inflammatory and antirheumatic agents, non-steroids

439

1416

1.74

23.35

2.2

37.04

36.67

g/l

0.58

377

1204

Diseases of spleen

136

4.61

23.28

2.0

2.3

37.71

37.48

g/l

0.08

116

Eosinophilic disease (BM)

5.37

23.22

2.5

1.3

36.22

37.57

g/l

0.69

Oxicams

440

1460

1.74

23.22

2.1

2.2

37.94

36.79

g/l

2.82

370

1246

Other pleural conditions

231

1141

2.09

23.21

2.8

2.2

34.69

37.36

g/l

8.58

200

956

Insulin, fast-acting or short human

634

4153

1.54

23.14

1.8

2.1

35.69

37.85

g/l

14.70

554

3547

Idiopathic thrombocytopenic purpura

256

3.47

23.10

2.6

2.5

38.76

37.63

g/l

1.01

218

Allergic asthma (mode)

311

1658

1.86

23.08

1.9

1.7

38.43

39.02

g/l

0.98

279

1419

Pacemaker

668

4310

1.53

23.07

2.1

2.2

36.32

37.01

g/l

2.08

550

3561

Acute upper respiratory infections of multiple and unspecified sites

1148

6252

1.39

23.03

3.1

2.0

37.89

37.87

g/l

0.04

1001

5362

Injuries to unspecified part of trunk, limb or body region

194

898

2.22

23.01

1.6

2.3

35.84

37.75

g/l

3.27

161

780

Other encephalitis

208

3.76

23.01

1.8

2.8

36.89

38.04

g/l

0.57

183

Myeloproliferative diseases (CML excluded)

181

819

2.29

22.88

3.0

2.3

38.57

37.64

g/l

1.29

155

707

Disorders of continuity of bone

173

766

2.32

22.82

3.0

2.0

38.01

37.75

g/l

0.19

151

682

Basal cell carcinoma, including avohilmo

1110

6348

1.39

22.82

2.5

2.2

37.24

37.17

g/l

0.14

917

5323

Carcinoma in situ of skin of scalp and neck

235

3.64

22.82

1.8

1.4

37.32

36.43

g/l

0.64

195

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

542

3442

1.60

22.81

2.4

2.1

37.70

37.82

g/l

0.19

470

2945

Fenamates

283

989

1.96

22.72

2.0

2.1

37.70

37.15

g/l

0.77

246

840

Basal cell carcinoma

1087

6280

1.39

22.62

2.5

2.2

37.21

37.16

g/l

0.09

898

5263

Abnormal serum enzyme levels

570

3626

1.58

22.59

2.1

2.2

36.98

37.45

g/l

1.04

500

3122

Gastroduodenal ulcer

508

3181

1.62

22.54

1.9

2.3

35.95

37.22

g/l

4.02

433

2692

Spondyloarthritis

308

1686

1.86

22.52

2.0

2.1

36.38

37.80

g/l

3.07

275

1443

Carcinoma in situ of skin of other and unspecified parts of face

185

853

2.25

22.38

2.1

1.4

36.79

37.01

g/l

0.20

162

682

Other diseases of hard tissues of teeth

977

5181

1.42

22.32

2.6

2.0

38.41

37.79

g/l

2.44

837

4467

Complications of internal orthopaedic prosthetic devices, implants and grafts

445

2715

1.67

22.29

1.8

2.2

36.31

37.34

g/l

2.61

366

2250

Gastric ulcer

359

2067

1.77

22.28

1.8

2.2

36.06

37.25

g/l

2.63

301

1746

Metatarsalgia

178

806

2.26

22.27

2.4

1.9

38.35

37.87

g/l

0.46

156

694

Rheumatism, unspecified

255

1321

1.97

22.21

2.1

38.34

37.62

g/l

1.18

228

1121

Enterocolitis due to Clostridium difficile

227

1133

2.06

22.12

3.5

2.1

35.08

37.41

g/l

5.66

196

950

Implicit fungal Sepsis

299

3.21

22.12

3.2

2.2

34.25

37.92

g/l

4.74

261

Encephalitis

219

3.61

22.01

1.8

2.7

36.88

38.13

g/l

0.66

193

Other/unspecified reactive arthropathies

135

548

2.54

21.75

2.5

2.4

37.74

37.92

g/l

0.12

117

484

Other enthesopathy of foot (+metatarsalgia)

185

859

2.20

21.74

2.4

2.0

38.30

37.89

g/l

0.39

162

743

Deforming dorsopathies

441

2700

1.65

21.60

2.2

2.1

38.10

37.57

g/l

1.04

376

2292

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

173

785

2.26

21.59

3.1

2.2

37.73

37.81

g/l

0.06

158

679

Bipolar affective disorders

258

1353

1.93

21.52

1.8

2.1

38.36

38.29

g/l

0.06

228

1198

Secondary uncertain malignant neoplasm

265

1414

1.92

21.27

1.9

2.2

35.65

37.32

g/l

3.72

239

1192

L04AC Interleukin inhibitors

331

3.00

21.27

1.5

2.1

37.65

38.48

g/l

0.55

295

Benign neoplasm: Transverse colon

226

1151

2.03

20.96

2.5

2.3

36.98

37.50

g/l

0.66

187

988

Charcot foot

143

4.29

20.96

2.7

2.8

35.44

38.11

g/l

2.13

124

Functional dyspepsia

436

2684

1.65

20.95

2.3

2.2

38.32

37.78

g/l

1.14

379

2317

Personality disorders

361

2113

1.73

20.94

1.6

2.0

38.59

38.52

g/l

0.07

321

1872

Cirrhosis of liver, NAS

124

495

2.62

20.90

1.6

2.5

34.04

37.41

g/l

6.57

109

429

Papulosquamous disorders

663

4486

1.50

20.86

2.1

2.3

37.76

g/l

0.01

575

3869

Persons with potential health hazards related to communicable diseases

461

2851

1.62

20.82

2.0

1.9

37.84

38.58

g/l

1.73

411

2530

Elevated blood glucose level

160

714

2.30

20.82

1.7

2.1

36.40

38.04

g/l

2.05

130

625

Type 1 diabetes, wide definition, subgroup 1

317

1793

1.79

20.72

1.8

2.1

36.01

38.41

g/l

10.02

278

1567

Persistent mood disorders

322

1834

1.78

20.69

2.0

2.1

38.02

37.77

g/l

0.27

288

1582

Diseases of external ear

563

3690

1.55

20.67

1.8

2.2

38.00

37.68

g/l

0.60

435

3170

Non-selective monoamine reuptake inhibitors

667

4387

1.49

20.65

2.1

2.2

38.05

37.62

g/l

1.06

573

3725

Other peripheral vascular diseases

165

750

2.26

20.57

1.6

2.3

38.15

37.89

g/l

0.21

147

649

Paracetamol of NSAID medication

270

699

1.96

20.55

2.6

1.9

37.89

37.11

g/l

1.03

232

616

Abnormal findings in nipple discharge synovial fluid wound secretions

107

4.82

20.50

3.6

2.3

36.50

38.30

g/l

1.05

Behavioural syndromes associated with physiological disturbances and physical factors

421

2579

1.65

20.48

1.9

2.0

38.67

38.15

g/l

1.09

361

2255

Disorders of muscles

180

847

2.17

20.47

1.6

1.9

37.91

37.45

g/l

0.48

162

736

Alcoholic liver disease

199

977

2.09

20.35

1.4

2.3

34.59

37.76

g/l

7.47

162

851

Nonorganic sleeping disorders, excluding more controls

255

1358

1.90

20.35

1.5

2.2

39.21

38.12

g/l

2.55

222

1191

Psoriasis

477

3025

1.60

20.30

1.9

2.2

37.51

37.96

g/l

0.82

418

2616

Spondylopathies (FG)

199

975

2.07

20.24

1.8

2.5

37.90

38.34

g/l

0.43

178

845

Valvular operations

274

1500

1.86

20.22

1.6

2.0

36.77

38.11

g/l

3.33

239

1231

Carcinoma in situ of skin of scalp and neck

254

3.36

20.21

1.8

2.4

37.32

36.62

g/l

0.48

215

Migraine without aura

239

1248

1.94

20.19

2.0

2.1

39.40

38.54

g/l

1.56

210

1105

Hypoparathyroidism

100

366

2.88

20.11

1.7

2.3

37.32

37.67

g/l

0.24

318

Benign neoplasm: Ascending colon

277

1528

1.86

20.11

2.1

2.2

36.88

37.47

g/l

0.77

231

1298

Other general symptoms and signs

289

3.06

20.09

1.5

2.4

38.22

37.93

g/l

0.17

251

Sequelae of other external causes

118

468

2.61

20.06

3.0

2.4

37.27

37.46

g/l

0.11

113

409

Pyogenic arthritis

133

557

2.46

20.03

2.7

2.3

36.43

37.71

g/l

1.37

117

471

Other embolism and thrombosis

249

1329

1.92

19.94

2.6

2.1

36.50

37.59

g/l

1.83

223

1128

Generalized anxiety disorder

190

920

2.09

19.91

1.8

2.2

40.07

38.42

g/l

4.04

167

809

Enthesopathies of lower limb, excluding foot

343

2016

1.72

19.71

2.3

2.1

38.63

37.76

g/l

1.74

299

1739

Other enthesopathies

464

2943

1.59

19.69

1.9

2.2

38.44

37.91

g/l

1.12

402

2531

Substance use, excluding alcohol

290

1626

1.81

19.65

1.6

2.1

38.10

38.24

g/l

0.14

237

1441

Malignant neoplasm of skin

1178

6653

1.35

19.60

2.5

2.2

37.27

37.24

g/l

0.05

972

5614

Benign neoplasm of other and unspecified endocrine glands

228

1189

1.96

19.59

2.2

1.4

37.35

37.84

g/l

0.52

187

1005

L01XX Other antineoplastic agents

142

623

2.38

19.49

3.6

2.4

38.56

37.33

g/l

1.57

127

537

Heart failure and coronary heart disease

690

3533

1.48

19.48

1.9

2.2

35.07

37.08

g/l

14.58

592

2908

COPD, early/later onset

875

5310

1.41

19.45

1.8

2.3

35.70

37.38

g/l

13.30

751

4486

Superficial injury of hip and thigh

266

1460

1.86

19.44

1.8

2.2

37.02

37.34

g/l

0.33

214

1242

Erosion of teeth, including avohilmo

261

1373

1.86

19.31

2.4

1.9

38.77

38.27

g/l

0.72

230

1190

Benign neoplasm: Stomach

194

964

2.07

19.24

2.4

1.4

37.18

37.64

g/l

0.51

167

799

Coronary atherosclerosis

1263

6165

1.33

19.24

2.2

2.3

36.82

37.66

g/l

5.12

1116

5220

Disorders of skin appendages

689

4767

1.46

19.21

2.2

2.1

37.88

38.10

g/l

0.47

615

4122

Thoracic aortic aneurysm

273

1520

1.84

19.20

2.2

2.3

36.94

37.75

g/l

1.39

229

1306

Mycoses

439

2769

1.61

19.17

2.6

2.1

37.03

37.79

g/l

1.72

377

2371

Fracture of foot, except ankle

356

2130

1.69

19.15

2.1

38.18

g/l

0.00

307

1880

Benign neoplasm: Sigmoid colon

366

2215

1.69

19.07

2.3

2.2

37.55

37.43

g/l

0.14

318

1877

Other viral hepatitis

101

379

2.73

19.06

1.8

1.9

37.88

38.76

g/l

0.57

339

Cramp and spasm

100

375

2.77

19.05

2.5

2.4

38.59

37.79

g/l

0.63

332

Benign neoplasm: Rectum

323

1892

1.74

18.98

2.2

1.4

37.01

37.64

g/l

1.06

288

1580

Benign neoplasm: Rectum, anus and anal canal

360

2172

1.69

18.92

2.2

1.5

37.12

37.61

g/l

0.80

320

1821

COPD, hospital admissions

865

5279

1.40

18.90

1.8

2.3

35.76

37.37

g/l

12.30

740

4458

Budesonide

204

1035

2.00

18.90

2.0

2.3

37.40

38.37

g/l

1.24

173

890

Intracranial injury

908

6393

1.38

18.78

2.1

37.51

37.73

g/l

0.47

747

5475

Amiodarone users

220

1154

1.96

18.76

2.0

2.2

35.68

37.33

g/l

3.29

196

987

Infection of intervertebral disc (pyogenic)

129

4.35

18.73

1.5

2.1

32.53

37.04

g/l

3.84

106

Diseases of salivary glands

311

1806

1.75

18.73

2.1

37.81

37.70

g/l

0.11

259

1527

Other overlap syndromes

146

4.02

18.70

1.9

2.5

36.35

38.06

g/l

1.14

128

Other metabolic disorders

208

1068

1.98

18.66

3.3

2.0

37.70

38.19

g/l

0.57

193

925

Atopic dermatitis, strict definition with reimbursement

347

2008

1.69

18.65

1.8

2.0

38.26

38.64

g/l

0.53

301

1771

Migraine with aura and triptan purchases

186

918

2.05

18.56

1.4

1.8

39.76

38.73

g/l

1.63

167

798

Disorders of sclera, cornea, iris and ciliary body

852

6171

1.39

18.43

2.1

2.2

37.86

37.83

g/l

0.06

737

5301

Acute upper respiratory infections

1729

8581

1.27

18.36

2.9

2.0

37.98

37.69

g/l

1.15

1506

7322

Other disorders of bone

299

1730

1.75

18.24

3.4

1.9

38.06

38.18

g/l

0.13

256

1531

Benign neoplasm: Caecum

208

1081

1.98

18.22

2.6

1.4

37.39

37.58

g/l

0.17

175

896

Cervicalgia

336

2010

1.70

18.16

2.2

2.1

38.37

37.37

g/l

2.04

287

1703

Filling of root of tooth

242

3.20

18.16

2.8

2.7

36.60

38.25

g/l

1.48

218

Other and unspecified myopathies

178

877

2.09

18.13

1.7

2.2

36.28

37.36

g/l

1.25

140

750

Amputation of foot

249

3.21

18.10

1.5

2.7

33.16

37.06

g/l

5.13

209

Idiopathic urticaria

140

3.99

18.07

1.2

2.0

39.53

38.64

g/l

0.40

128

Hypothyroidism, strict autoimmune

1102

5463

1.34

18.07

1.8

2.3

37.86

37.97

g/l

0.23

932

4617

COPD related to multimorbidity

754

4515

1.42

17.92

1.8

2.2

35.54

37.37

g/l

13.22

641

3805

Postprocedural endocrine and metabolic disorders, not elsewhere classified

194

987

2.00

17.90

3.2

2.0

37.90

38.08

g/l

0.16

179

857

Other and unspecified injuries of head

121

513

2.43

17.83

1.6

2.2

36.61

37.81

g/l

1.11

446

Psoriatic and enteropathic arthropathies

176

866

2.07

17.80

1.7

2.5

38.02

38.40

g/l

0.33

154

749

Spondylopathies in diseases classified elsewhere

112

4.50

17.75

21.5

1.3

37.12

37.88

g/l

0.44

Adalimumab

136

606

2.29

17.74

1.4

2.2

37.75

38.36

g/l

0.53

122

540

Carcinoma in situ of skin of other and unspecified parts of face

185

936

2.05

17.64

2.1

2.2

36.79

36.76

g/l

0.03

162

775

Pain in thoracic spine

234

1276

1.86

17.48

2.8

2.0

39.00

37.62

g/l

2.97

210

1098

Decubitus ulcer and pressure area

126

551

2.37

17.38

1.5

2.3

33.34

37.08

g/l

6.70

102

463

Open wound of ankle and foot

174

862

2.06

17.36

2.3

2.2

35.11

37.96

g/l

6.08

151

758

Viral hepatitis

119

507

2.40

17.27

1.7

2.1

37.71

38.31

g/l

0.39

104

451

Chronic viral hepatitis

298

2.86

17.09

1.5

1.7

38.73

38.91

g/l

0.08

272

Dentofacial anomalies [including malocclusion]

351

2130

1.65

17.09

2.3

2.0

38.74

38.25

g/l

0.93

315

1839

Extrapyramidal and movement disorders

651

4571

1.44

17.04

2.1

2.2

38.55

37.30

g/l

6.41

545

3856

Other malignant neoplasms of skin (=non-melanoma skin cancer)

1034

6146

1.34

17.01

2.5

2.2

37.14

37.16

g/l

0.03

852

5154

Aortic aneurysm

434

2763

1.57

16.96

2.1

2.3

36.45

37.48

g/l

2.79

362

2346

Gonarthrosis,primary

1598

7978

1.27

16.85

1.9

2.3

37.19

37.62

g/l

1.99

1358

6821

Other extrapyramidal and movement disorders in other diseases

399

2543

1.59

16.82

2.3

2.2

38.67

37.44

g/l

4.10

342

2165

Injury of unspecified body region

148

700

2.17

16.80

1.6

2.4

35.53

37.57

g/l

2.71

121

610

Haemorrhage, not elsewhere classified

308

2.84

16.80

2.5

2.6

36.87

37.38

g/l

0.32

258

Myocardial infarction

958

5120

1.36

16.78

2.1

2.3

36.18

37.48

g/l

8.79

821

4300

Type 1 diabetes, wide definition

328

1988

1.67

16.77

1.8

2.1

35.95

38.28

g/l

9.71

287

1731

Meniscus derangement

879

4408

1.37

16.77

2.2

2.3

38.12

37.83

g/l

0.75

758

3779

Fall on and from stairs and steps

416

2684

1.57

16.56

2.2

2.1

37.81

37.65

g/l

0.22

346

2295

Panic disorder

177

896

2.00

16.50

1.5

2.2

38.78

38.38

g/l

0.35

155

787

Other hammer toe(s) (acquired)

309

1738

1.69

16.49

1.8

2.5

37.19

37.45

g/l

0.28

250

1435

Motor neuron disease

131

3.96

16.48

1.1

1.6

40.01

37.17

g/l

2.56

114

Cholelithiasis, broad definition with cholecystitis

1454

7862

1.28

16.34

2.1

2.2

37.21

37.76

g/l

2.72

1231

6705

Other and unspecified drugs and medicaments

155

755

2.11

16.29

2.9

2.2

37.54

37.72

g/l

0.13

140

652

Temporomandibular joint disorders

210

1133

1.88

16.20

2.4

2.0

38.72

38.07

g/l

0.97

186

953

Radiculopathy

299

1793

1.70

16.14

2.3

2.1

38.43

37.19

g/l

3.05

264

1511

Other and unspecified acquired haemolytic anaemias

4.88

16.13

3.3

1.6

35.58

37.25

g/l

0.68

Noninfectious colitis NAS

229

1275

1.83

16.09

2.4

2.1

37.16

37.78

g/l

0.77

198

1090

Scoliosis

135

626

2.20

16.03

1.8

2.0

38.16

37.40

g/l

0.66

115

534

Other degenerative diseases of the nervous system

458

2284

1.54

16.00

1.8

2.2

37.58

37.09

g/l

0.79

348

1941

Spirochaetal infections, other/unspecified

167

843

2.04

15.97

2.4

38.20

37.68

g/l

0.45

129

730

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

328

2017

1.64

15.87

1.8

2.1

38.54

38.39

g/l

0.18

282

1788

Thyrotoxicosis

399

2576

1.57

15.85

1.8

2.1

37.38

37.83

g/l

0.90

346

2193

Degeneration of macula and posterior pole

880

5400

1.36

15.85

2.1

2.3

37.05

37.17

g/l

0.23

701

4505

Other diseases of the respiratory system

381

2439

1.59

15.80

2.0

2.2

36.42

37.21

g/l

1.59

323

2044

Other respiratory disorders and diseases

381

2439

1.59

15.80

2.0

2.2

36.42

37.21

g/l

1.59

323

2044

Disorders of the thyroid gland

1540

8027

1.26

15.68

1.9

2.2

37.89

37.69

g/l

0.63

1318

6862

5-aminosalicylic acid

281

1668

1.70

15.65

1.8

2.1

37.83

38.53

g/l

1.07

244

1441

Motor neuron disease (with DMD)

136

3.80

15.62

1.1

1.6

40.01

37.21

g/l

2.49

119

All influenza (not pneumonia)

231

1300

1.80

15.61

4.7

1.8

37.17

38.44

g/l

2.22

196

1110

Chronic pancreatitis

227

1276

1.82

15.54

1.9

2.3

35.34

37.80

g/l

5.61

200

1105

Other viral diseases

374

2382

1.58

15.49

3.0

2.0

37.29

38.36

g/l

2.53

344

2093

Mucosal proctocolitis

190

1010

1.91

15.45

2.4

2.2

37.83

37.95

g/l

0.10

176

895

Mental and behavioural disorders due to alcohol

795

5708

1.37

15.37

1.6

2.3

37.02

37.88

g/l

2.85

677

4997

Chronic ulcer of skin, not elsewhere classified

141

679

2.14

15.36

2.5

2.2

35.22

37.70

g/l

3.96

120

586

Protozoal diseases

252

2.96

15.22

5.4

2.6

35.30

37.62

g/l

1.96

219

Anaemia in chronic diseases classified elsewhere

209

3.18

15.21

1.9

2.6

35.53

37.44

g/l

1.58

177

Sleep disorders

300

1827

1.66

15.20

1.4

2.1

38.88

38.06

g/l

1.75

255

1607

Other disorders of eyelid

789

5633

1.37

15.19

2.1

2.2

37.83

37.24

g/l

2.16

661

4737

Fracture of lower leg, including ankle

859

6405

1.35

15.12

2.0

2.2

37.66

37.88

g/l

0.51

719

5482

Etanercept

106

457

2.38

15.07

1.4

2.3

36.84

38.25

g/l

1.38

404

Retinal detachments and breaks

625

4457

1.42

15.07

2.4

2.3

37.04

37.40

g/l

0.76

537

3795

Use of pramipexole

396

2586

1.56

15.06

1.9

2.2

37.95

37.39

g/l

1.09

324

2193

Migraine without aura and triptan purchases

178

933

1.93

15.04

1.5

1.9

39.39

38.92

g/l

0.54

157

822

Crystal arthropathies, rheuma endpoint

160

3.52

14.98

1.6

2.7

35.75

37.14

g/l

0.74

131

Hallux valgus (acquired)

520

2572

1.48

14.97

1.9

2.4

37.37

37.92

g/l

1.11

428

2167

Vasomotor and allergic rhinitis

496

3339

1.47

14.92

2.0

2.1

38.74

38.15

g/l

1.37

427

2903

Fissure and fistula of anal and rectal regions

380

2465

1.56

14.80

2.0

2.1

38.24

37.85

g/l

0.62

324

2139

Benign neoplasm: Caecum

208

1159

1.84

14.78

2.6

2.2

37.39

37.52

g/l

0.11

175

997

Pneumonia derived septicemia

289

2.77

14.78

4.2

2.6

36.87

37.48

g/l

0.35

247

Atopic dermatitis, strict definition

325

1990

1.61

14.74

1.8

2.0

38.22

38.69

g/l

0.67

287

1765

KRA_PSY_EATING, excluding more controls

269

2.77

14.73

1.4

1.7

39.17

39.39

g/l

0.13

236

Abnormal spermatozoa

1437

0.33

14.66

1.7

2.4

35.66

37.41

g/l

1.11

1233

Insomnia

227

1296

1.78

14.64

1.5

2.1

39.21

37.95

g/l

2.78

196

1139

Major coronary heart disease event

1289

6782

1.28

14.64

2.1

2.3

36.60

37.55

g/l

6.41

1106

5758

Agoraphobia

127

3.72

14.63

1.9

1.7

38.10

39.07

g/l

0.40

116

Ptosis of eyelid

214

1206

1.82

14.61

2.6

2.3

38.35

37.34

g/l

2.15

196

1036

Major coronary heart disease event excluding revascularizations

1199

6478

1.29

14.57

2.2

2.3

36.47

37.51

g/l

7.10

1026

5486

Acute pancreatitis

340

2161

1.60

14.57

1.7

2.2

36.46

37.58

g/l

2.47

299

1844

Excessive attrition of teeth

508

1865

1.49

14.55

2.0

1.9

38.87

38.02

g/l

2.42

434

1594

Fracture of forearm

842

5915

1.34

14.54

1.9

2.2

37.70

37.81

g/l

0.20

692

5027

Sequelae with surgical and medical care as external cause

352

2259

1.58

14.50

2.2

2.1

36.38

37.41

g/l

2.21

315

1911

Eosinophilia

139

3.68

14.47

2.5

1.8

36.22

37.69

g/l

0.89

123

Cholelithiasis

1392

7782

1.26

14.47

2.1

2.2

37.24

37.75

g/l

2.30

1177

6634

Collagenous colitis

166

866

1.96

14.45

3.2

2.2

37.24

37.60

g/l

0.32

144

750

Mental and behavioural disorders due to alcohol, excluding acute intoxication

698

5096

1.38

14.44

1.6

2.2

37.05

37.87

g/l

2.47

590

4462

769

5372

1.36

14.38

2.7

2.2

36.93

37.08

g/l

0.30

634

4470

Benign neoplasm of other and unspecified endocrine glands

228

1315

1.77

14.32

2.2

37.35

37.72

g/l

0.37

187

1145

Thyroiditis, ILD-related definition

174

923

1.92

14.30

2.5

2.2

38.85

38.05

g/l

1.03

151

799

Abnormal findings on diagnostic imaging of other body structures

228

1316

1.77

14.28

2.6

2.3

37.36

37.69

g/l

0.34

203

1129

Actinic keratosis

718

5017

1.38

14.27

2.8

2.2

36.86

37.00

g/l

0.28

592

4171

Other spirochaetal diseases

418

2795

1.52

14.21

2.7

2.2

38.75

37.82

g/l

2.38

344

2408

Nonischemic cardiomyopathy

116

535

2.23

14.16

1.8

2.1

35.77

37.68

g/l

2.18

457

Thyrotoxicosis, other and/or unspecified

306

1911

1.62

14.10

1.9

2.2

37.49

37.95

g/l

0.76

271

1643

Sequelae of injuries of lower limb

158

817

1.97

14.07

2.2

2.3

38.61

37.98

g/l

0.78

141

717

Allergic purpura

218

3.00

14.05

1.8

2.6

37.84

38.08

g/l

0.12

190

Oesophageal varices

368

2.51

14.04

1.5

2.3

33.89

37.84

g/l

6.07

316

Psoriasis vulgaris

304

1899

1.62

14.02

1.8

2.1

37.34

37.81

g/l

0.62

265

1666

Lyme disease

414

2771

1.51

14.02

2.7

2.2

38.77

37.82

g/l

2.43

340

2388

Opening and dilatation of root channel of tooth

106

472

2.30

14.01

2.4

2.3

37.65

38.15

g/l

0.34

420

Other and unspecified urticaria

278

1700

1.66

13.93

2.6

2.0

38.07

37.88

g/l

0.20

245

1479

Pneumococcal septicemia

276

2.75

13.84

4.3

2.7

36.99

37.51

g/l

0.29

236

Nonorganic sleeping disorders

255

1528

1.69

13.81

1.5

2.1

39.21

38.09

g/l

2.69

222

1348

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

780

5714

1.35

13.81

2.3

2.2

38.57

37.80

g/l

2.92

667

4946

Poisoning by drugs, medicaments and biological substances

304

1904

1.61

13.78

2.0

2.1

38.25

38.36

g/l

0.11

265

1692

Missing teeth due to accident, extraction or parodontitis

202

1138

1.81

13.77

3.0

2.0

36.79

37.54

g/l

0.94

177

976

Skin changes due to chronic exposure to nonionizing radiation

731

5134

1.36

13.75

2.7

2.2

36.91

37.02

g/l

0.20

603

4265

Diabetic retinopathy

581

2597

1.43

13.72

1.8

2.0

35.99

36.87

g/l

2.81

497

2232

Carcinoma in situ of skin

159

834

1.96

13.71

1.8

1.4

36.82

37.31

g/l

0.42

139

685

Myocardial infarction, without ST-elevation

745

5117

1.36

13.68

2.1

2.2

36.13

37.11

g/l

4.33

626

4279

Fracture of skull and facial bones

315

1995

1.60

13.67

2.3

2.1

37.66

38.01

g/l

0.42

272

1746

Sub-endpoint used in defining T1D endpoints

448

3006

1.48

13.67

1.8

2.0

35.84

37.74

g/l

9.05

397

2569

Benign neoplasm: Adrenal gland

141

711

2.04

13.61

1.9

1.4

36.54

37.97

g/l

1.63

115

602

Myeloid leukaemia

223

2.96

13.58

1.6

1.4

37.45

g/l

0.00

186

Bronchiectasis

168

901

1.92

13.54

2.8

2.3

36.61

37.65

g/l

1.37

150

749

Secondary and unspecified malignant neoplasm of lymph nodes, excluding all cancers (controls excluding all cancers)

256

1548

1.68

13.52

2.1

1.4

36.22

37.72

g/l

3.15

234

1302

Propionic acid derivatives

457

1539

1.50

13.51

2.3

2.1

38.06

36.95

g/l

3.08

395

1321

Other crystal arthropathies

171

3.29

13.50

1.6

2.0

35.75

36.81

g/l

0.52

138

Other complications of surgical and medical care, not elsewhere classified

164

872

1.92

13.46

2.7

2.1

37.24

37.77

g/l

0.49

142

753

Neuromuscular dysfunction of bladder

162

859

1.93

13.44

2.2

2.5

37.10

37.77

g/l

0.65

144

742

Myocardial infarction, strict

876

4863

1.33

13.39

2.0

2.3

36.24

37.44

g/l

6.89

749

4075

Primary biliary cholangitis (PBC)

182

3.17

13.36

1.4

1.9

37.39

38.55

g/l

0.64

161

Benign neoplasm: Stomach

194

1092

1.82

13.36

2.4

2.2

37.18

37.55

g/l

0.40

167

934

Paralytic ileus and intestinal obstruction

412

2781

1.50

13.34

2.2

36.62

37.37

g/l

1.41

350

2351

Pemphigoid

271

2.76

13.33

1.6

2.5

38.33

36.61

g/l

1.56

224

Congenital malformations, deformations and chromosomal abnormalities

767

5510

1.34

13.31

1.8

2.1

38.47

38.22

g/l

0.55

670

4783

Transient ischemic attack

935

5970

1.31

13.27

2.2

37.43

37.36

g/l

0.14

782

5034

Cardiomyopathy, Hypertrophic obstructive

157

3.36

13.27

1.5

2.4

37.16

38.74

g/l

0.94

134

Anti-inflammatory and antirheumatic products, non-steroids

455

1539

1.50

13.18

2.6

2.1

37.67

36.95

g/l

1.50

399

1321

Psoriatic arthropathies

153

800

1.95

13.18

1.8

2.2

37.59

38.08

g/l

0.40

131

699

Guillain-Barre syndrome

133

3.59

13.16

1.9

2.6

38.31

37.37

g/l

0.37

115

Cervical disc disorders

577

4157

1.40

13.11

2.2

2.1

38.49

37.57

g/l

3.12

490

3553

Localized swelling, mass and lump of skin and subcutaneous tissue

476

3319

1.45

13.05

2.1

2.2

37.76

37.59

g/l

0.23

410

2831

Early onset COPD

390

2622

1.51

12.99

2.1

2.3

36.23

37.87

g/l

5.94

343

2255

Special screening examination for neoplasms

387

2.39

12.98

3.4

2.3

37.19

37.11

g/l

0.05

338

Alcohol induced polyneuropathy

4.31

12.98

1.3

1.9

36.30

37.40

g/l

0.35

Dental caries 2

1047

6436

1.28

12.96

2.5

2.1

38.66

38.18

g/l

1.73

902

5611

Poisoning by medicine

274

1701

1.63

12.92

2.1

38.35

38.41

g/l

0.06

241

1511

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

224

1277

1.72

12.91

1.6

2.1

37.69

37.92

g/l

0.20

198

1122

Allergic rhinitis

354

2307

1.53

12.88

2.1

2.0

38.82

38.45

g/l

0.54

309

2029

Dental caries 2 and operation codes

1021

6336

1.29

12.82

2.5

2.1

38.70

38.18

g/l

1.94

880

5521

Restless leg syndrome

212

1238

1.75

12.81

2.2

38.45

37.61

g/l

1.15

181

1064

Drug-induced polyneuropathy

4.71

12.75

14.7

1.3

37.90

37.17

g/l

0.34

Stomatitis and related lesions

129

644

2.04

12.73

2.4

1.8

37.23

37.90

g/l

0.61

111

552

Inflammatory bowel disease

448

3103

1.46

12.71

2.2

2.1

37.62

38.12

g/l

0.88

383

2713

Fibroblastic disorders

388

2616

1.50

12.71

2.5

2.2

38.03

37.32

g/l

1.52

330

2213

Acute myeloid leukaemia and myelodysplastic syndromes

173

3.18

12.59

1.7

2.5

36.62

36.75

g/l

0.05

147

Bullous disorders

120

589

2.10

12.55

2.0

2.3

38.10

37.23

g/l

0.86

108

507

COPD, hospital admissions 3, with asthma pneumonia sepsis

505

3041

1.43

12.54

2.0

2.2

34.83

37.21

g/l

15.24

429

2535

Open wound of forearm

146

766

1.94

12.50

2.2

36.60

37.54

g/l

0.94

127

671

Vitamin B12 deficiency anaemia

202

1172

1.76

12.50

1.8

2.2

36.49

37.38

g/l

1.28

174

988

Macular pucker

288

1833

1.60

12.48

1.6

2.2

37.70

37.24

g/l

0.62

230

1543

Acute pancreatitis (for exclusion)

340

2242

1.54

12.44

1.7

2.1

36.46

37.49

g/l

2.17

299

1919

Lupus erythematosus

218

2.88

12.37

2.3

2.1

37.99

38.12

g/l

0.06

191

Carcinoma in situ of skin of lower limb, including hip

186

3.08

12.35

3.1

1.4

37.65

37.16

g/l

0.24

149

Other infectious diseases

149

792

1.93

12.34

2.8

2.1

34.88

37.51

g/l

4.48

133

685

Traumatic subdural haemorrhage

224

1318

1.70

12.31

2.4

2.1

36.93

36.64

g/l

0.27

178

1110

Disorders of synovium and tendon

747

5082

1.33

12.31

1.8

2.2

38.17

37.78

g/l

0.99

641

4349

Inflammatory diseases of the central nervous system

138

715

1.97

12.29

2.1

2.3

36.39

37.68

g/l

1.11

113

623

Lesion of lateral popliteal nerve

416

2.30

12.27

2.1

2.2

38.08

37.54

g/l

0.31

361

Demyelinating diseases of the central nervous system

123

612

2.05

12.25

1.6

2.1

39.40

38.15

g/l

1.26

109

540

COPD, hospital admission 2, with asthma infections

584

3630

1.39

12.25

1.9

2.2

35.10

37.29

g/l

14.93

497

3051

Other and unspecified visual disturbances

161

881

1.86

12.16

2.4

2.0

38.13

37.53

g/l

0.65

145

763

Specific personality disorders

281

1785

1.59

12.06

1.7

2.0

38.58

38.54

g/l

0.04

247

1584

Melanocytic naevi

376

2546

1.49

12.03

2.3

1.4

37.96

38.14

g/l

0.24

344

2191

Alcohol-induced chronic pancreatitis

120

598

2.06

12.01

2.0

2.4

36.09

37.78

g/l

1.69

101

531

Conjunctivitis (acute, non atopic)

370

2490

1.49

12.00

2.7

2.0

38.04

38.01

g/l

0.03

323

2152

Artificial opening status

112

546

2.12

11.96

2.6

2.1

35.97

37.61

g/l

1.54

100

476

Striking against or struck by other objects

430

2989

1.45

11.96

1.8

2.1

37.84

38.19

g/l

0.55

362

2619

Herpesviral [herpes simplex] infections

180

1023

1.79

11.95

3.3

2.2

37.50

37.82

g/l

0.28

163

888

Juvenile arthritis (FINNGEN)

198

2.88

11.95

1.8

1.9

38.90

38.64

g/l

0.11

175

Vitreous haemorrhage

178

1013

1.79

11.83

1.9

2.3

35.67

37.60

g/l

3.78

158

871

Other and unspecified mood [affective] disorders

364

2.34

11.82

1.6

2.2

38.15

38.71

g/l

0.36

319

Biomechanical lesions, not elsewhere classified

443

2.23

11.80

2.5

2.4

38.88

37.60

g/l

1.62

387

Coxarthrosis, primary

1053

7264

1.27

11.79

2.0

2.3

37.47

37.30

g/l

0.41

877

6134

Emotionally unstable personality disorder

132

682

1.96

11.77

1.5

1.8

39.19

38.76

g/l

0.37

119

614

Mental and behavioural disorders due to sedatives or hypnotics

102

481

2.16

11.76

1.4

2.2

38.95

38.24

g/l

0.51

424

Malignant neoplasm of urinary organs, excluding all cancers (controls excluding all cancers)

213

1277

1.70

11.73

1.9

1.4

36.32

37.59

g/l

2.18

187

1054

Internal derangement of knee

522

3760

1.39

11.71

1.7

2.3

38.22

37.94

g/l

0.52

438

3245

General examination and investigation of persons without complaint and reported diagnosis

902

3705

1.30

11.70

2.0

2.1

38.09

37.57

g/l

1.39

730

3233

Artificial joint re-operation

146

788

1.91

11.65

1.7

2.4

36.31

37.37

g/l

1.16

127

665

Disorders of vitreous body and globe

837

6332

1.30

11.59

2.1

2.3

37.59

37.56

g/l

0.04

718

5378

Benign neoplasm: Rectum

323

2144

1.53

11.57

2.2

37.01

37.46

g/l

0.66

288

1816

Alcohol use disorder, ICD-based

630

4701

1.35

11.54

1.6

2.2

37.14

37.89

g/l

1.98

537

4109

Dislocation, sprain and strain of joint and ligaments of hip

340

2.41

11.50

1.5

2.3

36.40

37.24

g/l

0.49

297

COPD-related respiratory insufficiency

229

1409

1.66

11.45

2.0

2.2

34.92

37.39

g/l

8.07

188

1166

Other diseases of lip and oral mucosa

249

1561

1.62

11.42

2.3

2.1

38.14

37.54

g/l

0.90

217

1320

Myeloid leukaemia

245

2.69

11.42

1.6

2.7

37.45

37.55

g/l

0.04

209

Other disorders of glucose regulation and pancreatic internal secretion

138

734

1.92

11.40

2.2

35.74

37.55

g/l

2.47

119

634

Suppurative and necrotic conditions of lower respiratory tract

108

529

2.10

11.39

2.5

2.4

34.01

37.45

g/l

6.08

459

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

364

2.32

11.39

1.5

1.8

38.89

38.62

g/l

0.14

334

Ocular pain

124

637

1.98

11.36

1.7

2.2

38.37

37.98

g/l

0.34

110

556

Benign neoplasm: Rectum, anus and anal canal

360

2453

1.49

11.33

2.2

2.1

37.12

37.42

g/l

0.41

320

2073

Chronic tubulo-interstitial nephritis

342

2.38

11.29

2.2

2.0

35.71

38.33

g/l

2.46

294

Myelodysplastic syndrome

4.05

11.20

1.8

1.9

37.41

35.80

g/l

0.71

Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)

220

1348

1.66

11.14

2.5

1.4

37.06

37.11

g/l

0.05

181

1077

Faecal incontinence

170

973

1.78

11.13

1.6

2.2

38.07

37.17

g/l

1.07

147

813

Transport accidents

576

3768

1.36

11.13

1.8

2.1

38.27

38.20

g/l

0.09

493

3333

Other disorders of skin and subcutaneous tissue, not elsewhere classified

238

1488

1.62

11.09

2.3

2.1

35.90

37.59

g/l

3.46

188

1264

Pain and other conditions associated with female genital organs and menstrual cycle

228

1348

1.64

11.06

1.8

1.9

40.03

38.39

g/l

4.64

193

1175

Disorders of vitreous body

812

6182

1.30

11.05

2.1

2.3

37.56

g/l

0.01

698

5256

Benign neoplasm of mouth and pharynx

179

1041

1.75

11.03

2.7

1.5

37.24

37.68

g/l

0.37

146

873

Ulcerative colitis

349

2373

1.48

11.00

2.4

2.0

37.83

38.07

g/l

0.29

300

2071

Traumatic subarachnoid haemorrhage

255

2.58

10.95

2.5

1.7

37.40

37.00

g/l

0.19

222

Social phobias

364

2.28

10.92

1.3

1.9

38.89

38.58

g/l

0.16

326

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

417

2928

1.43

10.92

2.0

2.1

38.71

38.55

g/l

0.24

365

2593

Ankylosing spondylitis

137

737

1.89

10.92

1.6

2.0

37.99

37.47

g/l

0.40

122

643

Candidiasis

207

1257

1.67

10.84

3.0

2.1

36.43

37.74

g/l

1.85

172

1080

Recurring oral aphthae, including avohilmo

215

1320

1.65

10.80

2.3

2.2

37.89

37.64

g/l

0.25

189

1135

Other diseases of pancreas

141

771

1.87

10.78

2.0

2.4

37.17

37.47

g/l

0.23

121

666

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

167

960

1.77

10.77

3.1

2.3

37.00

37.77

g/l

0.80

150

837

Infections with a predominantly sexual mode of transmission

335

2267

1.49

10.73

1.8

1.9

38.35

38.77

g/l

0.58

290

2008

Covid-19 suspected case

255

1632

1.58

10.68

2.8

2.1

37.74

38.44

g/l

1.01

222

1435

Sequelae of injuries, of poisoning and of other consequences of external causes

343

2341

1.48

10.65

2.5

2.1

38.22

37.99

g/l

0.31

293

2054

Gingival hyperplasia

247

2.59

10.65

1.9

34.68

37.48

g/l

2.13

211

Exclusions for E4_PCOS_BROAD

234

1471

1.61

10.60

3.1

2.0

37.31

37.98

g/l

0.84

212

1283

Other local infections of skin and subcutaneous tissue

161

920

1.78

10.57

2.8

2.2

35.85

37.81

g/l

3.50

138

802

Exclusions for E4_PCOS_CONSORTIUM

982

4886

1.27

10.55

2.1

37.67

38.11

g/l

1.34

825

4180

Cryoglobulinemia

13.44

10.49

4.9

1.0

37.92

36.96

g/l

—

Spondylolisthesis/Spondylolysis

275

1800

1.55

10.48

2.5

2.1

37.92

37.51

g/l

0.53

235

1538

Iridocyclitis

343

2353

1.47

10.40

2.3

2.0

37.86

37.79

g/l

0.07

302

2022

Pollen allergy

181

1059

1.70

10.38

2.4

2.0

38.76

38.80

g/l

0.03

155

952

Sarcoidosis

218

1359

1.63

10.33

2.0

2.1

38.36

37.81

g/l

0.73

196

1184

Hallux rigidus

226

1422

1.61

10.29

2.2

2.4

38.10

37.67

g/l

0.48

182

1202

Carbimazole or st.post thyroidectomy, condition for graves disease

296

1979

1.51

10.22

2.4

2.1

37.80

37.96

g/l

0.19

258

1702

Diagnoses used for exclusion with ILD

421

3009

1.41

10.21

2.2

2.1

37.51

37.44

g/l

0.08

360

2556

Hypermobility syndrome

263

2.48

10.21

2.3

1.8

39.94

38.39

g/l

1.30

248

Benign neoplasm: Adrenal gland

141

787

1.84

10.14

1.9

2.4

36.54

37.73

g/l

1.24

115

681

Delirium, not induced by alcohol and other psychoactive substances

204

1257

1.65

10.12

1.9

2.2

34.50

37.03

g/l

5.11

161

1052

Keratitis

500

3680

1.37

10.10

2.0

2.1

37.97

37.92

g/l

0.07

427

3168

Other and unspecified local infections of skin and subcutaneous tissue

150

853

1.79

10.05

2.9

2.2

35.68

37.87

g/l

4.05

132

746

Other inflammatory liver diseases

114

596

1.96

10.01

1.7

2.5

35.28

37.85

g/l

3.36

520

Other viral diseases, not elsewhere classified

236

1504

1.58

10.00

3.0

2.1

37.01

38.10

g/l

1.75

219

1321

Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)

184

1111

1.69

9.96

1.9

1.4

36.12

37.63

g/l

2.49

162

928

Fall involving bed

293

2.41

9.96

2.2

2.3

36.10

36.75

g/l

0.41

246

Dementia in Alzheimer disease

134

2010

0.56

9.94

1.5

2.2

36.44

36.51

g/l

0.04

1641

Other or unspecified ileus, impaction or obstruction

291

1951

1.51

9.92

2.1

36.50

37.36

g/l

1.24

245

1654

Other/unspecified enthesopathies of lower limb, excluding foot

109

563

1.97

9.88

1.8

2.0

38.37

37.67

g/l

0.51

100

491

Ulcerative ileocolitis

274

2.43

9.88

3.1

2.2

38.11

38.16

g/l

0.02

243

Lesion of ulnar nerve

219

1383

1.61

9.84

1.7

2.0

37.52

37.76

g/l

0.22

193

1214

Carcinoma in situ of skin

159

928

1.76

9.84

1.8

2.3

36.82

37.26

g/l

0.37

139

780

Speech and linguistic disorders, excluding more controls

303

2.29

9.83

1.8

2.0

37.77

38.23

g/l

0.25

253

Respiratory insufficiency

136

756

1.83

9.78

1.4

1.6

36.32

37.99

g/l

2.44

112

615

Other benign neoplasms of skin

539

3956

1.35

9.78

3.0

1.4

37.62

g/l

0.01

444

3327

Heartburn

163

958

1.73

9.72

1.9

2.3

38.52

37.64

g/l

1.17

135

821

Diplopia

209

1312

1.62

9.66

2.2

2.0

37.76

37.58

g/l

0.16

182

1131

Paraplegia, diplegia of upper limbs

183

2.79

9.65

1.8

2.7

35.41

38.05

g/l

1.68

158

Temporomandibular joint disorders, including avohilmo

484

3565

1.36

9.62

2.0

2.1

39.11

38.30

g/l

2.61

421

3104

Carpal tunnel syndrome

928

6726

1.25

9.62

2.1

2.2

37.97

37.74

g/l

0.60

817

5734

Alcohol abuse, main dg, excluding more controls

202

1260

1.62

9.53

1.2

2.4

37.19

38.10

g/l

0.96

172

1118

Vascular disorders of the intestines

124

679

1.87

9.48

2.1

35.40

37.14

g/l

2.23

108

568

Exposure to other and unspecified inanimate mechanical forces

101

517

1.99

9.43

2.5

2.4

38.11

37.89

g/l

0.13

450

Speech disturbances, not elsewhere classified

152

886

1.75

9.41

2.0

2.2

37.67

37.32

g/l

0.28

119

767

Algoneurodystrophy

214

2.59

9.39

1.3

1.8

39.91

38.33

g/l

1.28

194

Impacted cerumen

173

1046

1.69

9.35

1.7

2.2

37.46

37.41

g/l

0.03

107

904

Other diseases of stomach and duodenum

119

647

1.88

9.33

2.2

2.5

36.23

37.52

g/l

1.26

105

562

Other dermatomyositis

5.24

9.32

1.4

2.4

37.51

38.14

g/l

0.14

Malignant melanoma, excluding all cancers (controls excluding all cancers)

277

1866

1.50

9.31

2.1

1.5

37.85

37.61

g/l

0.27

230

1559

Oral leukoplakia and related diseases, including avohilmo

154

904

1.74

9.30

2.0

2.2

38.60

37.73

g/l

1.08

126

776

Benign neoplasm: Rectosigmoid junction

386

2.17

9.30

2.0

1.4

38.37

37.60

g/l

0.60

324

Mixed hyperlipidaemia

386

2.16

9.28

1.3

2.1

36.71

37.60

g/l

0.64

339

Other lack of coordination

137

3.06

9.26

1.8

2.7

39.42

37.27

g/l

1.25

117

Emphysema

133

750

1.81

9.26

2.5

2.3

35.09

37.40

g/l

4.18

120

634

Unspecified acute lower respiratory infection

216

1380

1.58

9.24

2.6

2.0

36.19

37.64

g/l

2.52

187

1190

Other specified and unspecified personality disorders

117

633

1.87

9.22

1.6

2.1

38.51

38.37

g/l

0.09

103

560

Abnormal results of function studies

133

750

1.80

9.21

2.3

2.4

38.02

37.93

g/l

0.06

113

664

Bullous pemphigoid

218

2.60

9.18

1.5

2.7

38.24

36.48

g/l

1.31

182

Hemiplegia

461

2.04

9.17

1.6

2.2

38.02

37.69

g/l

0.16

398

Other bursopathies

207

1313

1.60

9.17

2.3

2.0

37.59

37.34

g/l

0.23

181

1125

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

194

1210

1.62

9.15

1.8

2.2

38.65

38.39

g/l

0.24

167

1085

Alcohol-induced acute pancreatitis

310

2.29

9.15

2.3

2.7

36.58

37.78

g/l

0.65

273

Colonic or urogenital fistula

409

2966

1.39

9.15

2.2

2.1

38.08

37.83

g/l

0.36

349

2563

Anogenital herpesviral [herpes simplex] infection

334

2.22

9.15

1.7

38.73

38.76

g/l

0.02

297

Carcinoma in situ of skin of lower limb, including hip

220

2.59

9.06

3.1

2.3

37.65

36.78

g/l

0.51

181

Other shoulder lesions

132

746

1.80

9.05

1.5

1.8

38.26

37.81

g/l

0.32

119

647

Total colectomy

338

2.22

8.98

2.4

37.02

37.82

g/l

0.43

299

Total colectomy operation

338

2.22

8.98

2.4

37.02

37.82

g/l

0.43

299

Pyothorax

398

2.12

8.97

2.7

2.4

34.40

37.45

g/l

3.87

339

Superficial injury of abdomen, lower back and pelvis

206

1311

1.59

8.97

1.9

2.1

37.96

37.77

g/l

0.18

181

1140

Insulin, fast-acting (human)

189

1179

1.62

8.94

1.8

2.0

36.12

38.11

g/l

4.66

166

1038

Hydronephrosis

170

1035

1.67

8.92

1.8

2.0

35.77

38.05

g/l

4.89

152

879

Intestinal malabsorption

372

2.15

8.90

1.7

2.6

37.25

38.00

g/l

0.45

327

Intestinal adhesions without obstruction

143

833

1.75

8.89

2.7

2.0

37.70

37.48

g/l

0.15

117

704

Microscopic polyangiitis

4.21

8.84

1.6

2.0

31.31

37.11

g/l

2.57

Other localized connective tissue disorders

175

2.74

8.79

2.8

2.0

36.81

37.95

g/l

0.55

153

therapeutic use

297

2.31

8.79

1.6

2.2

37.36

37.61

g/l

0.10

253

Dermatographic urticaria

482

1.98

8.76

1.8

2.3

38.98

38.13

g/l

0.66

431

Abrasion of teeth

336

1731

1.44

8.75

2.5

2.0

38.68

37.97

g/l

1.27

284

1480

Mental and behavioural disorders due to opioids

180

2.66

8.74

1.7

1.6

38.93

38.64

g/l

0.09

164

Ascites

131

749

1.79

8.73

1.6

2.3

33.92

37.52

g/l

7.08

116

636

Monoamine oxidase A inhibitors

186

1165

1.62

8.71

1.8

2.3

38.18

37.62

g/l

0.60

165

1004

Synovial cyst of popliteal space [Baker]

124

698

1.81

8.69

2.7

1.9

37.71

37.33

g/l

0.30

111

591

Cervicobrachial syndrome

297

2055

1.46

8.68

2.0

2.1

38.93

37.73

g/l

3.12

268

1752

Multifocal fibrosclerosis

4.22

8.67

1.3

2.6

37.28

37.82

g/l

0.14

Otitis externa

306

2133

1.45

8.62

2.0

2.1

38.77

37.70

g/l

2.46

245

1862

Other specified/unspecified inflammatory spondylopathies

317

2.22

8.62

1.8

1.9

39.27

37.87

g/l

1.14

276

Abnormality of white blood cells, not elsewhere classified

4.14

8.61

2.2

1.8

37.09

38.71

g/l

0.69

Dermatopolymyositis, unspecified

4.87

8.60

6.2

2.8

36.89

38.27

g/l

0.36

Ankylosing spondylitis, ICD10

131

751

1.77

8.59

1.6

2.3

38.05

37.96

g/l

0.05

116

668

Problems related to lifestyle

131

751

1.77

8.56

1.5

2.3

37.58

38.12

g/l

0.38

114

653

Allergic urticaria

113

621

1.85

8.53

1.8

2.2

38.00

37.88

g/l

0.08

544

Carcinoma in situ of skin of ear and external auricular canal

128

3.06

8.50

1.7

1.4

36.42

36.36

g/l

0.02

100

Calculus of kidney and ureter

481

3623

1.34

8.47

2.1

2.2

37.43

37.52

g/l

0.12

422

3117

Inflammatory diseases of female pelvic organs

778

4673

1.26

8.45

1.6

2.2

38.35

38.09

g/l

0.60

651

3985

Hyperplasia of prostate

628

2768

1.30

8.44

2.2

2.4

37.65

37.30

g/l

0.65

539

2431

Hypoglycaemia, other or unspecified

105

567

1.89

8.41

1.7

2.3

35.88

37.55

g/l

1.81

495

Deviated nasal septum

497

3767

1.33

8.32

2.8

2.3

38.70

37.66

g/l

4.03

436

3297

Neuralgia and neuritis, unspecified

409

2.05

8.31

2.7

1.8

38.29

37.51

g/l

0.54

357

Other disorders of gingiva or/and edentulous alveolar ridge

396

2.06

8.28

2.2

1.9

34.84

37.88

g/l

3.24

340

Thyrotoxicosis with toxic multinodular goitre

114

638

1.83

8.22

1.5

2.2

36.52

37.49

g/l

1.25

535

Carcinoma in situ of skin of trunk

306

2.24

8.22

2.3

1.4

36.04

36.99

g/l

0.68

248

Drug-induced cataract

199

2.55

8.21

2.5

2.7

37.75

37.70

g/l

0.02

174

Injuries to the neck

288

2004

1.45

8.20

2.8

2.0

38.40

38.02

g/l

0.44

243

1752

Hypothyroidism, other/unspecified

1353

7535

1.19

8.19

2.0

2.2

37.87

37.73

g/l

0.34

1155

6444

Other infective otitis externa

523

1.91

8.18

2.2

2.3

39.11

37.66

g/l

1.75

456

Follicular lymphoma

427

2.03

8.16

1.5

1.4

36.83

37.76

g/l

0.69

361

Asthma and opportunity respiratory infection

504

1.94

8.15

2.5

36.38

37.15

g/l

0.59

425

Personal history of other diseases and conditions

121

687

1.77

8.05

3.2

2.0

38.09

38.78

g/l

0.66

100

604

Other symptoms and signs involving the circulatory and respiratory systems

518

1.90

8.05

1.5

2.3

37.69

37.93

g/l

0.12

443

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

328

2343

1.41

8.04

1.8

2.0

38.54

38.38

g/l

0.18

282

2081

Eating disorder

358

2.08

8.04

1.4

1.6

39.17

39.30

g/l

0.08

324

Symptoms and signs involving emotional state

183

2.58

7.98

1.5

2.0

37.88

38.82

g/l

0.56

158

Secondary malignant neoplasm of respiratory and digestive organs, excluding all cancers (controls excluding all cancers)

112

1932

0.57

7.96

2.0

1.4

36.34

37.62

g/l

1.14

1617

Other disorders of the musculoskeletal system and connective tissue

234

1579

1.50

7.90

2.2

37.43

37.50

g/l

0.07

211

1364

Postmenopausal bleeding

456

1868

1.35

7.89

2.1

2.0

37.54

37.27

g/l

0.40

374

1584

Parkinson's disease, excluding more controls

227

1483

1.51

7.87

2.1

38.10

36.83

g/l

2.87

184

1252

Artificial joint operation, meniscal resection

1488

8452

1.18

7.87

2.0

2.2

37.38

37.63

g/l

0.85

1258

7237

Alcohol dependence

406

3017

1.36

7.86

1.5

2.3

36.98

37.89

g/l

1.86

341

2646

Benign neoplasm: Descending colon

118

678

1.78

7.80

2.1

1.4

36.21

37.83

g/l

1.76

571

Left bundle-branch block

118

677

1.78

7.80

1.7

2.2

36.74

38.32

g/l

1.88

557

Acute posthaemorrhagic anaemia

306

2.18

7.74

3.1

2.6

35.10

37.03

g/l

1.39

257

Mental disorders, not otherwise specified

103

568

1.84

7.72

1.8

2.0

38.38

38.42

g/l

0.02

504

Primary gonarthrosis, bilateral

857

6124

1.23

7.71

1.8

2.3

37.17

37.50

g/l

0.87

725

5169

Abscess of anal and rectal regions

115

656

1.78

7.71

1.3

2.0

37.20

38.12

g/l

0.89

103

585

Epilepsy

432

3239

1.34

7.71

1.9

2.3

37.40

37.54

g/l

0.17

357

2775

Inguinal hernia

916

5059

1.23

7.68

2.6

2.1

37.85

37.56

g/l

0.74

796

4334

Colectomy operation

282

1984

1.44

7.67

2.6

2.1

36.29

37.40

g/l

2.09

239

1678

Other and unspecified glaucoma

131

779

1.72

7.66

1.8

2.4

36.55

37.13

g/l

0.49

108

647

Benign neoplasm of mouth and pharynx

179

1149

1.58

7.65

2.7

2.2

37.24

37.65

g/l

0.33

146

998

Hypothyreosis and Thyroxine purchase for inclusion criteria

1404

7894

1.18

7.61

2.0

2.2

37.81

37.73

g/l

0.18

1197

6750

Carcinoma in situ of skin of trunk

316

2.17

7.61

2.3

2.2

36.04

36.73

g/l

0.45

269

Familial hypercholesterolemia

252

1739

1.47

7.60

2.4

2.1

37.21

37.35

g/l

0.13

206

1436

Retinal vascular occlusion

210

1399

1.52

7.59

2.3

2.2

36.29

37.22

g/l

1.28

182

1164

Intestinal stricture

482

3692

1.32

7.59

2.2

36.52

37.40

g/l

2.14

406

3125

Fall on same level involving ice and snow

824

6724

1.23

7.57

1.9

2.2

37.74

37.73

g/l

0.01

684

5753

Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)

624

4331

1.27

7.56

2.5

1.4

35.84

37.58

g/l

8.66

551

3644

Other skin changes

263

1833

1.45

7.53

2.8

2.2

36.79

37.19

g/l

0.49

219

1563

Parkinson's disease, strict definition, excluding more controls

211

1381

1.52

7.51

2.0

2.1

38.24

36.78

g/l

3.33

172

1166

Retinal detachment with retinal break

215

1443

1.51

7.49

2.2

36.72

37.53

g/l

1.05

183

1232

Other/unspecified disorders of vestibular function

378

2.04

7.49

1.7

2.3

37.54

g/l

0.00

327

Superficial injury of shoulder and upper arm

156

974

1.62

7.47

2.1

38.15

37.67

g/l

0.44

129

854

Retinal vascular disorders

212

1420

1.52

7.47

2.3

2.2

36.31

37.24

g/l

1.30

184

1181

Other demyelinating diseases of the central nervous system

226

2.35

7.47

1.5

1.9

39.22

38.80

g/l

0.17

206

Cyst of kidney

124

733

1.73

7.43

2.6

2.4

37.73

37.54

g/l

0.14

115

632

Dipeptidyl peptidase 4 (DPP-4) inhibitors

210

1407

1.52

7.41

1.5

2.2

35.32

37.57

g/l

5.25

181

1197

Disorders of orbit

379

2.02

7.40

2.9

2.4

38.40

38.01

g/l

0.27

332

Other specified/unspecified bacterial intestinal infections

111

638

1.77

7.34

2.3

37.01

37.71

g/l

0.45

554

Angina pectoris

1022

5749

1.21

7.29

2.2

2.3

37.00

37.59

g/l

2.35

895

4848

Melanoma in situ

403

1.99

7.29

2.2

1.4

37.12

37.28

g/l

0.08

333

Benign neoplasm: Other and unspecified parts of mouth

294

2.17

7.28

2.7

1.3

37.16

38.08

g/l

0.45

253

Superficial injury of thorax

210

1410

1.51

7.27

1.4

2.2

37.10

37.52

g/l

0.41

171

1218

Procreative management

349

2155

1.37

7.26

1.6

1.9

39.37

38.47

g/l

2.02

317

1905

Suicide or other Intentional self-harm

296

2118

1.41

7.26

1.9

2.1

38.45

38.26

g/l

0.21

256

1879

Acute and subacute iridocyclitis

273

1930

1.43

7.22

2.4

2.1

37.98

37.82

g/l

0.16

241

1672

Nummular dermatitis

129

776

1.69

7.21

2.2

2.4

38.67

37.73

g/l

1.12

109

670

Mental and behavioural disorders due to use of other stimulants, including caffeine

111

2.94

7.21

1.1

1.5

38.60

40.04

g/l

0.46

102

Other juvenile arthritis

162

2.57

7.20

1.9

1.6

38.84

38.58

g/l

0.10

147

Unspecified nephritic syndrome

206

2.41

7.19

1.9

2.6

36.74

37.62

g/l

0.38

177

Other/unspecified rheumatoid arthritis

211

1424

1.50

7.18

1.7

2.1

36.36

37.31

g/l

1.52

180

1189

Other obstetric conditions, not elsewhere classified

225

982

1.49

7.17

1.4

1.7

39.77

39.66

g/l

0.10

203

892

D07AA Corticosteroids, weak (group I)

181

1180

1.55

7.14

1.7

2.2

38.34

38.12

g/l

0.20

152

1034

Disorders of vestibular function (Vertigo)

726

5849

1.24

7.12

2.0

2.2

38.28

37.44

g/l

3.71

602

4929

Secondary thrombocytopenia

102

3.09

7.12

2.9

1.6

36.16

37.83

g/l

0.85

Diabetic retinopathy, strict definition

269

1667

1.43

7.11

1.6

1.9

35.33

36.98

g/l

4.10

224

1433

Urolithiasis

511

3981

1.29

7.11

2.1

2.2

37.40

37.48

g/l

0.09

445

3417

Olecranon bursitis

548

1.82

7.11

2.0

1.9

37.07

37.27

g/l

0.11

476

Anterior Iridocyclitis

291

2087

1.41

7.09

2.3

2.1

37.92

37.76

g/l

0.18

257

1809

Carcinoma in situ of skin of ear and external auricular canal

142

2.75

7.07

1.7

2.3

36.42

36.80

g/l

0.13

113

Acute pharyngitis

153

957

1.60

7.03

2.8

2.0

38.41

38.42

g/l

0.01

140

851

Crushed, pushed or stepped on by crowd or human stampede

442

1.90

6.98

2.8

2.2

37.71

38.27

g/l

0.33

392

Hyperhidrosis

159

2.57

6.98

3.1

2.5

40.31

38.35

g/l

1.90

138

Benign neoplasm: Rectosigmoid junction

432

1.93

6.91

2.0

2.7

38.37

37.24

g/l

1.03

372

Folate deficiency anaemia

3.34

6.90

2.5

1.7

34.53

37.72

g/l

1.05

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

228

2.28

6.88

1.6

1.7

36.48

39.22

g/l

2.95

209

Blepharochalasis

469

3632

1.30

6.88

1.9

2.2

37.81

37.32

g/l

1.04

389

3069

Sacroiliitis, not elsewhere classified

260

2.19

6.88

2.1

1.6

38.53

38.11

g/l

0.16

229

Complications of cardiac and vascular prosthetic devices, implants and grafts

199

2.40

6.80

1.8

2.8

35.31

36.87

g/l

0.78

164

Other orthopaedic follow-up care

505

1.84

6.79

1.8

2.0

37.79

38.26

g/l

0.29

439

Superficial injury of ankle and foot

130

795

1.65

6.78

1.7

2.2

37.51

38.16

g/l

0.55

107

706

Parodontitis, under 40 years

294

2.09

6.77

1.3

38.20

39.87

g/l

1.03

267

Parodontitis, under 40 years, or operation codes

294

2.09

6.77

1.3

38.20

39.87

g/l

1.03

267

Dissociative [conversion] disorders

217

2.30

6.76

1.2

1.8

39.60

38.12

g/l

0.85

191

Exfoliative dermatitis

3.19

6.76

1.6

2.7

37.28

37.43

g/l

0.04

Vitamin deficiency, wide

413

1.93

6.75

2.6

2.3

36.77

37.70

g/l

0.71

357

Vitamin deficiency

413

1.93

6.75

2.6

2.3

36.77

37.70

g/l

0.71

357

Diseases of male genital organs

777

3194

1.24

6.75

2.0

2.3

37.74

37.64

g/l

0.15

686

2817

Diseases of the ear and mastoid process

1788

7903

1.15

6.71

2.1

38.39

37.68

g/l

5.13

1516

6863

Bacterial, viral and other infectious agents

111

654

1.72

6.70

2.8

2.2

37.20

38.08

g/l

0.71

100

585

Adhesive capsulitis of shoulder

244

1720

1.43

6.61

1.8

2.0

38.10

37.54

g/l

0.73

208

1472

Melanoma in situ of other and unspecified parts of face

107

2.97

6.60

2.3

1.2

36.06

37.19

g/l

0.39

Anosmia

2.95

6.58

2.3

1.2

37.06

39.33

g/l

0.82

Trigger finger

192

1294

1.50

6.57

1.6

2.0

38.16

37.69

g/l

0.52

171

1126

Other symptoms and signs involving the nervous and musculoskeletal systems

562

4472

1.26

6.57

1.9

2.2

39.03

37.70

g/l

5.89

489

3823

Panniculitis affecting regions of neck and back

306

2.07

6.56

1.9

39.32

37.69

g/l

1.44

264

Fracture at wrist and hand level

443

3424

1.30

6.53

2.1

2.2

38.29

38.03

g/l

0.39

380

2971

Alcohol abuse, main dg

202

1377

1.48

6.53

1.2

2.1

37.19

37.85

g/l

0.62

172

1229

Other congenital malformations

547

1.77

6.50

1.7

2.3

39.41

38.26

g/l

1.04

483

Post-traumatic stress disorder

333

2.00

6.50

1.3

1.9

39.91

38.93

g/l

0.72

301

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

213

939

1.48

6.49

1.3

1.6

39.67

39.72

g/l

0.05

193

855

Other disorders of bladder

190

1283

1.50

6.49

2.2

2.3

37.25

37.60

g/l

0.31

157

1091

Lung cancer and mesothelioma

295

1837

1.39

6.48

2.2

1.9

36.30

38.03

g/l

5.12

258

1528

Other specified/unspecified soft tissue disorders

433

1.88

6.48

2.5

1.9

38.25

37.18

g/l

0.97

365

Follicular cysts of skin and subcutaneous tissue

257

1835

1.41

6.48

2.6

2.1

37.30

37.77

g/l

0.66

232

1594

Disorders of optic nerve and visual pathways

129

799

1.64

6.46

2.4

2.3

37.91

38.00

g/l

0.05

112

699

Speech and linguistic disorders

373

1.92

6.45

1.8

1.9

37.93

38.43

g/l

0.27

325

COPD, hospital admissions 1, only main diagnosis

592

4043

1.26

6.42

2.0

2.2

35.61

37.26

g/l

9.28

497

3412

Pneumothorax

112

671

1.70

6.42

2.3

2.1

37.54

37.74

g/l

0.12

100

579

Injuries to the wrist and hand

1417

8891

1.16

6.40

2.0

2.2

37.98

37.86

g/l

0.31

1230

7661

Benign neoplasm: Pancreas

237

2.22

6.38

2.7

1.4

37.94

37.63

g/l

0.17

194

Follicular lymphoma, hilmo

466

1.85

6.36

1.5

2.8

36.82

37.41

g/l

0.37

403

MS-disease / Multiple Sclerosis

493

1.81

6.35

1.6

2.1

39.97

38.39

g/l

1.53

435

Xerosis cutis

150

2.58

6.34

1.7

2.6

37.20

37.70

g/l

0.19

130

Melanocytic naevi of trunk

150

967

1.57

6.34

2.1

1.4

38.32

38.01

g/l

0.30

137

826

Suggestive for eosinophilic asthma

146

937

1.58

6.33

2.1

2.2

36.88

37.68

g/l

0.91

134

808

Benign neoplasm of major salivary glands

147

945

1.58

6.32

1.9

1.4

38.25

37.64

g/l

0.52

127

793

Cervicocranial syndrome

147

944

1.58

6.32

1.8

2.1

38.77

37.38

g/l

2.46

132

803

Special screening examination for other diseases and disorders

108

642

1.70

6.32

3.2

2.2

38.34

37.58

g/l

0.68

557

Arthropathic psoriasis

164

1080

1.54

6.32

1.8

2.3

37.51

37.79

g/l

0.21

141

955

Other disorders of optic [2nd] nerve and visual pathways

532

1.78

6.30

2.4

2.5

37.30

37.71

g/l

0.23

469

Fracture of neck

100

585

1.74

6.29

3.6

2.2

37.56

37.34

g/l

0.12

507

Disorders of psychological development

470

1.79

6.25

1.7

1.8

37.95

38.65

g/l

0.43

413

Gonarthrosis, primary, with knee surgery

945

6498

1.19

6.25

2.0

2.3

36.87

37.42

g/l

2.03

800

5488

Superficial injury of wrist and hand

230

1621

1.43

6.23

1.8

2.1

38.23

38.18

g/l

0.04

197

1426

Melanocytic naevi

376

2865

1.32

6.23

2.3

2.1

37.96

38.02

g/l

0.07

344

2475

Dermatitis due to substances taken internally

439

1.85

6.21

3.4

2.7

37.23

37.54

g/l

0.19

380

Malignant neoplasm of bone and articular cartilage, excluding all cancers (controls excluding all cancers)

145

2.57

6.21

6.8

1.2

39.35

37.61

g/l

1.45

122

Inflammatory disease of uterus

158

1036

1.54

6.18

1.8

2.0

38.29

38.40

g/l

0.09

134

911

Portal vein thrombosis

128

2.68

6.17

1.8

2.0

35.91

37.59

g/l

0.67

112

Diseases of inner ear

835

6830

1.20

6.13

1.9

2.2

38.32

37.50

g/l

3.89

693

5790

Assault

132

832

1.60

6.13

1.7

2.2

37.68

38.35

g/l

0.46

112

754

Other and unspecified erythematous conditions

274

2.10

6.13

2.5

2.2

38.46

37.86

g/l

0.36

236

Congenital malformations of the circulatory system

171

1107

1.51

6.10

1.4

2.2

38.00

g/l

0.00

145

973

Squamous cell neoplasms and carcinomas of the skin

220

1549

1.44

6.09

2.5

2.2

37.06

36.90

g/l

0.15

181

1275

Parodontitis, under 40 years and operation codes

273

2.07

6.07

1.3

38.19

39.90

g/l

1.05

252

Amenorrhoea

370

1.91

6.07

2.0

1.8

39.42

38.43

g/l

0.69

330

Carcinoma in situ of other and unspecified digestive organs

236

2.19

6.04

2.2

1.3

35.09

37.46

g/l

1.64

198

Carcinoma in situ of colon

118

2.75

6.04

2.5

1.3

34.62

37.29

g/l

1.47

Crohn's disease NAS

487

1.79

6.02

1.8

2.3

36.22

38.08

g/l

1.39

431

Parodontitis, operation under 40 years and operation codes

274

2.06

6.02

1.3

38.19

39.91

g/l

1.05

253

Childhood asthma (age<16), excluding more controls

329

1.86

6.01

1.5

1.4

39.51

40.70

g/l

1.00

300

Hernia of abdominal wall

674

5532

1.23

6.00

2.2

37.39

37.63

g/l

0.45

595

4731

Hyperkinetic disorders, excluding more controls

260

2.07

5.99

1.3

1.7

39.76

39.95

g/l

0.09

234

Umbilical hernia

378

2901

1.31

5.98

2.0

2.2

36.85

37.76

g/l

1.97

340

2538

Palmar fascial fibromatosis [Dupuytren]

250

1809

1.40

5.89

2.5

2.1

37.72

37.10

g/l

0.83

209

1524

Other disorders of patella

186

1274

1.47

5.89

1.9

2.3

39.31

38.27

g/l

1.59

163

1126

Arterial embolism and thrombosis

573

1.72

5.89

1.4

2.3

34.83

37.26

g/l

3.02

482

Idiopathic pulmonary fibrosis

134

860

1.59

5.88

2.1

2.3

35.66

37.24

g/l

2.38

117

729

Other and unspecified psoriasis

106

642

1.68

5.88

2.2

2.4

37.47

37.78

g/l

0.23

560

Ectropion of eyelid

413

1.86

5.84

1.5

2.3

36.76

36.43

g/l

0.17

331

Childhood asthma (age<16)

333

1.84

5.82

1.5

1.4

39.51

40.62

g/l

0.90

304

Benign neoplasm: Descending colon

118

738

1.63

5.79

2.1

2.3

36.21

37.47

g/l

1.21

641

Eating disorders

551

1.72

5.79

2.0

1.8

38.72

38.77

g/l

0.03

488

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

335

2544

1.33

5.75

1.4

2.4

36.59

38.28

g/l

5.02

295

2235

Melanoma in situ

438

1.83

5.73

2.2

2.6

37.12

37.15

g/l

0.02

376

Congenital malformations of cardiac septa

435

1.80

5.72

1.4

2.3

37.92

38.34

g/l

0.20

381

Sulfonylureas

645

4220

1.23

5.70

1.7

2.3

35.54

37.13

g/l

8.51

540

3499

Other and unspecified injuries of lower leg

563

1.71

5.69

2.0

2.2

36.61

38.02

g/l

1.14

493

Atypical facial pain

438

1.81

5.67

2.0

2.3

38.16

37.98

g/l

0.10

374

Dental caries 2, only avohilmo

948

6346

1.18

5.65

2.5

2.1

38.88

38.18

g/l

3.07

810

5532

Other/unspecified enthesopathies, not elsewhere classified

131

843

1.57

5.65

1.5

1.8

38.23

37.41

g/l

0.83

116

725

Thrombotic microangiopathy

4.04

5.65

5.0

1.5

36.57

37.82

g/l

0.32

Undefined dementia

1247

0.58

5.65

1.4

2.1

34.49

36.22

g/l

1.27

983

Ulcerative colitis, NAS

177

1213

1.47

5.64

2.1

2.2

38.08

37.97

g/l

0.09

156

1063

Systemic disorders of connective tissue in diseases classified elsewhere

4.83

5.64

5.2

1.2

39.85

38.05

g/l

0.41

Disorders of ocular muscles, binocular movement, accommodation and refraction

570

4589

1.24

5.63

2.2

2.1

38.52

38.08

g/l

0.97

503

3966

Somnolence, stupor and coma

374

1.88

5.63

1.2

2.8

35.64

37.63

g/l

1.55

322

Cardiac arrest

445

1.75

5.62

2.1

35.42

39.21

g/l

5.50

361

Other and/or unspecified nontoxic goitre

135

877

1.56

5.61

2.3

2.2

38.36

37.59

g/l

0.84

121

746

Ovarian cyst

470

2141

1.28

5.61

1.7

2.0

38.22

37.67

g/l

1.22

403

1835

Adenomyosis (Endometriosis of uterus)

199

1397

1.44

5.60

2.3

2.1

38.36

37.31

g/l

1.72

174

1195

Misadventures to patients during surgical and medical care

199

1398

1.44

5.58

1.9

2.1

36.05

37.59

g/l

2.63

171

1200

Benign neoplasm: Other and unspecified parts of mouth

326

1.95

5.58

2.7

2.6

37.16

37.74

g/l

0.26

283

Respiratory disorders in diseases classified elsewhere

123

2.63

5.57

1.6

2.2

36.40

37.78

g/l

0.78

108

Hypothyroidism, strict autoimmune, 3 medication purchases required

1239

7323

1.16

5.57

1.8

2.2

37.84

37.75

g/l

0.18

1053

6241

Tubulo-interstitial nephritis, not specified as acute or chronic

101

613

1.67

5.55

2.6

1.9

36.14

38.09

g/l

1.92

526

Golimumab

197

2.22

5.55

1.3

1.6

37.14

38.77

g/l

0.88

187

Chronic laryngitis and laryngotracheitis

206

1458

1.43

5.55

1.6

2.1

36.90

37.56

g/l

0.66

167

1249

Other follicular disorders

530

1.72

5.53

1.9

2.3

38.77

38.11

g/l

0.52

468

Benign neoplasm: Skin of eyelid, including canthus

221

1585

1.41

5.52

3.0

1.4

37.75

37.69

g/l

0.05

184

1317

Other erythematous conditions

306

1.97

5.52

2.5

2.1

38.04

37.70

g/l

0.17

267

Persons encountering health services in other circumstances

466

3708

1.26

5.50

2.3

2.1

37.52

37.95

g/l

0.82

417

3131

Benign neoplasm: Small intestine

385

1.86

5.50

2.5

1.4

36.82

37.83

g/l

0.69

325

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

349

1.91

5.50

2.2

2.5

38.08

37.66

g/l

0.25

304

Bronchitis, not specified as acute or chronic

126

809

1.58

5.50

2.0

2.2

38.60

37.84

g/l

0.69

106

678

Systemic atrophies primarily affecting the central nervous system

407

1.83

5.48

1.3

2.6

39.31

37.42

g/l

2.14

352

Nontoxic goitre/thyroid nodule

447

3549

1.27

5.47

2.1

2.2

38.15

37.49

g/l

1.53

377

2982

Barrett oesophagus

481

1.76

5.46

2.0

2.6

36.37

37.54

g/l

0.93

418

Disorders of oesophagus in diseases classified elsewhere

193

2.25

5.46

3.8

2.5

34.26

37.29

g/l

2.01

160

Mononeuritis multiplex

5.49

5.40

2.5

4.5

40.39

38.75

g/l

0.41

Disorders of speech understanding and production

215

2.13

5.37

2.0

2.3

36.73

37.86

g/l

0.50

181

Cluster headache, strict

233

2.10

5.37

1.8

2.8

41.34

38.34

g/l

2.76

208

Specific development disorders of speech and language

269

1.99

5.36

2.0

2.1

37.39

38.14

g/l

0.35

232

Exophthalmic conditions

2.94

5.35

4.0

1.9

37.45

38.13

g/l

0.32

Acute gastritis

120

768

1.58

5.34

1.5

2.3

37.04

37.34

g/l

0.21

664

Open wound of hip and thigh

227

2.11

5.34

1.3

2.7

38.04

38.09

g/l

0.02

203

Hyperaldosteronism

248

2.07

5.33

2.4

2.6

36.43

37.44

g/l

0.59

217

Otalgia

106

659

1.63

5.32

1.7

2.1

38.61

37.82

g/l

0.66

572

Visual impairment including blindness (binocular or monocular)

104

645

1.64

5.29

2.3

2.0

37.22

37.30

g/l

0.04

543

Injury of eye and orbit

170

1172

1.46

5.28

1.4

2.1

37.47

38.15

g/l

0.67

140

1045

Unspecified dementia

1198

0.59

5.24

1.4

2.2

34.49

36.34

g/l

1.40

974

Coronary revascularization (ANGIO or CABG)

791

4644

1.19

5.23

1.8

2.3

36.39

37.39

g/l

4.69

693

3891

Crohn disease

155

1052

1.49

5.22

1.6

2.2

36.96

37.97

g/l

0.92

134

924

IBD patients in KELA-register

272

2034

1.35

5.22

2.3

2.0

37.56

38.25

g/l

0.98

239

1797

Psoriatic arthropathies, ICD10

149

1005

1.50

5.21

1.8

2.3

37.59

37.82

g/l

0.16

127

881

Maternal care for other conditions predominantly related to pregnancy

175

1199

1.45

5.19

1.6

1.8

39.20

39.34

g/l

0.11

155

1085

Benign neoplasm: Kidney

299

1.95

5.19

2.3

1.4

38.58

37.62

g/l

0.64

247

Cholecystectomy

1065

8138

1.16

5.19

2.1

2.2

37.39

37.66

g/l

0.72

906

6905

Other and unspecified iridocyclitis

349

1.87

5.16

3.0

2.2

37.54

37.95

g/l

0.22

307

Benign neoplasm: Duodenum

238

2.08

5.15

2.9

1.4

36.46

37.74

g/l

0.67

195

Benign neoplasm: Parotid gland

116

744

1.58

5.14

2.0

1.4

38.18

37.76

g/l

0.27

100

622

Disorders of synovium and tendon in diseases classified elsewhere

159

2.33

5.12

1.7

37.75

37.09

g/l

0.23

139

Ventral hernia

350

2721

1.30

5.11

2.4

2.1

37.54

37.62

g/l

0.09

302

2298

Perineal laceration during delivery

741

0.49

5.09

1.3

1.6

41.31

39.49

g/l

2.44

672

Chronic hepatitis, not elsewhere classified

287

1.96

5.08

1.6

2.7

37.84

38.40

g/l

0.27

255

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

327

2521

1.30

5.06

1.6

2.1

38.48

38.13

g/l

0.48

287

2216

Superficial injury of forearm

113

722

1.58

5.06

1.7

2.1

38.19

37.86

g/l

0.25

642

Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)

212

1535

1.40

5.06

2.1

1.4

38.12

37.59

g/l

0.70

176

1287

Plantar fascial fibromatosis

129

850

1.53

5.04

2.7

1.9

39.35

37.77

g/l

3.40

114

737

Event of undetermined intent

454

1.74

5.04

2.0

2.3

37.92

38.04

g/l

0.06

404

Carcinoma in situ of other and unspecified digestive organs

254

2.03

5.04

2.2

2.8

35.09

37.07

g/l

1.25

213

Autoimmune hyperthyroidism

447

1.74

5.02

2.1

2.4

38.30

38.54

g/l

0.16

389

Dental caries 1 and operation codes, only avohilmo

385

1505

1.29

5.02

2.5

2.6

37.96

37.83

g/l

0.15

341

1283

Other disorders of nervous system

103

647

1.62

5.01

2.3

2.2

38.45

37.67

g/l

0.76

563

Dermatophytosis

190

1353

1.42

5.00

2.4

2.1

37.26

37.66

g/l

0.45

165

1162

Oral leukoplakia and related diseases

578

1.66

5.00

1.6

2.4

37.97

37.38

g/l

0.44

501

Triptan medication for migraine, min. 3 purchases

578

3747

1.22

4.99

2.1

2.0

39.35

38.57

g/l

2.69

506

3300

Coronary artery bypass grafting

491

3023

1.25

4.98

1.6

2.3

35.95

37.20

g/l

4.54

427

2509

Disorders of refraction and accommodation

291

2207

1.32

4.94

2.1

2.0

38.62

38.14

g/l

0.66

259

1923

Rosacea

154

1058

1.47

4.93

2.0

2.2

38.00

37.89

g/l

0.07

140

919

Hepatic failure, not elsewhere classified

319

1.89

4.92

1.6

2.8

33.87

37.53

g/l

3.38

273

Chondrocostal junction syndrome [Tietze]

312

1.90

4.90

1.9

2.0

37.84

37.86

g/l

0.01

270

Disorders of purine and pyrimidine metabolism

3.38

4.90

1.6

1.2

36.26

37.00

g/l

0.19

Other disorders of penis

133

889

1.51

4.88

1.7

2.2

37.35

37.46

g/l

0.06

110

772

Other/unspecified synovitis and tenosynovitis

152

1043

1.47

4.88

1.8

1.9

37.59

37.67

g/l

0.05

132

894

Benign neoplasm: Spinal meninges

2.79

4.86

1.3

1.2

37.14

38.03

g/l

0.19

Other symptoms and signs involving the urinary system

151

1039

1.47

4.81

2.2

2.3

37.06

37.48

g/l

0.31

127

883

Benign neoplasm of breast

158

1096

1.46

4.81

2.0

1.4

39.07

37.96

g/l

1.53

131

911

Extreme obesity with alveolar hypoventilation

365

1.82

4.81

1.4

2.6

35.69

37.79

g/l

2.16

318

Astigmatism

430

1.74

4.81

2.3

2.4

39.50

37.78

g/l

1.77

372

Urethral stricture

576

1.64

4.80

2.3

2.5

37.54

37.51

g/l

0.02

491

severe traumatic brain injury, does not include concussion

334

2605

1.29

4.79

2.3

2.1

37.06

37.24

g/l

0.21

270

2194

Cluster headache, wide

265

1.96

4.77

1.9

2.8

41.50

38.16

g/l

3.61

236

Gluteal tendinitis

308

1.89

4.76

1.9

2.0

39.53

37.37

g/l

1.70

264

Background retinopathy and retinal vascular changes

191

2.16

4.76

2.1

3.0

37.91

37.33

g/l

0.27

165

Recurring oral aphthae

388

1.78

4.76

2.8

2.6

37.27

37.74

g/l

0.25

343

Polycythaemia vera

323

1.87

4.75

2.9

1.4

38.47

37.47

g/l

0.56

263

Malignant neoplasm of other connective and soft tissue, excluding all cancers (controls excluding all cancers)

389

1.78

4.73

4.5

1.4

37.71

37.80

g/l

0.04

334

Maternal care for known or suspected fetal abnormality and damage

119

692

1.54

4.73

1.7

40.28

39.52

g/l

0.87

112

631

Acne

424

1.73

4.72

2.1

1.5

38.38

39.21

g/l

0.59

381

Other symptoms and signs involving general sensations and perceptions

316

1.87

4.72

2.1

2.6

37.20

37.61

g/l

0.20

273

Acute bronchiolitis

194

2.06

4.71

5.7

2.0

37.06

38.88

g/l

1.08

171

Benign neoplasm of urinary organs

435

1.73

4.68

2.2

1.4

38.31

37.61

g/l

0.50

362

Haemorrhoids and perianal venous thrombosis

415

3329

1.25

4.67

2.1

2.2

37.29

37.33

g/l

0.04

352

2821

Disorders of myoneural junction and muscle in diseases classified elsewhere

2.95

4.67

2.0

2.3

36.04

37.72

g/l

0.45

Medical abortion

830

3840

1.18

4.64

1.7

2.2

38.13

37.87

g/l

0.54

698

3240

Other diseases of oesophagus

146

1006

1.47

4.63

1.8

2.4

37.54

37.28

g/l

0.21

128

866

Hypopituitarism

481

1.68

4.61

3.1

2.3

36.89

37.74

g/l

0.45

436

Follow-up examination after treatment for malignant neoplasms

150

1041

1.46

4.58

2.2

2.1

37.14

37.07

g/l

0.05

127

884

Other or ill-defined heart diseases

407

1.74

4.57

1.3

2.0

36.99

38.31

g/l

0.96

351

Other Crohn's disease

475

1.68

4.56

1.3

2.2

35.74

38.28

g/l

2.11

419

Diseases of peritoneum

153

1068

1.45

4.55

1.9

2.2

36.45

37.47

g/l

1.15

133

914

Testicular dysfunction

235

1.99

4.54

1.5

2.6

38.23

37.95

g/l

0.09

203

Postprocedural disorders of nervous system

438

1.71

4.53

2.1

2.0

40.19

38.29

g/l

2.06

396

Pustulosis palmaris et plantaris

387

1.76

4.52

2.1

2.4

37.62

38.05

g/l

0.25

343

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

2.59

4.51

5.5

1.7

36.32

39.31

g/l

1.28

Thyroiditis

625

1.59

4.50

2.2

2.3

38.87

37.81

g/l

0.97

541

502

3657

1.22

4.49

2.2

2.1

36.77

36.79

g/l

0.03

388

3001

Other psoriatic arthropathies

142

980

1.46

4.48

1.8

2.3

37.54

37.84

g/l

0.22

121

860

Other aneurysm

556

1.63

4.48

2.0

2.3

36.18

37.47

g/l

1.16

475

Other otitis externa (chronic)

587

1.61

4.47

2.2

2.4

37.50

37.71

g/l

0.11

511

Malignant neoplasm of bone and articular cartilage of other and unspecified sites, excluding all cancers (controls excluding all cancers)

2.65

4.47

7.2

1.2

39.39

38.74

g/l

0.31

Benign neoplasm: Pancreas

273

1.92

4.46

2.7

2.6

37.94

37.33

g/l

0.40

234

Deficiency of other B group vitamins

203

2.08

4.46

3.7

2.1

36.55

37.63

g/l

0.70

174

Tinnitus

338

2668

1.28

4.44

2.2

38.49

37.69

g/l

1.88

294

2320

Acute peritonitis

612

1.59

4.43

2.1

2.4

35.74

37.52

g/l

1.98

531

Attention to artificial openings

360

1.78

4.43

1.8

2.0

34.51

37.87

g/l

3.64

318

Other noninfective disorders of lymphatic vessels and lymph nodes

302

1.86

4.40

1.6

2.4

34.29

38.28

g/l

3.67

262

Infection due to other mycobacteria

138

2.32

4.40

1.7

2.0

33.22

37.60

g/l

2.07

111

Pustular psoriasis

428

1.71

4.39

2.0

2.3

37.43

37.88

g/l

0.26

375

Pneumonia due to Streptococcus pneumoniae

331

1.81

4.39

5.4

1.8

36.83

38.28

g/l

1.09

278

Inflammatory bowel disease, strict (require KELA)

272

2091

1.31

4.37

2.3

2.1

37.56

38.21

g/l

0.91

239

1854

Other deformities of toe(s)

303

1.85

4.36

1.7

2.0

37.78

37.22

g/l

0.28

255

Malignant melanoma

228

1714

1.34

4.36

2.0

2.2

37.71

37.39

g/l

0.34

189

1451

Acute generalized exanthematous pustulosis

399

1.73

4.35

3.7

2.5

37.88

37.60

g/l

0.15

344

Seborrhoeic keratosis

332

2623

1.28

4.35

2.3

2.2

37.22

37.60

g/l

0.55

282

2202

Lactose intolerance

218

2.01

4.35

1.4

1.6

38.68

37.84

g/l

0.42

196

Bursitis of shoulder

191

2.09

4.35

2.8

1.6

38.55

37.09

g/l

0.93

163

Diffuse brain injury

232

1.97

4.33

2.6

1.6

37.27

37.47

g/l

0.09

203

Bicipital tendinitis

423

1.71

4.30

2.4

2.1

38.64

37.69

g/l

0.68

371

Lichen ruber planus, wide definition including periferal and oral lichen planus

298

2327

1.29

4.29

2.2

38.47

37.68

g/l

1.49

255

1984

Viral infections of the central nervous system

601

1.58

4.28

2.4

2.2

37.50

37.79

g/l

0.14

522

Other and unspecified nonorganic psychotic disorders

199

1467

1.36

4.28

1.5

2.1

37.97

38.41

g/l

0.47

171

1303

Other disorders of cornea

133

916

1.47

4.27

1.8

2.1

38.44

37.74

g/l

0.64

114

791

827

0.54

4.26

1.2

2.3

33.67

37.12

g/l

2.36

709

Atopic conjunctivitis

276

1.87

4.25

1.4

1.7

38.25

38.07

g/l

0.08

243

Melanocytic naevi of trunk

150

1057

1.43

4.25

2.1

2.2

38.32

37.86

g/l

0.51

137

930

Seborrhoeic dermatitis

129

884

1.47

4.25

2.0

2.4

38.56

37.64

g/l

1.06

104

771

Use of antiglaucoma preparations and miotics

137

951

1.46

4.25

2.3

2.4

36.06

37.00

g/l

1.02

108

781

Thyrotoxicosis with diffuse goitre

172

1241

1.40

4.24

2.0

2.2

38.24

38.15

g/l

0.08

157

1082

Endometriosis

440

2122

1.24

4.24

2.0

38.54

37.64

g/l

2.52

371

1813

Cerebral cysts

432

1.69

4.24

1.4

2.3

37.12

37.78

g/l

0.25

384

Benign neoplasm: salivary glands, exclude unknown (D119)

131

902

1.47

4.23

2.0

2.3

38.23

37.65

g/l

0.45

112

786

Wet age-related macular degeneration

292

2239

1.29

4.22

2.4

2.1

36.49

36.79

g/l

0.42

235

1813

Other and unspecified disorders of vitreous body

616

5175

1.19

4.20

2.1

2.3

38.08

37.60

g/l

1.25

525

4410

Other and unspecified rosacea

118

797

1.50

4.19

2.0

2.3

38.20

37.97

g/l

0.15

108

696

Benign neoplasm: Kidney

322

1.81

4.19

2.3

2.6

38.58

37.73

g/l

0.55

277

Obsessive-compulsive disorder

277

1.86

4.18

2.0

2.1

38.60

38.70

g/l

0.04

251

Other benign neoplasms of skin

539

4500

1.20

4.18

3.0

2.2

37.62

37.49

g/l

0.20

444

3814

Adrenocortical insufficiency

293

1.84

4.17

1.9

2.4

37.39

37.78

g/l

0.16

262

Benign neoplasm: Skin of ear and external auricular canal

367

1.75

4.16

2.3

1.4

37.85

37.42

g/l

0.23

310

Carcinoma in situ of colon

142

2.27

4.16

2.5

2.2

34.62

37.20

g/l

1.44

117

Atrial septal defect

248

1.91

4.16

1.5

2.1

37.52

38.17

g/l

0.23

221

Focal brain injury

511

1.62

4.15

1.7

1.9

37.19

37.35

g/l

0.08

442

Drug-induced neutropenia

107

711

1.53

4.13

3.2

2.4

34.88

37.85

g/l

5.62

614

Ankylosing spondylitis, strict definition

286

1.84

4.13

1.6

2.5

38.59

38.47

g/l

0.04

260

Other diseases of jaws

551

1.60

4.13

3.1

1.9

38.40

37.92

g/l

0.32

474

Other disorders of adrenal gland

345

1.77

4.13

1.9

2.4

37.39

37.73

g/l

0.15

309

Entropion and trichiasis of eyelid

142

998

1.44

4.13

2.3

37.47

37.04

g/l

0.37

118

834

Acute laryngitis and tracheitis

627

1.55

4.11

1.5

1.8

39.71

38.45

g/l

1.36

552

Bell's palsy

158

1131

1.41

4.11

2.3

2.1

37.90

37.70

g/l

0.14

133

974

Nail disorders

105

695

1.53

4.11

1.6

2.3

37.61

37.99

g/l

0.28

608

Peroneal tendinitis

2.51

4.10

2.1

1.9

40.27

38.86

g/l

0.76

Other and unspecified parapsoriasis

3.24

4.09

1.5

2.0

36.79

36.32

g/l

0.11

Benign neoplasm: Pituitary gland, craniopharyngeal duct

391

1.71

4.09

3.2

1.3

38.29

38.30

g/l

0.01

336

Vitamin D deficiency

123

2.33

4.09

1.1

2.2

38.11

39.09

g/l

0.33

108

Other salmonella infections

317

1.80

4.08

2.3

2.0

38.23

38.13

g/l

0.04

271

Benign neoplasm: Duodenum

260

1.90

4.07

2.9

2.7

36.46

37.40

g/l

0.45

221

Ulcerative enterocolitis

224

1.95

4.05

2.0

2.4

36.79

38.06

g/l

0.57

193

Alzheimer’s disease (undefined)

105

0.00

4.05

0.0

2.1

—

35.59

—

Glucosamine medication

835

5775

1.16

4.03

2.3

2.2

37.23

37.32

g/l

0.17

719

4814

Melanoma in situ of other and unspecified parts of face

138

2.28

4.02

2.3

2.7

36.06

36.99

g/l

0.32

116

Benign neoplasm of major salivary glands

147

1045

1.42

4.01

1.9

2.2

38.25

37.52

g/l

0.67

127

896

Pain associated with micturition

155

1112

1.41

4.00

2.6

2.1

38.40

37.65

g/l

0.84

126

946

Mantle cell lymphoma

2.57

3.99

2.0

1.8

36.83

36.43

g/l

0.13

Mental and behavioural disorders due to tobacco

113

765

1.49

3.99

1.8

2.4

37.24

37.92

g/l

0.57

677

Vulvovaginal ulceration/inflammation in other diseases

341

1.75

3.98

1.8

1.9

39.34

38.36

g/l

1.06

307

Polycystic ovarian syndrome, consortium definition

879

4601

1.16

3.97

1.9

2.1

37.99

38.07

g/l

0.12

691

3958

Spontaneous abortion

350

2957

0.80

3.94

1.9

2.2

39.20

38.20

g/l

2.78

302

2549

N06DA Anticholinesterases

377

3748

0.81

3.93

1.9

2.2

37.07

36.65

g/l

0.67

273

3067

Use of anticholinesterases

377

3748

0.81

3.93

1.9

2.2

37.07

36.65

g/l

0.67

273

3067

Type 1 diabetes, definitions combined

548

1.58

3.93

2.2

2.0

37.42

38.93

g/l

1.41

497

Unspecified/other endometriosis

574

1.56

3.91

2.0

1.7

39.29

38.35

g/l

0.88

498

Presence of other functional implants

921

5697

1.15

3.91

2.3

2.2

36.98

37.46

g/l

1.58

730

4872

Colitis, primary sclerosing, strict definition

2.86

3.91

2.3

37.57

38.96

g/l

0.47

Congenital malformations and deformations of the musculoskeletal system

501

1.60

3.90

1.4

1.9

38.40

38.60

g/l

0.09

448

Fentanyl

133

933

1.44

3.89

6.0

1.6

36.16

37.28

g/l

1.33

104

756

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

481

1.61

3.88

1.7

2.3

37.81

38.03

g/l

0.09

426

Presence of other devices

229

2967

0.77

3.87

2.3

2.2

37.38

37.07

g/l

0.34

184

2490

Malignant neoplasm of kidney, except renal pelvis

145

1036

1.42

3.87

1.8

2.3

36.07

37.37

g/l

1.67

128

888

Use of donepezil

195

2483

0.75

3.87

1.8

2.2

37.18

36.59

g/l

0.61

135

2008

Unspecified lump in breast

209

1581

1.33

3.86

1.8

2.1

38.72

37.84

g/l

1.37

180

1341

Acidosis

180

2.06

3.86

2.1

2.2

33.21

37.19

g/l

2.40

157

Smoking dependency

113

771

1.48

3.85

1.8

2.4

37.24

37.92

g/l

0.57

682

Other sleep disorders

143

1019

1.42

3.85

1.5

2.1

37.93

37.43

g/l

0.44

108

892

Emergency coronary revascularization (for ACS)

917

5763

1.15

3.84

1.8

2.3

36.32

37.20

g/l

4.34

793

4833

Other and unspecified vascular occlusions

150

1081

1.40

3.81

2.2

2.4

36.13

37.12

g/l

1.08

131

910

Other specified/unspecified spondylopathies

244

1.89

3.81

1.3

2.0

37.24

37.19

g/l

0.02

202

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

146

2.15

3.80

1.8

1.7

37.32

39.13

g/l

0.79

131

Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease

3.20

3.80

1.4

1.2

36.05

36.81

g/l

0.17

Clear cell adenocarcinoma of kidney, excluding all cancers (controls excluding all cancers)

439

1.65

3.80

1.5

1.3

36.60

37.78

g/l

0.81

375

Benign neoplasm of urinary organs

462

1.63

3.79

2.2

2.6

38.31

37.32

g/l

0.81

403

Dissection of aorta

310

1.78

3.79

1.6

2.6

35.17

37.18

g/l

1.59

267

Corneal scars and opacities

230

1.91

3.79

1.7

2.7

37.38

37.15

g/l

0.07

196

Type 1 diabetes, strict (exclude DM2)

546

1.56

3.76

2.2

2.0

37.34

38.93

g/l

1.51

495

Benign neoplasm of eye and adnexa

135

957

1.43

3.76

1.4

37.65

37.74

g/l

0.06

113

789

Malignant neoplasm of urinary organs

155

1126

1.39

3.76

1.7

2.2

36.06

37.45

g/l

1.97

137

960

Acute alcohol intoxication, ICD10

240

1857

1.30

3.76

1.3

2.2

37.66

37.97

g/l

0.28

208

1644

Benign neoplasm: Small intestine

433

1.65

3.75

2.5

36.82

37.24

g/l

0.23

371

Psychotic depression

478

1.61

3.75

1.6

2.5

37.30

37.87

g/l

0.26

408

Iridocyclitis in diseases classified elsewhere

148

2.15

3.74

1.9

2.4

38.40

37.27

g/l

0.56

129

Duodenal ulcer

167

1228

1.37

3.74

1.8

2.4

35.79

37.23

g/l

1.98

148

1048

Benign neoplasm: Parotid gland

116

801

1.47

3.74

2.0

2.3

38.18

37.57

g/l

0.45

100

701

Unknown and unspecified causes of morbidity

560

0.48

3.74

1.1

2.2

39.40

38.21

g/l

0.34

472

Later onset COPD

490

3216

1.20

3.74

1.6

2.3

35.24

36.97

g/l

8.48

411

2653

Other epidermal thickening

379

1.69

3.73

2.2

2.6

36.95

37.76

g/l

0.50

330

Visual field defects

125

876

1.44

3.73

2.0

36.77

37.55

g/l

0.77

105

755

Oesophagitis

527

1.58

3.72

2.1

2.5

36.44

37.46

g/l

0.77

459

Other and unspecified mononeuropathies of upper limb

224

1.91

3.72

1.4

2.0

39.64

38.22

g/l

0.69

197

Contact with sharp object, undetermined intent

135

2.19

3.71

1.8

2.0

37.35

38.31

g/l

0.28

120

Postzoster neuralgia

129

2.24

3.71

3.5

2.3

38.46

36.65

g/l

1.37

106

Injury of other and unspecified intrathoracic organs

575

1.55

3.71

1.5

2.2

36.53

37.60

g/l

0.92

501

Benign paroxysmal vertigo

412

3398

1.22

3.71

2.0

2.2

38.13

37.43

g/l

1.76

344

2875

Disorders of optic nerve, not elsewhere classified

197

1.98

3.70

2.5

3.2

37.56

37.65

g/l

0.03

169

Other and unspecified follicular disorders

305

1.77

3.68

2.3

2.6

39.11

37.94

g/l

0.80

276

Status post-ami

815

0.61

3.68

1.6

2.3

36.06

36.60

g/l

0.32

654

Septal defects

409

1.64

3.67

1.4

2.3

38.24

38.37

g/l

0.05

362

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

182

1359

1.35

3.67

2.6

2.1

37.96

38.02

g/l

0.05

163

1198

Type1 diabetes, definitions combined, early onset

245

1.84

3.66

1.5

1.4

36.77

39.82

g/l

2.21

226

Complications of labour and delivery

559

3680

0.84

3.63

2.2

2.1

38.61

38.21

g/l

0.87

492

3163

Primary coxarthrosis, bilateral

453

3780

1.21

3.63

2.2

38.12

37.17

g/l

2.78

375

3154

Psoriasis (vulgaris), strict definition

248

1.85

3.62

1.5

2.6

37.20

38.23

g/l

0.42

220

Benign neoplasm: Spinal meninges

105

2.38

3.61

1.3

1.9

37.14

37.06

g/l

0.02

Vascular diseases of the intestine

383

1.67

3.61

2.3

2.2

34.43

37.07

g/l

2.08

328

Other sexually transmitted chlamydial diseases

226

1.87

3.59

1.4

40.30

39.48

g/l

0.41

206

Other secondary gout

3.84

3.59

5.2

1.4

35.05

36.97

g/l

0.45

Ulcerative colitis (strict definition, all Crohn cases excluded)

163

1202

1.37

3.58

2.8

2.2

38.34

37.98

g/l

0.35

144

1069

All dysplastic lesions of the cervix uteri, vagina or vulva

253

1970

1.28

3.58

1.7

1.9

38.67

38.71

g/l

0.04

225

1732

Post-traumatic wound infection, not elsewhere classified

192

1.97

3.57

1.7

2.5

35.48

38.33

g/l

1.72

167

Cholecystitis

208

1592

1.32

3.57

1.9

2.2

36.66

37.23

g/l

0.69

169

1327

Single spontaneous delivery

416

2678

0.82

3.55

2.1

2.0

37.76

37.67

g/l

0.11

363

2243

Ulcerative colitis (strict definition, require KELA)

187

1410

1.33

3.55

2.6

2.1

38.01

37.99

g/l

0.01

167

1245

Alzheimer’s disease (Atypical or mixed)

1027

0.62

3.55

1.5

2.0

34.93

36.02

g/l

0.69

820

Allergic contact dermatitis

153

1119

1.38

3.55

1.4

2.3

37.55

38.08

g/l

0.47

133

977

Cardiac murmurs and other cardiac sounds

653

1.49

3.54

1.8

2.1

38.57

37.87

g/l

0.65

555

Coxarthrosis, primary, with hip surgery

749

6181

1.15

3.53

2.1

2.3

37.58

37.24

g/l

0.87

623

5211

Other disorders of iris and ciliary body

236

1.86

3.52

2.3

2.9

35.60

37.57

g/l

1.09

203

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

248

1921

1.28

3.52

2.0

1.9

38.94

38.49

g/l

0.52

220

1696

Leiomyoma of uterus

551

2622

1.19

3.52

2.0

1.4

38.07

38.31

g/l

0.42

459

2235

Alzheimer’s disease (undefined), excluding more controls

0.00

3.52

0.0

1.6

—

35.52

—

Delivery

420

2681

0.83

3.51

2.1

2.0

37.74

37.67

g/l

0.09

368

2246

Chondropathies

185

1398

1.33

3.47

1.9

2.0

37.68

38.02

g/l

0.31

151

1230

Other disorders of ear

1398

8403

1.11

3.47

2.2

38.10

37.58

g/l

2.59

1145

7262

Other neurotic disorders

457

1.60

3.47

1.5

2.6

37.27

37.73

g/l

0.24

391

Mental and behavioural disorders due to cannabinoids

106

2.29

3.47

1.8

1.5

39.15

39.73

g/l

0.17

Moderate visual impairment, binocular

274

1.79

3.46

1.7

1.9

36.84

36.59

g/l

0.09

228

Other specified/unspecified hearing loss

124

881

1.42

3.46

2.0

2.1

37.86

37.30

g/l

0.53

108

755

Drug-induced hypoglycaemia without coma

133

2.16

3.45

1.1

2.9

34.65

37.60

g/l

1.17

115

Ill-defined and unknown causes of mortality

736

0.56

3.45

1.9

2.3

34.12

36.80

g/l

1.67

617

Cluster headache, strict, including avohilmo

334

1.70

3.44

1.7

2.3

41.35

38.37

g/l

3.43

300

Pure hyperglyceridaemia

188

1.96

3.43

1.3

2.3

38.20

37.32

g/l

0.31

168

Occupational exposure to risk-factors

302

0.33

3.43

1.3

2.7

39.64

37.70

g/l

—

266

Delivery, wide proxy

348

2269

0.81

3.43

2.0

37.32

37.41

g/l

0.09

303

1871

Otitis externa, unspecified

127

907

1.41

3.42

1.8

2.2

39.08

37.91

g/l

1.65

107

790

Dental caries 3 and operation codes, only avohilmo

429

1782

1.21

3.41

2.4

2.6

38.00

37.97

g/l

0.02

381

1525

Other abnormal uterine and vaginal bleeding

318

1830

1.25

3.41

2.0

37.44

37.33

g/l

0.10

220

1544

Other keratitis

130

933

1.40

3.40

2.0

2.1

37.67

37.81

g/l

0.09

110

816

Hyphaema and other vascular disorders of iris and ciliary body

161

2.04

3.40

2.3

3.0

35.01

37.58

g/l

1.34

139

Malignant neoplasm of mesothelium and soft tissue, excluding all cancers (controls excluding all cancers)

661

1.49

3.39

3.5

1.4

36.85

37.64

g/l

0.57

551

Impingement syndrome of shoulder

322

2616

1.24

3.39

2.5

2.3

38.21

37.78

g/l

0.59

257

2268

Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)

179

1350

1.33

3.38

2.2

1.4

36.71

37.38

g/l

0.63

144

1122

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

203

1561

1.31

3.37

2.5

2.1

37.93

38.02

g/l

0.08

182

1376

Crohn's disease of small intestine

501

1.55

3.33

1.6

2.2

35.98

38.09

g/l

1.55

440

Other specified congenital malformation syndromes affecting multiple systems

2.51

3.32

1.6

1.9

37.72

39.67

g/l

0.56

Corneal ulcer

216

1679

1.29

3.32

2.3

2.0

37.56

37.93

g/l

0.37

187

1466

Recurrent dislocation and subluxation of joint

399

1.62

3.30

1.8

2.2

37.55

38.12

g/l

0.22

357

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

109

691

1.44

3.30

1.3

1.6

39.93

39.52

g/l

0.29

626

Other and unspecified tonsillitis

304

2082

1.24

3.30

1.5

1.9

38.43

38.66

g/l

0.25

279

1867

Aortic valve malfunction, age under 60 years

114

805

1.43

3.29

1.8

2.1

36.42

38.02

g/l

1.77

101

719

Open wound of abdomen, lower back and pelvis

198

1.90

3.28

1.6

2.2

36.93

38.13

g/l

0.45

177

Single delivery by forceps and vacuum extractor

547

0.61

3.28

1.3

1.6

38.56

39.26

g/l

0.33

495

Disorders of breast

592

4720

1.17

3.28

2.0

2.1

38.66

37.95

g/l

2.10

492

4008

Central retinal artery occlusion

228

1.84

3.27

3.2

2.4

36.91

36.74

g/l

0.05

194

Abnormal blood-pressure reading, without diagnosis

355

1.65

3.25

2.2

2.4

37.81

38.05

g/l

0.11

308

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

363

2999

1.22

3.25

2.6

2.1

37.36

37.93

g/l

0.99

326

2611

Cluster headache, wide,, including avohilmo

363

1.64

3.24

1.7

2.3

41.48

38.32

g/l

4.10

325

Premature rupture of membranes

923

0.67

3.23

1.7

39.92

39.20

g/l

0.64

836

Viral and other specified intestinal infections

178

1320

1.32

3.23

1.4

1.9

37.28

38.41

g/l

1.68

158

1144

Benign neoplasm of meninges

137

1003

1.38

3.22

1.9

1.4

37.26

37.61

g/l

0.28

115

829

Parkinson's disease, including avohilmo

246

1954

1.27

3.22

2.0

2.2

38.05

37.16

g/l

1.76

198

1633

Coeliac disease

149

1105

1.36

3.21

2.7

2.1

38.30

37.87

g/l

0.42

128

952

Left ventricular outflow tract obstruction (LVOTO), broad definition

119

851

1.41

3.21

1.8

2.2

36.48

37.99

g/l

1.69

106

760

Subacute thyroiditis

311

1.70

3.20

2.9

2.1

38.34

37.81

g/l

0.25

268

Graves ophthalmopathy, strict

186

1.92

3.20

1.2

1.8

38.63

38.37

g/l

0.10

165

Ulcer of oesophagus

105

736

1.44

3.19

2.0

2.5

37.38

37.28

g/l

0.06

643

Unspecified urinary incontinence

126

912

1.40

3.18

1.4

2.1

36.93

37.41

g/l

0.33

763

Migraine, single triptan purchase ok & required. ICD-code if available is included

920

5518

1.13

3.18

2.0

2.1

39.04

38.23

g/l

4.02

809

4816

Triptan medication for migraine, single purchase ok

920

5518

1.13

3.18

2.0

2.1

39.04

38.23

g/l

4.02

809

4816

Other obstructive and reflux uropathy

304

1.70

3.16

1.5

2.0

35.75

38.58

g/l

1.74

267

Nontoxic multinodular goitre

288

2334

1.24

3.15

1.7

2.2

37.73

37.47

g/l

0.30

233

1967

Other noninflammatory disorders of vulva and perineum

104

729

1.44

3.14

1.4

1.8

37.14

37.74

g/l

0.40

627

Pediculosis, acariasis and other infestations

421

1.58

3.14

1.5

2.2

38.69

37.93

g/l

0.46

374

Dissection of cerebral arteries, nonruptured

2.90

3.14

1.6

2.0

38.21

38.99

g/l

0.20

Dislocation, sprain and strain of joints and ligaments at neck level

153

1144

1.35

3.12

2.3

2.2

38.99

38.24

g/l

0.78

132

1014

Other and unspecified primary disorders of muscles

2.78

3.11

1.3

2.8

40.77

38.86

g/l

0.71

Use of disulfiram, acamprosate or naltrexone

102

714

1.44

3.11

1.4

2.2

38.43

38.07

g/l

0.22

638

Burns and corrosions

154

1154

1.34

3.11

2.0

2.1

36.66

37.91

g/l

1.61

135

1021

Organic, including symptomatic, mental disorders

813

5176

1.14

3.10

1.9

2.2

36.42

37.05

g/l

1.88

621

4367

Ganglion

229

1810

1.27

3.10

2.2

2.0

39.00

37.90

g/l

2.06

194

1567

Ulcerative proctitis

471

1.54

3.07

1.3

2.1

38.02

38.15

g/l

0.06

411

Other and unspecified trigeminal disorders

106

2.22

3.07

1.4

2.0

38.44

37.85

g/l

0.16

Senility

2.63

3.06

1.1

1.5

35.37

35.52

g/l

—

Achilles tendinitis

129

944

1.38

3.05

2.8

2.0

38.13

37.61

g/l

0.40

110

837

Hyperfunction of pituitary gland

315

1.67

3.05

3.1

2.0

38.02

38.12

g/l

0.05

286

Carrier of infectious disease

182

1.90

3.04

1.3

1.8

36.93

37.95

g/l

0.33

162

Congenital malformations of heart and great arteries

135

963

1.37

3.04

1.7

2.2

38.13

37.95

g/l

0.11

111

854

Benign neoplasm: Skin of ear and external auricular canal

402

1.59

3.03

2.3

2.4

37.85

37.24

g/l

0.36

351

Appendectomy

808

6884

1.13

3.03

2.2

2.1

38.29

38.11

g/l

0.35

706

5980

Postpartum care and examination

457

0.58

3.02

1.1

1.6

38.05

39.72

g/l

0.87

417

Unspecified misadventure during surgical and medical care

498

1.53

3.02

1.8

2.5

36.52

37.52

g/l

0.71

436

Benign neoplasm: Pituitary gland, craniopharyngeal duct

426

1.57

3.01

3.2

2.4

38.29

38.03

g/l

0.13

375

Disorder of external ear, unspecified

279

1.71

3.00

1.7

2.5

38.12

37.68

g/l

0.22

246

Other specified and unspecified retinal disorders

333

1.65

2.99

2.7

2.6

36.18

37.60

g/l

0.90

290

Benign neoplasm: Skin of eyelid, including canthus

221

1750

1.27

2.99

3.0

2.2

37.75

37.40

g/l

0.38

184

1489

Lichen planus, including avohilmo

250

2008

1.25

2.99

2.3

2.2

38.49

37.61

g/l

1.49

214

1712

Disorders of lacrimal system and orbit in diseases classified elsewhere

205

1.84

2.99

1.2

1.8

38.62

38.61

g/l

0.01

183

Degenerative macular diseases

187

1452

1.30

2.97

1.9

2.2

37.54

37.17

g/l

0.34

155

1212

Injury of muscle and tendon at lower leg level

192

1495

1.29

2.97

2.9

2.2

38.58

37.87

g/l

0.90

168

1325

Abdominal aortic aneurysm (AAA)

154

1155

1.33

2.95

1.7

2.2

35.77

37.04

g/l

1.60

126

950

Postprocedural disorders of digestive system, not elsewhere classified

296

1.68

2.94

1.9

2.6

36.19

37.41

g/l

0.55

256

Diseases of tongue

574

1.48

2.94

2.2

2.0

39.13

37.56

g/l

1.66

484

Other arterial embolism and thrombosis

281

1.70

2.94

1.3

2.6

35.01

37.04

g/l

1.15

237

Supplementary factors related to causes of morbidity and mortality classified elsewhere

372

3115

1.20

2.93

1.7

2.1

37.56

37.85

g/l

0.38

288

2697

Bitten or struck by other mammals

113

815

1.40

2.93

2.2

2.4

38.45

38.23

g/l

0.15

104

720

Contusion of toe(s) without damage to nail

142

2.00

2.92

1.2

2.7

40.51

39.06

g/l

0.64

133

Generalized skin eruption due to drugs and medicaments

351

1.62

2.91

3.7

2.4

37.25

37.63

g/l

0.19

305

Use of other anti-dementia drugs

283

3005

0.81

2.91

1.8

2.2

36.30

36.49

g/l

0.18

189

2447

Use of memantine

283

3005

0.81

2.91

1.8

2.2

36.30

36.49

g/l

0.18

189

2447

Other and specified injuries of hip and thigh

200

1.84

2.90

1.3

2.2

36.60

37.00

g/l

0.11

172

Monocytic leukaemia

3.28

2.90

4.0

1.4

34.94

36.81

g/l

0.41

!Aliquae complicationes praecoces traumatis

336

1.63

2.88

2.4

34.78

37.97

g/l

2.63

297

Early complications of trauma

336

1.63

2.88

2.4

34.78

37.97

g/l

2.63

297

Crohn's disease of large intestine

383

1.58

2.87

1.4

2.3

38.11

38.20

g/l

0.04

338

Other ill-defined and unspecified causes of mortality

647

0.58

2.87

1.3

2.4

33.93

36.89

g/l

1.71

543

Antibody deficiency with near-normal immunoglobulins or with hyperimmunoglobulinaemia

5.74

2.86

9.3

1.0

40.66

37.26

g/l

—

Other hearing loss

441

3694

1.18

2.86

2.3

2.1

37.47

36.90

g/l

1.26

356

3103

Meralgia paraesthetica

276

1.69

2.84

1.5

2.3

39.04

37.69

g/l

0.86

234

Other and unspecified bullous disorders

2.24

2.83

3.4

2.1

38.87

37.82

g/l

0.39

Excessive, frequent and irregular menstruation

461

2180

1.18

2.82

1.8

1.9

37.83

37.69

g/l

0.18

374

1864

Tonsillectomy and adenotomy

402

3310

0.84

2.82

1.7

1.9

39.35

38.71

g/l

1.28

349

2954

Colitis, primary sclerosing

2.31

2.80

2.2

2.0

38.13

38.48

g/l

0.09

Complications of genitourinary prosthetic devices, implants and grafts

217

1.78

2.80

2.0

37.97

37.47

g/l

0.19

186

Epiphora

210

1.80

2.79

2.9

2.2

38.03

37.81

g/l

0.07

179

Benign neoplasm of middle ear and respiratory system

102

731

1.41

2.78

2.6

1.4

38.16

37.82

g/l

0.23

613

Viral warts

110

799

1.39

2.76

2.0

2.3

37.50

38.13

g/l

0.49

701

Sequelae of injuries of neck and trunk

233

1.74

2.75

2.6

2.9

37.36

38.09

g/l

0.27

206

Injury of muscle and tendon at hip and thigh level

116

851

1.37

2.75

1.8

2.2

38.67

37.88

g/l

0.81

105

754

Graves ophthalmopathy

211

1.79

2.75

1.2

1.8

38.62

38.65

g/l

0.01

189

Personal history of malignant neoplasm

349

1.60

2.74

4.4

1.8

37.79

38.26

g/l

0.17

309

malignant neoplasm of male genital organs, excluding all cancers (controls excluding all cancers)

447

2325

1.18

2.74

2.1

1.5

36.97

37.46

g/l

0.90

381

2014

Hepatocellular carcinoma, excluding all cancers (controls excluding all cancers)

249

1.72

2.73

3.1

1.4

36.66

36.84

g/l

0.06

202

Retinal breaks without detachment

218

1746

1.26

2.72

2.4

2.2

37.94

37.79

g/l

0.14

184

1502

Viral encephalitis, not elsewhere classified/unspecified

168

1.88

2.71

4.0

2.6

36.83

37.58

g/l

0.18

145

Corns and callosities

643

1.43

2.70

1.7

2.4

37.20

37.87

g/l

0.52

556

Clear cell adenocarcinoma of kidney

479

1.51

2.70

1.5

2.6

36.60

37.32

g/l

0.41

415

Other specified/unspecified disorders of bone/cartilage

227

1.75

2.70

1.7

1.9

37.77

37.68

g/l

0.03

198

Maternal care for other known or suspected fetal problems

800

0.70

2.69

1.6

1.7

39.50

39.56

g/l

0.03

728

Polyp of the female genital tract

413

2036

1.18

2.68

1.9

2.0

38.12

37.51

g/l

1.34

354

1734

Pulmonary oedema

169

1.87

2.67

1.8

2.4

34.47

36.55

g/l

1.20

136

Salpingitis and oophoritis

214

1714

1.26

2.66

1.6

2.3

37.63

38.06

g/l

0.46

186

1480

Myocardial infarction, with ST-elevation

266

2183

1.23

2.65

1.8

2.2

35.86

37.20

g/l

3.13

227

1833

Glaucoma suspect

400

4684

0.85

2.65

1.9

2.2

37.80

37.35

g/l

0.82

331

3949

Other and unspecified mononeuropathies of lower limb

236

1.72

2.65

1.6

2.0

38.40

37.28

g/l

0.56

197

Autonomic disorders

184

1.83

2.65

2.3

36.47

37.83

g/l

0.45

159

Acute suppurative otitis media

205

1524

1.26

2.63

2.6

1.9

38.54

38.69

g/l

0.13

184

1355

Menorrhagia

444

2095

1.18

2.63

1.8

2.0

38.31

37.54

g/l

1.82

342

1785

Unspecific neurodegenerative disorder

527

4176

0.87

2.63

1.8

2.2

36.45

36.76

g/l

0.52

373

3465

Other diseases of appendix

107

2.11

2.62

1.9

38.57

37.72

g/l

0.23

Assault by bodily force

432

1.51

2.62

1.7

2.1

36.97

38.69

g/l

1.04

391

Scleritis and episcleritis

490

1.48

2.61

1.7

2.1

38.42

38.13

g/l

0.20

441

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

156

1207

1.30

2.57

1.7

2.0

39.19

38.34

g/l

1.15

140

1051

Type 1 diabetes, strict definition

337

1.58

2.57

1.4

37.33

39.79

g/l

1.86

309

Disturbance of activity and attention

318

1.59

2.56

1.3

1.5

40.09

39.77

g/l

0.16

293

Hyperkinetic disorders

350

1.56

2.53

1.3

1.5

39.76

39.77

g/l

0.00

323

Contact with heat and hot substances

396

1.53

2.52

1.6

2.4

36.19

38.15

g/l

1.77

350

Maze procedure for atrial fibrillation

2.69

2.51

1.3

1.7

35.36

37.72

g/l

0.89

Focal epilepsy, strict definition

243

1987

1.23

2.51

2.0

2.1

37.14

37.57

g/l

0.45

200

1705

Crohn disease (strict definition, require KELA)

429

1.50

2.50

1.8

2.1

36.47

38.19

g/l

0.94

383

Benign neoplasm: Prostate

2.55

2.50

1.2

1.3

35.88

35.81

g/l

—

Orchitis and epididymitis

118

883

1.35

2.49

1.7

2.2

37.55

37.51

g/l

0.02

100

756

Malignant neoplasm of digestive organs

454

5155

0.86

2.49

2.1

2.2

36.52

37.19

g/l

1.43

378

4325

Sequelae of injuries of head

422

1.51

2.48

3.1

2.5

37.98

38.22

g/l

0.13

369

Cysts of oral region, not elsewhere classified

342

1.57

2.48

2.3

2.1

37.19

37.88

g/l

0.35

295

Other congenital malformations of upper alimentary tract

0.00

2.46

0.0

2.8

—

37.49

—

Crohn disease (strict definition, require KELA, min 2 HDR)

423

1.50

2.45

1.8

2.1

36.29

38.14

g/l

1.03

379

Schizophrenia or delusion, excluding more controls

316

2635

1.19

2.45

1.9

2.1

37.56

38.13

g/l

0.87

261

2307

Right side

0.00

2.44

0.0

1.9

—

36.97

—

Use of levodopa decarboxylase inhibitor

203

1638

1.25

2.42

2.1

2.2

38.37

37.16

g/l

2.52

165

1365

Combinations of oral blood glucose lowering drugs

406

3495

1.17

2.39

1.6

2.3

37.07

37.72

g/l

1.33

358

3004

Burns and corrosions of external body surface, specified by site

118

889

1.34

2.39

2.1

2.2

36.30

37.83

g/l

1.78

101

789

Acute alcohol intoxication

326

2756

1.19

2.39

1.4

2.3

37.30

37.80

g/l

0.62

279

2400

Benign neoplasm of brain and other parts of central nervous system

558

1.43

2.39

2.1

1.4

38.95

38.16

g/l

0.53

471

Type of accident

341

2895

1.18

2.38

1.7

2.1

37.50

37.79

g/l

0.35

259

2501

Graves disease, strict definition

106

787

1.36

2.37

2.3

2.1

38.51

38.20

g/l

0.27

690

Atrophic disorders of skin

176

1400

1.26

2.37

1.7

2.1

38.25

37.80

g/l

0.50

157

1181

Benign neoplasm of breast

158

1241

1.28

2.37

2.0

39.07

37.76

g/l

2.00

131

1046

Other disorders of pigmentation

411

1.50

2.37

2.3

2.1

37.79

37.78

g/l

0.01

358

Alcohol withdrawal state with delirium

669

1.39

2.36

1.2

2.3

35.71

37.80

g/l

1.94

594

Diseases of appendix

969

8015

1.10

2.36

2.5

2.1

38.18

37.94

g/l

0.60

841

6957

Other disorders of the genitourinary system

182

1456

1.26

2.35

2.1

2.2

37.36

37.47

g/l

0.09

159

1226

Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

613

4230

1.13

2.35

2.1

1.5

36.30

37.48

g/l

4.44

514

3553

Open wound of wrist and hand

510

4422

1.15

2.35

2.4

2.1

37.71

37.99

g/l

0.48

445

3868

Noninflammatory disorders of female genital tract

501

2190

1.15

2.34

2.0

1.9

38.22

37.70

g/l

1.13

423

1874

Procedures for purposes other than remedying health state

199

1.73

2.34

2.4

1.4

38.94

g/l

0.00

180

Malignant neoplasm of small intestine, excluding all cancers (controls excluding all cancers)

284

1.61

2.34

2.2

1.3

36.55

37.63

g/l

0.52

239

Benign neoplasm: Lip

177

1.78

2.33

1.8

1.3

36.91

37.80

g/l

0.26

146

Unstable angina pectoris

626

4604

1.13

2.33

2.2

2.3

36.82

37.22

g/l

0.90

537

3837

Fibrosis of liver

2.54

2.32

1.3

2.0

34.92

38.07

g/l

1.03

Contusion of other and unspecified parts of foot

284

1.60

2.32

2.4

2.3

37.74

38.84

g/l

0.53

257

Hordeolum and other deep inflammation of eyelid

429

1.48

2.31

2.8

2.4

38.82

37.78

g/l

0.58

385

Other specified disorders of external ear

365

1.53

2.31

1.5

2.6

37.20

37.46

g/l

0.12

323

Malignant neoplasm of respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)

347

2478

1.18

2.31

2.3

1.5

36.51

37.38

g/l

1.90

305

2075

Benign neoplasm: Cerebral meninges

117

887

1.33

2.30

2.0

1.4

36.99

37.56

g/l

0.48

101

736

Nasal polyp

258

2147

1.21

2.28

2.7

2.3

37.48

37.65

g/l

0.18

231

1856

Other disorders of electrolyte and fluid balance, not elsewhere classified

2.34

2.28

1.7

1.5

38.41

37.30

g/l

0.26

Alzheimer disease

363

3189

0.85

2.28

1.7

2.1

36.08

36.60

g/l

0.76

252

2611

Polyarteritis with lung involvement [Churg-Strauss]/EGPA

3.24

2.27

3.9

1.5

37.08

38.73

g/l

—

Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)

438

2275

1.16

2.25

2.1

1.5

36.96

37.40

g/l

0.77

371

1966

Irregular menses

467

3305

1.15

2.23

1.9

2.0

38.33

38.56

g/l

0.36

403

2906

Ingrowing nail

400

1.49

2.22

1.9

2.4

38.39

38.32

g/l

0.04

353

Papilloedema, unspecified

150

1.83

2.22

1.2

2.4

37.42

38.16

g/l

0.18

132

Strabismus

295

2487

1.19

2.21

2.1

38.60

37.90

g/l

1.27

257

2157

Malignant neoplasm of breast, ER-positive, excluding all cancers (controls excluding all cancers)

398

2789

1.16

2.21

1.9

1.4

38.07

37.93

g/l

0.18

318

2323

Otitis media, unspecified

622

1.37

2.20

2.8

2.0

39.42

38.18

g/l

1.31

547

Secondary parkinsonism, excluding more controls

188

1.73

2.19

2.8

1.8

36.42

36.62

g/l

0.06

161

Benign neoplasm of eye and adnexa

135

1052

1.29

2.19

1.4

2.3

37.65

37.67

g/l

0.01

113

908

Lichen simplex chronicus

289

1.58

2.19

2.4

2.8

36.88

37.75

g/l

0.54

253

Parkinson's disease

227

1876

1.22

2.19

2.1

2.2

38.10

37.19

g/l

1.76

184

1575

Blindness, monocular

2.22

2.18

5.6

2.1

37.21

37.45

g/l

—

Oesophageal obstruction

354

1.52

2.17

3.2

2.7

36.48

37.13

g/l

0.29

306

Cerebral aneurysm, nonruptured

111

844

1.33

2.16

1.5

2.2

38.14

37.89

g/l

0.16

728

Burns and corrosions of multiple and unspecified body regions

159

1.79

2.16

2.1

2.3

36.01

38.39

g/l

1.17

142

All dysplastic lesions of the cervix uteri

200

1630

1.23

2.14

1.8

1.9

39.01

38.90

g/l

0.10

179

1445

Acute appendicitis

887

7610

1.10

2.13

2.5

2.1

38.16

38.00

g/l

0.34

776

6617

Corneal degeneration

138

1.85

2.13

1.2

1.8

36.63

38.04

g/l

0.32

119

Malignant neoplasm of breast, HER2-negative, excluding all cancers (controls excluding all cancers)

534

3078

1.14

2.12

2.0

1.4

37.95

38.07

g/l

0.18

442

2583

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

504

1.42

2.11

2.3

2.1

39.02

38.86

g/l

0.09

454

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

471

1.43

2.11

1.8

2.2

36.56

38.19

g/l

0.92

419

Injuries involving multiple body regions

276

1.57

2.10

2.5

36.52

37.75

g/l

0.61

241

Dementia in other diseases classified elsewhere

481

1.43

2.10

1.7

2.4

37.75

36.92

g/l

0.48

410

Other and unspecified acute skin changes due to ultraviolet radiation

253

1.61

2.10

2.0

2.5

36.54

37.23

g/l

0.26

213

Alzheimer’s disease, wide definition, excluding more controls

239

1349

1.21

2.09

1.9

2.1

36.34

36.62

g/l

0.25

172

1128

Parkinson's disease, strict definition

211

1741

1.22

2.09

2.0

2.2

38.24

37.25

g/l

1.85

172

1457

Other maternal disorders predominantly related to pregnancy

471

3372

0.88

2.09

2.0

2.1

38.28

38.58

g/l

0.50

406

2951

Schizophrenia

111

1441

0.77

2.08

2.7

2.1

37.06

38.13

g/l

1.05

1279

Alkalosis

4.23

2.08

2.0

3.1

39.65

37.86

g/l

—

Postpartum haemorrhage

122

1364

0.78

2.07

1.7

1.9

40.01

39.12

g/l

0.99

102

1225

HSIL lesion of the cervix uteri, vagina or vulva

160

1281

1.25

2.07

1.7

1.8

38.16

38.81

g/l

0.65

139

1128

Coronary angioplasty

607

4160

1.12

2.07

1.9

2.3

36.53

37.30

g/l

2.55

530

3464

Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)

533

3078

1.13

2.07

2.0

1.4

37.96

38.07

g/l

0.15

441

2583

Other mental disorders due to brain damage and dysfunction and to physical disease

160

1284

1.26

2.06

2.4

2.2

38.38

37.22

g/l

1.78

119

1091

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

482

1.42

2.05

1.6

2.2

38.70

38.05

g/l

0.35

424

Medial epicondylitis

270

1.57

2.04

1.3

1.8

39.29

37.64

g/l

0.95

237

Cholangitis (primary sclerosing, PSC)

551

1.39

2.03

1.8

2.4

37.09

37.34

g/l

0.13

474

Alzheimer’s disease (Late onset), excluding more controls

230

1273

1.21

2.03

1.9

2.1

36.19

36.58

g/l

0.36

162

1059

Spontaneous rupture of synovium and tendon

102

774

1.33

2.03

2.0

1.9

37.16

37.45

g/l

0.20

664

HSIL lesion of the cervix uteri

139

1098

1.27

2.02

1.8

1.9

38.60

39.02

g/l

0.36

122

979

Maternal care related to the fetus and amniotic cavity and possible delivery problems

307

2117

0.85

2.01

2.5

1.9

39.55

38.78

g/l

1.72

276

1870

Carcinoma in situ of skin of lip

2.90

1.99

1.1

33.98

37.09

g/l

—

Other acute skin changes due to ultraviolet radiation

337

1.50

1.99

1.8

2.3

36.98

37.82

g/l

0.40

290

Inguinal hernia, bilateral

148

1184

1.26

1.97

2.6

2.1

37.47

37.50

g/l

0.02

127

1012

Other, unspecified and serous retinal detachments

290

1.54

1.95

2.1

2.7

37.08

37.20

g/l

0.04

250

Ulcerative rectosigmoiditis

675

1.34

1.95

1.8

2.2

38.84

37.93

g/l

0.79

598

Other acquired deformities of musculoskeletal system and connective tissue

421

1.44

1.95

2.3

34.99

38.00

g/l

3.06

365

Thyroiditis, unspecified

135

1.81

1.94

1.3

1.6

39.88

37.96

g/l

0.67

120

Prepatellar bursitis

380

1.46

1.93

1.6

1.9

37.78

37.50

g/l

0.13

324

Other and unspecified mononeuropathies, also in other diseases

267

1.56

1.92

2.0

2.3

38.35

37.40

g/l

0.42

225

Appendicitis, broad definition

950

7970

1.09

1.91

2.5

2.1

38.18

37.95

g/l

0.56

827

6918

Laparoscopic right hemicolectomy

610

1.36

1.91

2.1

2.6

36.86

37.22

g/l

0.21

522

Haemangioma, any site

704

1.33

1.90

2.9

1.3

38.31

38.05

g/l

0.14

601

Retinal haemorrhage

244

1.58

1.90

4.9

2.8

38.36

37.28

g/l

0.66

209

Focal epilepsy

253

2142

1.19

1.90

2.0

2.1

36.98

37.62

g/l

0.78

208

1843

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

152

1226

1.25

1.89

2.7

1.4

38.00

37.99

g/l

0.01

123

1041

Other predominantly sexually transmitted diseases, not elsewhere classified

138

1100

1.26

1.89

1.5

1.9

38.52

38.59

g/l

0.04

119

980

UC patients in KELA-register (code 208), prior to 1994

424

1.43

1.89

2.0

2.6

37.49

37.76

g/l

0.14

372

Lichen planus

173

1416

1.23

1.88

2.4

2.2

38.49

37.48

g/l

1.40

146

1218

Benign neoplasm: Parathyroid gland

1.98

1.88

1.2

1.3

37.79

37.98

g/l

—

Abnormal findings in secretions and smears from cervix uteri vagina vulva

472

3282

1.13

1.88

2.0

38.45

38.49

g/l

0.04

415

2832

Inguinal or femoral hernia, bilateral

150

1210

1.25

1.87

2.6

2.1

37.49

37.48

g/l

0.01

129

1035

Colorectal adenocarcinoma

209

2495

0.83

1.87

2.5

2.2

36.89

37.22

g/l

0.30

158

2088

Malignant neoplasm of bronchus and lung

203

2274

0.83

1.87

2.1

36.33

37.04

g/l

0.89

177

1887

Pedal cyclist injured in noncollision transport accidents

121

952

1.28

1.86

1.8

2.1

38.36

37.92

g/l

0.30

843

Perichondritis of external ear

175

1.69

1.86

1.3

2.4

37.58

36.87

g/l

0.24

149

Sudden idiopathic hearing loss

138

1106

1.26

1.84

2.2

2.1

38.15

37.57

g/l

0.58

105

966

Other secondary coxarthrosis

319

1.49

1.83

1.7

2.3

39.02

37.48

g/l

0.98

281

Paralytic strabismus

701

1.32

1.82

2.1

2.3

37.38

37.45

g/l

0.04

614

Benign leiomyoma with endometriosis

189

1567

1.21

1.82

2.1

1.5

37.86

37.72

g/l

0.12

153

1306

Arterial embolism and thrombosis of lower extremity artery

361

1.46

1.81

1.4

2.6

33.88

37.09

g/l

3.05

309

Acute appendicitis, no complications

652

5885

1.11

1.81

2.4

2.1

38.46

38.14

g/l

0.71

571

5162

Other strabismus

220

1845

1.19

1.80

2.2

2.1

39.10

38.05

g/l

1.90

194

1618

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

1127

0.76

1.80

2.8

2.2

37.82

37.35

g/l

0.31

966

Infectious mononucleosis

377

1.44

1.80

1.5

39.01

39.32

g/l

0.12

344

Oral lichen ruber planus, including avohilmo

573

1.36

1.80

2.1

2.5

38.87

37.85

g/l

1.09

493

Erythema intertrigo

200

1.62

1.80

1.8

3.3

36.30

37.83

g/l

0.62

171

Injury of blood vessels at shoulder and upper arm level

3.56

1.79

1.7

36.58

36.48

g/l

—

Benign neoplasm of bone and articular cartilage

616

1.34

1.78

1.5

1.3

38.95

38.32

g/l

0.41

526

Leiomyoma of uterus

794

4116

1.10

1.78

2.1

37.68

37.97

g/l

0.64

652

3495

Alzheimer disease, including avohilmo

446

3627

0.88

1.78

1.9

2.2

36.56

36.67

g/l

0.13

330

2967

Mouth breathing

508

4540

1.12

1.77

2.4

2.3

37.65

37.98

g/l

0.64

445

3988

Contact with and exposure to communicable diseases

174

2095

0.83

1.77

1.9

39.26

38.88

g/l

0.37

145

1879

Other or unspecified paralytic strabismus

2.28

1.77

1.0

2.7

40.66

39.25

g/l

0.66

Foreign body entering into or through eye or natural orifice

678

1.32

1.77

2.9

2.3

37.59

37.81

g/l

0.12

604

Aneurysms, operations, SAH

214

1801

1.19

1.76

1.9

2.1

37.52

37.75

g/l

0.21

181

1541

Polypectomy (DHB20)

670

1.32

1.76

2.4

2.3

37.49

37.61

g/l

0.07

591

Familial hypercholesterolemia, with ischemic heart disease

146

1185

1.24

1.76

2.0

2.1

36.33

37.33

g/l

1.09

117

967

Other and unspecified nerve root and plexus disorders, also in other diseases

217

1829

1.19

1.75

2.5

2.0

38.84

37.89

g/l

2.03

180

1602

Secondary polycythaemia

194

1.62

1.74

3.2

2.9

37.25

37.43

g/l

0.06

168

Trigeminal neuralgia

534

1.36

1.72

2.5

2.3

37.85

37.50

g/l

0.20

461

Malignant neoplasm of rectum

1084

0.76

1.71

2.4

2.2

38.00

37.36

g/l

0.42

926

Brachial plexus disorders

664

1.32

1.71

2.0

2.2

40.13

38.34

g/l

3.14

593

Varicose veins

915

6368

1.09

1.71

2.1

2.2

37.06

37.74

g/l

2.71

757

5403

Benign neoplasm of soft tissue of retroperitoneum and peritoneum

2.46

1.71

1.6

1.2

39.53

38.61

g/l

—

Other retinal artery occlusion

235

1.56

1.70

1.5

2.7

37.24

36.90

g/l

0.14

202

Viral haemorrhagic fevers, not elsewhere classified/unspecified

752

0.71

1.70

2.5

2.2

37.95

37.84

g/l

0.05

663

Benign neoplasm of meninges

137

1110

1.24

1.68

1.9

2.3

37.26

37.46

g/l

0.15

115

934

Benign neoplasm: Prostate

2.10

1.68

1.2

3.2

35.88

37.15

g/l

—

Adenocarcinoma and papilloma adenocarcinoma of rectum

1081

0.76

1.68

2.9

2.2

38.00

37.39

g/l

0.42

926

Renal agenesis and other reduction defects of kidney

2.65

1.68

1.4

3.5

37.15

38.18

g/l

—

Unspecified contracted kidney

2.32

1.67

1.5

2.7

34.01

38.01

g/l

1.05

Lung diseases due to external agents

186

1556

1.20

1.66

2.5

2.1

36.56

37.26

g/l

0.90

148

1310

Benign neoplasm of male genital organs

181

1.63

1.66

1.3

1.4

37.88

37.54

g/l

0.09

153

Dental caries 2 and operation codes, only avohilmo

894

5107

1.09

1.65

2.5

2.2

38.91

38.00

g/l

4.54

762

4423

Other puerperal infections

334

1.44

1.65

1.3

1.6

40.09

39.19

g/l

0.55

310

Haemangioma and lymphangioma, any site

747

1.29

1.65

2.8

1.3

38.29

38.10

g/l

0.10

636

Gonococcal infection

261

1.51

1.65

2.2

1.7

38.12

38.61

g/l

0.16

233

Myopia

108

853

1.27

1.64

2.1

2.2

38.76

38.21

g/l

0.41

100

752

Hydrocele

156

1285

1.22

1.64

2.5

2.3

37.20

37.24

g/l

0.03

138

1097

Pilonidal cyst

547

1.34

1.64

2.0

2.2

37.01

38.51

g/l

1.19

494

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

712

1.30

1.63

2.3

2.2

37.34

37.40

g/l

0.04

606

Disorders of parathyroid gland, other and/or unspecified

2.06

1.63

1.2

1.8

36.27

36.88

g/l

0.13

Contact with machinery

1087

0.77

1.62

2.0

2.1

37.87

37.72

g/l

0.08

962

Redundant prepuce, phimosis and paraphimosis

218

1844

1.18

1.62

2.1

2.4

37.04

38.09

g/l

1.44

194

1612

Status epilepticus

295

1.47

1.61

1.4

2.5

36.31

36.86

g/l

0.21

256

Other conditions related to polyarteritis nodosa

3.14

1.61

1.0

35.82

38.23

g/l

—

Presbyopia

515

1.35

1.60

1.4

2.2

38.34

38.03

g/l

0.13

456

Unspecified jaundice

490

1.36

1.59

1.7

2.2

35.02

37.37

g/l

1.91

423

Optic neuritis

296

1.46

1.59

1.6

2.3

39.85

38.34

g/l

0.83

265

Campylobacter enteritis

215

1.55

1.58

2.1

2.5

37.71

37.47

g/l

0.11

185

Other facial nerve disorders

223

1.54

1.58

2.3

38.98

37.93

g/l

0.47

190

Glaucoma-related operations

630

1.31

1.58

3.0

2.4

36.05

37.15

g/l

0.79

533

Other blood glucose lowering drugs, excl. Insulins

243

2090

1.17

1.58

1.5

2.2

35.70

37.47

g/l

3.71

209

1745

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

265

1.49

1.55

1.7

2.3

39.13

38.01

g/l

0.76

238

Pneumonitis due to solids and liquids

104

826

1.27

1.55

1.3

2.1

36.84

37.07

g/l

0.14

697

Focal epilepsy, mode (most common among epilepsy diagnosis)

217

1853

1.18

1.54

2.1

37.68

37.60

g/l

0.06

177

1588

Other condition

149

1231

1.22

1.54

2.0

2.1

37.93

37.84

g/l

0.06

130

1079

Vascular dementia (sudden onset)

0.00

1.53

0.0

2.4

—

35.35

—

Erectile dysfunction

118

954

1.25

1.52

2.2

2.3

37.19

37.27

g/l

0.05

103

807

Deep endometriosis

873

0.75

1.52

1.3

2.1

39.34

37.85

g/l

1.50

748

Complications of other internal prosthetic devices, implants and grafts

375

1.40

1.52

2.3

2.2

37.91

37.25

g/l

0.45

321

Orthopaedic devices associated with adverse incidents

178

1.60

1.51

1.1

2.4

38.60

37.40

g/l

0.22

149

Dislocation of lens

131

1.71

1.51

3.3

2.3

37.26

36.49

g/l

0.25

118

Pregnancy, childbirth and the puerperium

326

1941

0.88

1.51

1.6

2.1

37.21

g/l

0.00

279

1574

Respiratory tuberculosis, confirmed

178

1.60

1.51

1.4

2.6

36.50

36.68

g/l

0.04

146

Other drug-induced secondary parkinsonism

1.88

1.49

1.3

2.3

38.21

37.59

g/l

—

Malignant neoplasm of thymus, excluding all cancers (controls excluding all cancers)

2.46

1.48

4.2

1.1

34.48

38.47

g/l

—

Pregnancy with abortive outcome

807

3886

1.09

1.48

1.7

2.2

38.26

37.86

g/l

1.04

689

3271

Acute drug-induced interstitial lung disorder

1.93

1.48

9.7

2.0

37.03

37.29

g/l

0.06

Type 1 diabetes, strict definition, subgroup 1

300

1.44

1.47

1.4

37.22

40.13

g/l

1.99

276

Glaucoma secondary to other eye disorders

386

1.39

1.47

2.7

2.5

36.50

37.36

g/l

0.43

328

Reiter disease

2.09

1.46

5.1

1.8

38.11

38.54

g/l

0.10

Other diseases of peritoneum

429

1.36

1.46

1.6

2.2

37.65

37.51

g/l

0.05

370

Chronic iridocyclitis

429

1.36

1.46

2.4

38.81

37.70

g/l

0.94

373

Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)

207

1669

1.17

1.46

2.1

1.5

36.68

37.43

g/l

1.02

181

1373

Convergent concomitant strabismus

369

1.39

1.45

2.0

2.1

39.42

38.23

g/l

0.71

326

Outcome of delivery

115

572

1.25

1.45

1.6

1.8

39.53

39.38

g/l

0.10

104

527

Arthropathy in ulcerative colitis

1.82

1.45

1.5

1.8

39.80

38.86

g/l

0.36

Hypertrophic disorders of skin

404

1.37

1.44

2.4

2.3

37.78

37.91

g/l

0.06

361

Malignant neoplasm of mesothelium and soft tissue

439

1.36

1.44

2.9

2.7

36.42

37.09

g/l

0.31

382

Benign neoplasm: Parathyroid gland

103

1.79

1.43

1.2

2.0

37.79

37.29

g/l

—

Vascular dementia (mixed)

149

1.64

1.43

2.2

2.1

36.59

36.09

g/l

0.17

123

Contraceptive management

322

2562

0.88

1.43

2.1

2.0

38.86

38.63

g/l

0.33

286

2297

Burn and corrosion of wrist and hand

245

1.48

1.43

1.2

2.3

36.80

38.40

g/l

0.87

217

malignant neoplasm of female genital organs

146

1748

0.83

1.43

1.8

2.1

36.91

37.36

g/l

0.42

125

1440

Hereditary corneal dystrophies

329

1.42

1.43

1.5

2.6

38.73

37.32

g/l

1.00

283

Allergic contact dermatitis due to drugs in contact with skin

197

1.54

1.42

1.5

2.0

35.61

37.97

g/l

0.96

174

Secondary malignant neoplasm of other and unspecified sites

139

0.42

1.42

1.2

2.6

28.65

37.23

g/l

—

120

Use of galantamine

827

0.76

1.41

1.3

2.2

37.27

36.49

g/l

0.60

666

Peritonsillar abscess

205

1758

1.17

1.41

2.5

2.0

38.39

38.19

g/l

0.18

185

1546

Benign neoplasm of middle ear and respiratory system

102

820

1.25

1.40

2.6

2.2

38.16

37.66

g/l

0.39

709

Benign neoplasm of other and unspecified female genital organs

433

0.66

1.39

1.9

2.1

38.16

37.88

g/l

0.06

373

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

457

0.67

1.39

1.7

2.1

39.90

38.21

g/l

1.50

406

Other renal tubulo-interstitial diseases

166

1.58

1.38

2.1

1.9

35.30

38.98

g/l

1.19

148

Suppurative and unspecified otitis media

323

2537

1.13

1.37

2.4

1.9

38.78

38.35

g/l

0.62

290

2223

Tobacco use

408

1.36

1.37

1.5

2.6

36.75

38.11

g/l

1.09

363

Primary open-angle glaucoma, strict

317

3560

0.89

1.36

2.1

37.28

37.01

g/l

0.35

252

2934

Dislocation, sprain and strain of joints and ligaments of knee

679

5809

1.09

1.36

1.8

2.2

38.46

38.26

g/l

0.37

582

5110

Spinal enthesopathy

264

1.45

1.36

2.9

1.8

36.30

36.36

g/l

0.02

201

Arthropod-borne viral fevers and viral haemorrhagic fevers

947

0.78

1.36

3.0

2.2

37.13

37.75

g/l

0.37

833

Frontotemporal dementia

2.04

1.36

2.4

2.2

42.07

36.79

g/l

—

Other noninflammatory disorders of uterus, except cervix

301

1811

1.14

1.36

2.4

2.0

37.57

37.24

g/l

0.43

248

1527

Congenital malformations of genital organs

544

1.30

1.35

1.5

1.9

38.97

38.69

g/l

0.15

493

Atlantoaxial subluxation

2.02

1.35

1.3

1.8

36.55

38.81

g/l

0.75

Alzheimer’s disease (Atypical or mixed), excluding more controls

702

0.76

1.35

1.5

2.1

35.27

36.10

g/l

0.48

575

Benign neoplasm of brain and other parts of central nervous system

619

1.29

1.35

2.1

2.4

38.95

37.77

g/l

0.93

535

Neovascular glaucoma

393

1.36

1.34

2.7

2.4

36.50

37.39

g/l

0.45

335

Benign neoplasm of male genital organs

192

1.53

1.34

1.3

2.6

37.88

36.95

g/l

0.29

162

Transient global amnesia

1088

0.79

1.33

2.8

2.3

39.27

37.35

g/l

2.62

940

conjunctival haemorrhage

781

1.25

1.33

2.2

2.1

38.17

37.69

g/l

0.29

675

Congenital iodine-deficiency syndrome/hypothyroidism

300

1.42

1.33

2.7

2.1

37.04

37.32

g/l

0.11

254

Malignant neoplasm, without specification of site, excluding all cancers (controls excluding all cancers)

445

1.34

1.32

2.9

1.4

35.67

37.13

g/l

0.75

359

Malignant melanoma of skin

151

1272

1.19

1.32

1.9

2.3

38.07

37.47

g/l

0.65

125

1086

Sixth [abducent] nerve palsy

309

1.41

1.31

2.9

2.7

36.40

37.26

g/l

0.41

262

Other sideroblastic anaemias

2.43

1.31

1.1

1.5

34.45

35.88

g/l

—

Colorectal cancer

266

3014

0.88

1.30

2.4

2.1

37.10

37.21

g/l

0.10

212

2530

Benign neoplasm: Orbit, unspecified

2.05

1.29

1.5

1.1

37.66

39.28

g/l

0.41

Carcinoma in situ of breast, intraductal

766

1.25

1.29

1.7

1.4

38.45

38.07

g/l

0.28

645

Vascular dementia (subcortical)

319

1.40

1.29

1.8

2.4

35.36

36.45

g/l

0.63

260

Single delivery by caesarean section

102

727

0.81

1.29

2.1

1.5

39.16

39.06

g/l

0.07

665

Marfan's syndrome

2.10

1.28

2.0

1.9

37.54

39.05

g/l

—

Tongue abnormality

633

1.27

1.28

2.2

2.4

38.98

37.71

g/l

1.15

543

Any dementia

508

3919

0.91

1.27

1.8

2.2

36.00

36.82

g/l

1.97

369

3238

LSIL lesion of the cervix uteri, vagina or vulva

114

938

1.22

1.27

2.1

2.0

38.68

38.77

g/l

0.05

103

832

Nontoxic single thyroid nodule

723

1.25

1.27

2.6

2.2

39.02

37.67

g/l

1.28

625

Use of rasagiline

278

1.42

1.27

1.4

2.9

38.62

37.25

g/l

0.83

238

Other disorders of breast

136

1140

1.20

1.26

2.2

2.0

39.15

38.08

g/l

1.33

109

977

Antepartum haemorrhage, not elsewhere classified

440

1.32

1.26

2.3

1.7

40.14

39.48

g/l

0.41

404

Degeneration of the brain due to alcohol

212

1.48

1.24

1.3

2.9

38.26

37.35

g/l

0.35

181

Other diseases of spinal cord

245

1.44

1.24

4.0

2.8

35.94

37.80

g/l

0.87

216

Impotence

512

1.30

1.24

1.9

2.2

36.84

37.29

g/l

0.22

437

Other peripheral vertigo

118

979

1.21

1.23

2.0

2.4

39.11

37.70

g/l

1.85

843

Alzheimer’s disease, wide definition

290

2725

0.89

1.23

1.8

2.2

36.26

36.56

g/l

0.31

208

2220

Crohn disease (strict definition, all UC cases excluded)

347

1.36

1.23

1.5

2.3

35.39

38.15

g/l

1.74

310

Respiratory tuberculosis, bacteriologically and histologically confirmed

188

1.51

1.23

1.4

2.6

36.50

36.65

g/l

0.04

155

Malignant neoplasm of respiratory system and intrathoracic organs

248

2587

0.88

1.23

2.3

2.1

36.37

37.06

g/l

0.99

216

2151

Other lesions of median nerve

263

1.42

1.22

1.2

2.2

38.39

37.06

g/l

0.56

217

Other abnormal findings in urine

140

1.60

1.22

7.3

2.4

37.17

37.19

g/l

0.01

118

Hypertrophic scar

365

1.35

1.21

2.6

1.9

37.45

37.90

g/l

0.23

328

Alzheimer disease, excluding more controls

253

1486

1.14

1.21

1.9

2.2

36.56

36.70

g/l

0.12

176

1246

Injury of nerves and spinal cord at neck level

205

1.48

1.21

3.3

3.0

37.63

g/l

0.00

178

Degenerative diseases of the nervous system

434

3591

0.91

1.21

1.7

2.1

36.43

36.73

g/l

0.41

307

2956

Malignant neoplasm of eye, brain and central nervous system, excluding all cancers (controls excluding all cancers)

620

1.26

1.21

2.1

1.4

38.05

37.86

g/l

0.13

520

Other infective spondylopathies

2.42

1.21

1.5

1.0

31.40

38.98

g/l

—

Rheumatic fever incl heart disease

323

1.38

1.21

1.6

2.5

36.90

37.21

g/l

0.12

272

Other and unspecified disease of Bartholin gland

281

1.40

1.20

1.3

2.3

37.34

38.01

g/l

0.22

251

Degeneration of nervous system due to alcohol

214

1.47

1.20

1.3

2.9

38.26

37.26

g/l

0.39

181

Disorders of eyelid in diseases classified elsewhere

281

1.40

1.19

1.2

2.5

38.38

37.42

g/l

0.48

245

Asthma mixed form (mode), excluding more controls

392

1.33

1.19

2.3

1.6

39.39

38.36

g/l

0.61

321

Flat foot [pes planus] (acquired)

792

1.23

1.19

1.5

2.4

38.14

37.92

g/l

0.11

676

Benign neoplasm of ovary

196

1703

1.16

1.19

2.0

1.4

37.28

37.83

g/l

0.63

170

1413

Pathological resorption of teeth

214

1.46

1.19

1.1

1.9

38.19

38.22

g/l

0.01

188

Other diseases of biliary tract

110

911

1.21

1.18

2.4

2.3

36.87

37.31

g/l

0.31

764

Acute nasopharyngitis (common cold)

117

968

1.21

1.18

1.8

2.0

39.06

38.20

g/l

0.80

105

856

Benign neoplasm: Lip

215

1.46

1.17

1.8

2.4

36.91

37.90

g/l

0.30

181

Lesion of radial nerve

308

1.37

1.16

1.9

2.2

36.92

37.59

g/l

0.24

262

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)

625

1.26

1.15

2.3

1.4

35.32

37.26

g/l

1.93

514

Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)

243

2149

1.13

1.15

2.4

1.4

36.20

37.33

g/l

1.81

195

1774

Meningitis

404

1.32

1.14

2.1

2.4

36.95

38.05

g/l

0.52

358

Other diseases of gallbladder

457

1.30

1.14

2.7

2.4

38.12

37.34

g/l

0.46

391

Benign neoplasm: Orbit, unspecified

1.94

1.14

1.5

2.1

37.66

39.18

g/l

0.39

Contact with other hot fluids

192

1.47

1.12

1.1

2.4

36.60

38.56

g/l

0.94

173

Benign neoplasm: Scrotum

2.32

1.12

1.3

1.2

40.60

37.05

g/l

—

Benign lipomatous neoplasm

339

3062

1.11

2.8

1.4

38.24

37.81

g/l

0.71

284

2616

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

745

1.23

1.11

2.2

2.4

36.41

37.69

g/l

1.08

648

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

565

1.26

1.11

2.3

2.1

39.02

38.67

g/l

0.20

511

Other noninflammatory disorders of vagina

673

1.24

1.11

2.4

1.8

38.48

37.55

g/l

0.86

578

Primary open-angle glaucoma

406

4333

0.91

1.11

2.1

2.2

37.49

36.99

g/l

0.96

325

3576

Postpartum hemorraghe, all women as controls

122

1438

0.84

1.10

1.7

1.8

40.01

39.18

g/l

0.89

102

1299

Conductive hearing loss, unspecified

800

1.22

1.10

1.9

2.1

37.56

37.92

g/l

0.24

700

Benign neoplasm: Choroid

558

1.26

1.09

1.4

38.51

37.84

g/l

0.33

463

FESS (DNB20)

1159

0.83

1.09

1.8

2.2

38.58

37.92

g/l

0.44

1023

Other and unspecified abdominal hernia

399

1.31

1.09

1.3

1.7

37.88

37.23

g/l

0.35

346

Abnormalities of forces of labour

638

1.24

1.09

1.4

2.0

40.13

39.12

g/l

1.07

596

Other intracranial haemorrhages

304

1.36

1.08

1.9

2.1

37.60

37.14

g/l

0.21

254

Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)

849

0.80

1.08

2.3

1.4

37.21

37.44

g/l

0.12

701

Endometriosis of rectovaginal septum and vagina

749

0.78

1.07

1.3

1.9

39.18

37.10

g/l

2.24

646

Pyogenic granuloma

129

1.57

1.06

1.1

2.4

36.67

38.28

g/l

0.60

112

Colorectal cancer, excluding all cancers (controls excluding all cancers)

358

3147

1.10

1.05

2.3

1.5

36.53

37.35

g/l

1.53

289

2628

Lesion of sciatic nerve

498

0.74

1.05

1.5

2.3

38.21

37.01

g/l

0.60

413

Chromophobe cell carcinoma of kidney, excluding all cancers (controls excluding all cancers)

1.97

1.04

1.6

1.1

37.54

37.66

g/l

—

Pedestrian injured in transport accident

607

1.24

1.04

1.4

2.2

37.95

37.63

g/l

0.19

531

Benign neoplasm: Scrotum

2.05

1.01

1.3

40.60

37.56

g/l

—

L02BA Anti-estrogens

190

1672

1.14

1.00

2.0

2.2

38.13

37.90

g/l

0.24

161

1416

Disturbances of smell and taste

387

1.30

1.00

2.6

2.9

36.90

38.09

g/l

0.59

337

All dysplastic lesions of the vulva

361

1.31

1.00

1.2

2.2

35.74

38.13

g/l

1.29

322

Pyoderma

156

1.49

0.99

1.3

2.5

37.15

38.02

g/l

0.21

137

Granulosa cell carcinoma of ovary

0.00

0.99

0.0

2.6

—

38.01

—

Haemangioma, any site

774

1.21

0.99

2.9

2.3

38.30

37.81

g/l

0.31

672

Radial styloid tenosynovitis [de Quervain]

405

1.29

0.99

2.0

1.9

37.13

37.91

g/l

0.37

357

249

1.38

0.99

2.0

2.5

34.20

37.20

g/l

2.09

204

Benign neoplasm of soft tissue of retroperitoneum and peritoneum

1.90

0.98

1.6

2.6

39.53

37.83

g/l

—

Malignant neoplasm of breast, HER-negative

212

2381

0.89

0.98

2.0

2.3

37.46

37.49

g/l

0.02

175

1992

Systemic sclerosis,strict definition

1.72

0.96

1.3

1.8

37.21

37.89

g/l

0.19

Perforation of oesophagus

1.81

0.96

1.1

2.8

36.80

37.62

g/l

—

Other specified disorders of kidney and ureter

294

1.34

0.95

3.0

2.8

37.76

37.58

g/l

0.06

257

Right hemicolectomy

651

1.22

0.95

3.1

2.3

35.46

37.27

g/l

1.71

562

Episcleritis

408

1.28

0.95

1.5

2.1

38.95

38.07

g/l

0.70

369

Other benign neoplasm of uterus: Other parts/unspecified

480

1.26

0.95

2.9

1.4

36.84

37.07

g/l

0.10

374

Acute lymphadenitis

417

1.28

0.94

2.7

2.4

37.81

38.14

g/l

0.13

368

Noise effects on inner ear

374

0.72

0.94

1.9

2.6

38.05

37.58

g/l

0.12

327

Dronedarone medication

295

1.33

0.94

1.7

2.4

35.72

38.03

g/l

1.34

250

Benign neoplasm: Cerebral meninges

117

1001

1.17

0.93

2.0

2.3

36.99

37.41

g/l

0.33

101

849

Infective dermatitis

128

1103

1.16

0.93

1.5

2.4

37.48

37.57

g/l

0.06

106

959

Malignant neoplasm of bronchus and lung, excluding all cancers (controls excluding all cancers)

287

2168

1.11

0.93

2.2

1.4

36.38

37.40

g/l

2.12

251

1805

Other congenital malformations of nervous system

1.75

0.93

1.2

1.7

38.86

38.95

g/l

—

Dysplasia of cervi uteri

215

1481

1.12

0.93

1.9

1.8

39.01

38.19

g/l

1.25

189

1285

Infections of genitourinary tract in pregnancy

744

0.80

0.92

2.0

38.28

38.33

g/l

0.02

651

Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)

620

0.79

0.91

2.7

1.4

36.27

37.70

g/l

0.94

505

Maltreatment syndromes

270

1.34

0.91

2.1

1.8

38.63

38.95

g/l

0.10

249

Postprocedural musculoskeletal disorders, not elsewhere classified

728

1.20

0.90

2.3

2.4

37.20

37.49

g/l

0.15

627

Benign neoplasm of other and unspecified female genital organs

394

0.73

0.90

1.9

1.3

38.16

38.14

g/l

0.01

328

Postpartum hemorraghe, parous women as controls

122

1239

0.86

0.90

1.7

1.9

40.01

39.31

g/l

0.69

102

1115

Hydatidiform mole

101

0.49

0.90

1.0

2.0

43.18

38.08

g/l

—

Other abnormal products of conception

223

1328

1.12

0.89

1.7

2.0

40.00

38.94

g/l

2.23

204

1194

Mild mental retardation

153

0.58

0.89

1.9

2.0

36.93

38.70

g/l

—

139

Acquired stenosis of external ear canal

1.64

0.89

1.7

37.67

37.71

g/l

0.01

Schizoaffective disorder

565

1.23

0.89

1.7

2.3

37.71

38.25

g/l

0.30

505

Injury of blood vessels at lower leg level

1.90

0.89

1.5

1.6

38.27

38.11

g/l

—

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

415

0.74

0.88

2.5

2.4

36.69

37.87

g/l

0.42

366

Examination and encounter for administrative purposes

333

1.30

0.88

3.4

2.5

37.31

37.22

g/l

0.04

293

Benign neoplasm: Skin of trunk

342

1.29

0.88

3.0

1.4

38.95

38.21

g/l

0.37

296

Macular cyst

282

1.33

0.86

1.3

2.8

36.86

37.38

g/l

0.20

247

Malnutrition

170

1.43

0.86

1.8

2.2

31.63

37.92

g/l

1.84

140

Lateral epicondylitis

130

1130

1.15

0.86

1.7

1.9

38.82

37.88

g/l

1.11

112

990

Other disorders of bone density and structure

179

1.41

0.84

1.6

2.2

38.52

38.24

g/l

0.06

160

Burn and corrosion confined to eye and adnexa

154

1.44

0.84

1.7

2.3

36.50

38.89

g/l

0.88

139

Ménière disease

120

1040

1.16

0.84

1.6

2.3

38.21

37.54

g/l

0.58

103

890

Leisure time condition

196

1754

1.12

0.83

1.5

2.2

37.23

37.52

g/l

0.22

135

1520

Maternal care for known or suspected malpresentation of fetus

679

0.83

2.0

1.6

39.74

39.64

g/l

0.05

612

Frontotemporal dementia, wide, incl. Pick's disease

1.68

0.83

2.4

2.1

42.07

36.79

g/l

—

Suppurative otitis media, unspecified

190

0.63

0.83

1.8

2.3

37.42

38.20

g/l

0.26

162

Malignant neoplasm of bladder

818

1.18

0.83

1.6

2.3

36.59

36.76

g/l

0.08

686

Varicose veins of other sites

580

1.21

0.82

2.2

2.3

38.43

38.28

g/l

0.08

507

Malignant neoplasm of endocrine gland, excluding all cancers (controls excluding all cancers)

745

1.19

0.82

2.8

1.4

38.41

37.89

g/l

0.36

622

Carcinoma in situ of middle ear and respiratory system

1.74

0.82

2.1

1.2

41.72

37.02

g/l

—

Polyhydramnios

213

0.65

0.81

1.4

1.9

41.51

39.30

g/l

3.97

195

Other disorders of conjunctiva

175

1561

1.12

0.80

2.4

2.1

38.23

37.36

g/l

1.10

149

1329

Other problems related to primary support group, including family circumstances

629

1.20

0.80

2.0

38.12

38.62

g/l

0.24

561

Unspecified mental disorder

446

4155

1.07

0.80

2.0

2.1

37.89

38.19

g/l

0.49

384

3602

Contact with other hot metals

106

1.52

0.79

1.1

2.0

35.92

38.22

g/l

0.99

Car occupant injured in other and unspecified transport accidents

177

1581

1.12

0.79

1.9

2.1

38.45

37.99

g/l

0.45

151

1385

Other and unspecified injuries of thorax

131

1.46

0.79

1.5

2.2

34.28

38.17

g/l

1.15

110

Papillary adenocarcinoma of thyroid gland, excluding all cancers (controls excluding all cancers)

565

1.21

0.79

3.0

1.4

38.74

38.19

g/l

0.36

478

Granulosa cell carcinoma of ovary, excluding all cancers (controls excluding all cancers)

0.00

0.78

0.0

1.1

—

38.80

—

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum, excluding all cancers (controls excluding all cancers)

1073

0.85

0.78

2.7

1.4

37.51

37.58

g/l

0.04

889

Haemangioma and lymphangioma, any site

823

1.17

0.78

2.8

2.2

38.29

37.82

g/l

0.30

716

Burns and corrosions confined to eye and internal organs

182

1.38

0.78

1.6

2.2

37.05

39.10

g/l

0.82

163

Other symptoms and signs involving the digestive system and abdomen

184

1649

1.12

0.78

1.7

2.2

37.27

37.64

g/l

0.32

132

1398

Amblyopia ex anopsia

269

1.31

0.78

1.2

2.1

39.59

38.10

g/l

0.65

237

Presbycusis

205

1841

1.11

0.77

2.6

2.1

36.76

36.48

g/l

0.27

164

1519

Pedal cyclist injured in transport accident

230

2088

1.10

0.77

2.1

38.47

37.90

g/l

0.66

192

1830

Other benign neoplasms of connective and other soft tissue

101

871

1.16

0.77

2.4

1.4

37.55

37.88

g/l

0.21

740

Other benign neoplasms of uterus

604

1.20

0.76

2.7

1.4

36.18

37.35

g/l

0.74

483

Retained placenta and membranes, without haemorrhage

996

0.85

0.76

2.2

2.0

37.80

38.55

g/l

0.57

880

Pleural plaque

136

1200

1.14

0.76

2.1

37.22

37.03

g/l

0.17

113

1003

Other disorders of Eustachian tube

244

1.32

0.76

1.6

2.1

36.76

37.84

g/l

0.36

216

Malignant neoplasm of head and neck, excluding all cancers (controls excluding all cancers)

119

1040

1.15

0.76

3.0

1.4

38.08

37.69

g/l

0.33

100

865

Dementia

590

4320

0.94

0.75

1.8

2.3

36.51

36.85

g/l

0.63

430

3611

Benign neoplasm: Larynx

271

1.30

0.75

3.2

1.3

39.36

37.74

g/l

0.91

233

Use of rivastigmine

156

1744

0.89

0.75

2.0

2.2

37.08

36.53

g/l

0.55

118

1394

Chromophobe cell carcinoma of kidney

1.67

0.75

1.6

1.8

37.54

37.80

g/l

—

Carcinoma in situ of larynx

2.09

0.74

2.4

1.0

43.14

37.56

g/l

—

Asthma mixed form (mode)

423

1.23

0.74

2.2

1.7

39.39

38.12

g/l

0.82

346

Specific developmental disorder of motor function

2.05

0.74

1.0

2.2

40.54

41.07

g/l

—

Ethmoidectomy

105

1206

0.87

0.74

2.4

2.2

38.62

37.89

g/l

0.53

1064

Obstructed labour due to maternal pelvic abnormality

122

1387

0.88

0.74

2.3

2.1

38.75

38.29

g/l

0.41

104

1210

Benign neoplasm of bone and articular cartilage

699

1.18

0.73

1.5

2.3

38.95

38.00

g/l

0.71

613

Bacterial meningitis

290

1.28

0.73

2.3

2.7

36.19

38.20

g/l

0.88

256

Myocardial infarction, unclassifiable

280

2714

0.92

0.73

1.7

2.1

35.72

36.81

g/l

2.28

237

2226

Accidental poisoning by and exposure to alcohol

109

0.55

0.72

1.3

3.1

36.47

38.57

g/l

—

Malignant neoplasm of peripheral nerves and autonomic nervous system, excluding all cancers (controls excluding all cancers)

1.79

0.72

1.1

36.67

37.97

g/l

—

Carcinoma in situ of larynx

2.01

0.72

2.4

3.1

43.14

37.68

g/l

—

Vascular dementia

115

973

1.15

0.72

1.9

2.1

35.94

36.23

g/l

0.21

788

Other female pelvic inflammatory diseases

173

1554

1.12

0.72

1.5

2.2

37.80

38.02

g/l

0.17

125

1329

Palindromic rheumatism

1.60

0.72

1.5

1.4

36.31

38.17

g/l

0.69

Acute appendicitis, with complications

235

2145

1.10

0.72

2.6

2.1

37.32

37.77

g/l

0.52

205

1867

Labour and delivery complicated by fetal stress [distress]

108

827

0.87

0.72

1.8

1.6

39.49

39.65

g/l

0.11

102

750

Pre-eclampsia or eclampsia

188

1697

1.11

0.72

1.7

2.1

38.27

38.71

g/l

0.45

168

1488

311

2721

1.08

0.71

2.1

36.84

36.78

g/l

0.06

232

2213

Malignant neoplasm, without specification of site

309

1.27

0.71

2.5

2.4

35.64

36.47

g/l

0.32

254

Adenocarcinoma and papilloma adenocarcinoma of rectum, excluding all cancers (controls excluding all cancers)

1029

0.86

0.70

2.8

1.4

37.66

37.59

g/l

0.03

852

Calcaneal spur

1.52

0.70

1.1

1.6

38.59

37.88

g/l

—

Other benign neoplasm of uterus: Corpus uteri

1.66

0.69

1.6

1.2

32.94

38.70

g/l

—

Colon adenocarcinoma

129

1452

0.89

0.69

2.7

2.2

36.09

37.22

g/l

1.07

1222

Nonsuppurative otitis media

182

1420

1.11

0.69

2.0

1.9

37.83

38.31

g/l

0.50

162

1234

Motor disorders

1.85

0.68

1.0

2.1

40.54

41.17

g/l

—

Other fall from one level to another

230

2104

1.09

0.68

2.1

38.00

37.81

g/l

0.18

196

1835

Other obstructed labour

573

0.82

0.67

1.4

2.1

38.15

38.68

g/l

0.33

521

Obstructed labour due to malposition and malpresentation of fetus

123

1308

0.88

0.67

1.6

1.9

39.45

39.10

g/l

0.34

114

1182

malignant neoplasm of male genital organs

607

3649

1.06

0.67

2.2

2.4

36.58

37.19

g/l

1.56

499

3158

Benign neoplasm of thyroid gland

317

0.75

0.67

1.1

2.1

40.86

38.05

g/l

1.34

280

Brain meningioma, excluding all cancers (controls excluding all cancers)

494

1.20

0.66

2.5

1.4

36.42

37.76

g/l

0.86

403

Non-small cell lung cancer, adenocarcinoma, excluding all cancers (controls excluding all cancers)

670

1.17

0.66

1.7

1.4

36.77

37.64

g/l

0.61

558

Endometriosis diagnosis and infertility diagnosis occurring together

670

1.17

0.65

1.3

2.0

38.92

38.95

g/l

0.01

607

Respiratory tuberculosis, not confirmed

460

0.80

0.65

2.4

2.5

38.73

37.01

g/l

1.21

385

Acute poliomyelitis

128

0.62

0.65

1.4

2.2

33.90

37.61

g/l

—

110

Alzheimer’s disease (Late onset)

273

2528

0.92

0.64

1.8

2.2

36.08

36.46

g/l

0.40

193

2050

Endometriosis of pelvic peritoneum

139

1227

1.12

0.64

1.5

2.0

39.36

38.16

g/l

1.66

116

1067

Nonspecific lymphadenitis

459

1.20

0.64

1.9

2.1

39.26

38.44

g/l

0.59

407

Foreign body in alimentary tract

478

1.20

0.64

1.6

2.3

37.86

37.57

g/l

0.13

419

Tuberculosis, wide

850

1.15

0.63

2.0

2.3

37.24

37.01

g/l

0.14

716

Dementia due to Parkinsons disease, excluding more controls

190

1.33

0.63

1.4

1.9

35.25

36.72

g/l

0.36

160

Hepatocellular carcinoma

199

1.32

0.63

1.9

2.8

36.71

36.78

g/l

0.02

170

Benign mammary dysplasia

173

1570

1.11

0.63

2.7

2.1

38.21

37.57

g/l

0.69

143

1322

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

152

1371

1.11

0.62

2.7

2.2

38.00

37.87

g/l

0.09

123

1200

Childhood allergy (age < 16)

333

1.21

0.62

1.1

1.3

39.15

40.44

g/l

0.65

305

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

664

0.84

0.62

3.3

2.3

38.96

37.72

g/l

0.94

578

Small plaque parapsoriasis

1.70

0.62

1.8

2.5

36.70

36.74

g/l

—

Diseases of middle ear and mastoid

602

4683

1.05

0.62

2.3

2.1

38.42

38.12

g/l

0.58

534

4044

Other and unspecified acne

1.60

0.62

1.2

1.7

37.06

39.62

g/l

—

Other and unspecified water transport accidents

1.69

0.62

1.0

1.1

35.96

38.44

g/l

—

Macular hole

647

1.17

0.61

2.1

2.4

36.31

37.40

g/l

0.81

550

Unequal limb length (acquired)

1.68

0.61

1.0

2.4

39.32

40.59

g/l

—

Tuberculosis, IBD comorbidity

815

1.15

0.61

2.0

2.2

37.18

37.10

g/l

0.04

684

Malignant neoplasm of oral cavity, excluding all cancers (controls excluding all cancers)

416

1.21

0.61

2.7

1.4

37.36

37.96

g/l

0.38

350

Injury of blood vessels at wrist and hand level

1.59

0.61

1.9

1.2

39.33

39.32

g/l

—

Long labour

143

1386

0.90

0.61

2.3

1.9

38.82

38.95

g/l

0.09

129

1241

Multiple delivery

684

0.85

0.61

2.0

1.8

40.22

38.58

g/l

1.80

602

Oligomenorrhoea

236

1.28

0.60

1.6

2.0

38.88

37.80

g/l

0.48

207

Cholesteatoma of middle ear

563

0.83

0.59

1.8

2.3

38.00

37.27

g/l

0.38

486

Carcinoma in situ of middle ear and respiratory system

1.53

0.59

2.1

3.4

41.73

37.19

g/l

—

Toxic effects of substances chiefly nonmedicinal as to source

939

0.87

0.59

1.9

2.2

37.69

37.78

g/l

0.03

824

Postmenopausal atrophic vaginitis

327

1837

1.07

0.59

2.4

2.1

39.45

37.37

g/l

9.92

282

1565

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

571

4899

0.95

0.59

2.2

2.1

38.12

38.16

g/l

0.05

499

4223

Sequelae of other and unspecified infectious and parasitic diseases

418

1.20

0.59

2.8

2.0

37.27

38.15

g/l

0.36

369

Enterobiasis

0.00

0.59

0.0

1.0

—

39.12

—

Chorioretinal scars

1.75

0.58

2.0

2.3

39.27

37.35

g/l

—

Universal erythroderma, KELA reimbursement

123

1.39

0.58

1.4

2.4

40.40

37.36

g/l

—

105

Ovarian dysfunction, other/unspecified

1.73

0.58

2.7

2.4

38.48

39.11

g/l

—

Acute and transient psychotic disorders

111

989

1.13

0.57

2.2

37.42

38.00

g/l

0.42

871

Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced

1.70

0.57

1.8

1.3

37.20

36.68

g/l

—

Secondary parkinsonism+Parkinsonism in other disease

265

1.25

0.57

2.8

2.5

36.52

37.29

g/l

0.29

226

Other vitreous opacities

365

1.21

0.57

2.3

2.6

39.20

37.60

g/l

1.19

313

Other operation for atrial fibrillation

1.48

0.57

1.5

2.1

36.90

36.85

g/l

—

Vascular syndromes of brain in cerebrovascular disorders

505

0.83

0.56

2.3

2.5

38.23

36.95

g/l

0.86

435

Malignant neoplasm of other endocrine glands and related structures, excluding all cancers (controls excluding all cancers)

1.65

0.56

3.7

1.1

42.72

38.49

g/l

—

Use of selegiline

504

1.18

0.56

2.3

38.85

37.05

g/l

1.64

434

Benign neoplasm: Skin of lower limb, including hip

221

1.27

0.56

1.5

1.2

36.99

38.23

g/l

0.42

190

Benign neoplasm: Cranial nerves

248

1.26

0.55

3.1

1.3

37.77

37.92

g/l

0.05

212

Felty syndrome

1.55

0.55

1.1

2.2

39.42

37.37

g/l

—

Dystonia

495

1.18

0.55

1.2

2.2

40.02

37.78

g/l

2.05

435

Benign neoplasm: Choroid

607

1.16

0.55

1.4

2.4

38.51

37.58

g/l

0.52

528

Heterophoria

607

1.16

0.55

2.8

2.3

39.84

37.95

g/l

2.38

534

Other factor of the environment

1.43

0.54

3.4

1.5

40.05

38.11

g/l

0.85

Use of levodopa decarbox-comt-inhibitor

349

1.21

0.54

1.1

2.8

38.14

36.86

g/l

0.74

300

Haemorrhage in early pregnancy

206

2175

0.92

0.54

2.2

2.0

39.01

38.64

g/l

0.37

181

1904

Malignant neoplasm of prostate

598

3602

1.05

0.54

2.2

2.4

36.55

37.15

g/l

1.51

490

3113

Malignant neoplasm of accessory sinuses, excluding all cancers (controls excluding all cancers)

1.56

0.53

5.7

1.1

37.20

38.68

g/l

—

Von Willebrand disease

1.44

0.53

2.3

2.1

40.44

38.73

g/l

0.73

Chalazion

116

1043

1.11

0.53

3.2

2.2

38.63

37.56

g/l

1.26

908

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

187

1.29

0.53

3.9

1.3

38.84

38.15

g/l

0.25

156

Dementia, including avohilmo

641

4619

0.96

0.52

1.8

2.3

36.67

36.89

g/l

0.37

471

3868

Pre-eclampsia or poor fetal growth

234

2170

1.08

0.52

1.8

2.0

38.49

38.84

g/l

0.37

210

1909

Acute inflammation of orbit

1.51

0.52

11.0

1.1

38.02

38.50

g/l

—

Secondary parkinsonism

260

1.24

0.51

2.8

2.5

36.42

37.24

g/l

0.29

221

Communicating hydrocephalus

206

1.27

0.51

1.5

2.8

38.87

37.72

g/l

0.48

176

Persistent delusional disorders

724

0.87

0.51

1.5

2.2

36.14

37.79

g/l

1.42

621

Non-allergic asthma

819

1.13

0.50

2.1

2.3

37.75

37.67

g/l

0.04

702

Vertical strabismus

270

1.23

0.50

1.7

2.6

36.52

37.93

g/l

0.60

234

Embolic stroke

483

1.16

0.48

1.8

2.3

34.45

37.24

g/l

2.82

398

Contact with other and unspecified heat and hot substances

1.54

0.48

4.7

1.7

35.19

38.87

g/l

—

Lichen sclerosus et atrophicus

112

1013

1.11

0.48

1.6

2.0

38.68

37.66

g/l

1.15

844

Hypertrophy of breast in women and men

183

1693

1.08

0.48

2.0

2.2

38.09

38.23

g/l

0.11

157

1474

Medical treatment for female infertility

1097

0.90

0.47

1.6

1.7

39.45

39.47

g/l

0.01

995

Seminoma of testis, excluding all cancers (controls excluding all cancers)

1.47

0.47

1.9

1.3

36.03

39.22

g/l

—

Melanocytic naevi, other sites/unspecified

676

0.87

0.47

2.1

2.4

36.36

37.98

g/l

1.11

599

L01XE Protein kinase inhibitors

609

1.14

0.45

3.1

2.5

35.06

37.58

g/l

2.49

535

Malignant neoplasm of thyroid gland, excluding all cancers (controls excluding all cancers)

675

1.13

0.45

2.9

1.4

38.59

37.96

g/l

0.43

566

Torsion of ovary, ovarian pedicle and fallopian tube

147

1.30

0.45

1.4

2.0

40.16

37.79

g/l

1.28

135

Family history of malignant neoplasm

854

0.89

0.45

2.7

2.0

38.90

38.58

g/l

0.24

748

Lesion of plantar nerve

631

0.87

0.45

2.7

2.2

38.30

37.72

g/l

0.33

531

Carcinoma in situ of breast, lobular

1.47

0.45

5.3

1.3

39.35

38.52

g/l

—

Nontoxic diffuse goitre

311

1.20

0.45

3.9

2.1

38.38

37.81

g/l

0.27

270

Puerperal sepsis

106

1168

0.91

0.45

2.3

2.1

38.41

38.35

g/l

0.04

1032

Benign neoplasm: Connective and other soft tissue of trunk, unspecified

1.38

0.44

1.1

34.71

38.43

g/l

—

Foreign body on external eye

121

1324

0.91

0.44

2.2

38.57

38.00

g/l

0.50

106

1189

Calcific tendinitis of shoulder

491

0.85

0.44

2.2

2.0

37.66

38.00

g/l

0.12

436

LSIL lesion of the cervix uteri

667

1.13

0.44

2.5

2.0

39.48

38.97

g/l

0.31

607

Injury of muscle and tendon at shoulder and upper arm level

460

4398

1.05

0.44

2.2

37.81

37.68

g/l

0.17

397

3811

Benign neoplasm of thyroid gland

296

0.81

0.44

1.1

1.3

40.86

38.39

g/l

1.12

248

Impacted teeth

783

0.89

0.43

1.2

1.8

40.27

39.35

g/l

0.72

703

Carcinoma in situ of other and unspecified genital organs

162

0.74

0.43

1.3

2.2

33.60

37.86

g/l

—

147

Benign neoplasm: Male genital organ, other/unspecified

0.00

0.42

0.0

1.1

—

37.90

—

Embedded teeth, including avohilmo

462

1.15

0.42

1.8

1.9

39.05

38.74

g/l

0.15

417

Obstetric embolism

0.00

0.42

0.0

1.1

—

36.63

—

Malignant neoplasm of hypopharynx, excluding all cancers (controls excluding all cancers)

1.39

0.42

1.5

1.2

36.06

36.79

g/l

—

Cyst of spleen

0.00

0.41

0.0

3.8

—

37.95

—

Separation of retinal layers (serosa)

351

1.17

0.41

1.4

2.4

37.36

37.75

g/l

0.16

309

Traumatic cerebral oedema

0.00

0.41

0.0

1.3

—

37.74

—

Malignant neoplasm of corpus uteri

952

0.90

0.41

1.6

2.1

36.74

37.24

g/l

0.35

782

Tuberculosis of other organs, strict

268

1.20

0.41

2.0

2.5

35.89

36.74

g/l

0.33

225

Sequelae of injuries of upper limb

871

1.10

0.41

2.6

2.3

37.89

37.94

g/l

0.02

763

Other infective (teno)synovitis

1.49

0.41

1.0

1.2

40.64

38.38

g/l

—

Injury of nerves at forearm level

1.37

0.40

1.3

2.5

41.13

39.03

g/l

0.83

Benign lipomatous neoplasm of other sites/unspecified

882

1.10

0.40

3.4

1.4

37.37

37.56

g/l

0.11

729

Other and unspecified injuries of shoulder and upper arm

232

1.21

0.40

1.1

2.4

36.59

37.46

g/l

0.20

198

Other benign neoplasm of uterus: Other parts/unspecified

531

1.14

0.40

2.9

2.1

36.84

36.93

g/l

0.04

430

Other acantholytic disorders

1.45

0.40

1.6

3.2

34.96

37.96

g/l

—

Carcinoma in situ of breast, intraductal

864

1.10

0.39

1.7

2.0

38.45

37.78

g/l

0.60

737

Discharge from other and unspecified firearms

0.00

0.39

0.0

2.5

—

39.19

—

Malignant neoplasm of nasal cavity and sinuses

1.38

0.39

6.8

1.9

40.26

37.76

g/l

—

Colorectal adenocarcinoma, excluding all cancers (controls excluding all cancers)

209

2221

0.94

0.39

2.5

1.4

36.89

37.31

g/l

0.41

158

1847

Melanoma in situ, other sites/unspecified

1.41

0.39

1.2

1.1

35.78

37.26

g/l

—

Benign neoplasm: Bladder

1.39

0.38

2.4

1.2

38.49

36.93

g/l

0.41

Maternal care for known or suspected abnormality of pelvic organs

150

1114

0.93

0.38

2.7

1.9

39.66

39.00

g/l

0.89

135

997

Endometriosis ASRM stages 3,4

207

2200

0.94

0.38

1.6

2.0

38.57

38.01

g/l

0.72

168

1875

Benign leiomyoma with endometriosis

189

1773

1.07

0.38

2.1

37.86

37.62

g/l

0.22

153

1506

Other benign neoplasm of uterus: Corpus uteri

1.40

0.37

1.6

2.3

32.94

37.48

g/l

—

Other and unspecified degenerative diseases of nervous system

244

1.20

0.37

1.8

2.4

36.59

36.85

g/l

0.07

205

Malignant neoplasm of hypopharynx

1.48

0.36

1.0

2.6

35.83

37.02

g/l

—

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

364

0.85

0.36

2.5

1.3

36.69

38.26

g/l

0.61

308

Malignant neoplasm of breast, HER2-negative

606

4303

1.04

0.36

1.9

2.2

37.88

37.74

g/l

0.24

489

3625

Tooth eruption problems

624

1.11

0.35

1.6

1.8

39.21

38.94

g/l

0.15

564

Sequelae of infectious and parasitic diseases

688

1.11

0.35

2.9

2.1

36.76

37.48

g/l

0.40

595

Other rupture of muscle

1.41

0.35

1.0

1.8

36.30

38.57

g/l

—

Fitting and adjustment of other devices

429

4150

0.96

0.35

2.2

2.0

37.51

37.43

g/l

0.09

299

3445

Other benign neoplasms of uterus

651

1.11

0.35

2.7

2.1

36.17

37.32

g/l

0.72

533

Vestibular neuronitis

100

919

1.09

0.35

2.2

2.3

39.33

37.67

g/l

2.53

789

Convalescence

461

1.13

0.35

2.2

2.0

37.48

38.34

g/l

0.42

404

Squamous cell neoplasms and carcinoma of cervix

1.37

0.34

1.0

1.5

37.40

37.59

g/l

—

Vertigo of central origin

154

1.24

0.34

1.8

2.7

39.07

37.37

g/l

0.33

129

Other specified and unspecified disorders of lens

109

1.30

0.34

1.9

2.3

38.74

36.41

g/l

—

Divergent concomitant strabismus

614

1.11

0.34

1.9

2.2

39.23

38.01

g/l

1.18

535

Hypertrophy of breast

151

1413

1.07

0.34

1.5

2.1

38.45

38.39

g/l

0.04

128

1234

Renal cell carcinoma of kidney, excluding all cancers (controls excluding all cancers)

321

1.16

0.34

2.0

1.5

34.79

36.95

g/l

1.05

261

Benign neoplasm: Skin of other and unspecified parts of face

111

1198

0.92

0.33

3.9

2.2

36.50

37.54

g/l

0.93

1024

Cellulitis of external ear

0.68

0.33

1.8

1.7

40.48

38.04

g/l

—

Dislocation, sprain and strain of joints and ligaments of elbow

425

1.13

0.33

1.9

1.7

39.81

38.41

g/l

1.27

377

Embedded and impacted teeth

128

1168

0.93

0.33

1.4

1.9

39.97

38.93

g/l

1.30

115

1053

Brain meningioma

530

1.12

0.33

2.5

36.42

37.64

g/l

0.76

451

Endometriosis of ovary

165

1547

1.07

0.33

1.7

2.0

38.42

37.76

g/l

0.73

136

1338

Uterine polyps

913

1.09

0.33

1.7

2.0

38.46

37.63

g/l

0.87

788

Benign neoplasm: Skin of trunk

388

1.14

0.32

3.0

2.4

38.95

37.83

g/l

0.64

342

Conductive and sensorineural hearing loss

1155

7819

1.02

0.32

2.3

2.2

37.84

37.43

g/l

1.50

925

6732

Congenital malformations of breast

1.33

0.32

1.0

1.5

42.40

39.16

g/l

1.77

Schizophrenia or delusion

316

3027

1.04

0.32

1.9

2.0

37.56

38.19

g/l

1.01

261

2645

Antenatal screening

151

796

1.07

0.32

1.8

39.51

39.12

g/l

0.37

145

733

Malignant neoplasm of nasal cavity and middle ear

1.36

0.31

7.1

2.1

40.69

38.11

g/l

—

Other menopausal disorders

318

1754

1.05

0.31

2.0

39.08

37.69

g/l

4.44

279

1515

Mental retardation, excluding more controls

189

1.20

0.31

1.5

2.5

38.71

38.47

g/l

0.08

165

Pre-eclampsia

162

1525

1.06

0.31

1.8

2.0

38.14

38.70

g/l

0.54

143

1340

Tuberculosis of other organs

230

1.18

0.31

2.1

2.4

35.44

36.71

g/l

0.45

192

Anxious personality disorder

0.70

0.31

3.0

1.7

40.91

39.79

g/l

—

Pedal cyclist injured in collision with pedestrian or animal

1.30

0.30

2.6

2.2

41.90

38.50

g/l

—

Other corneal oedema

1.35

0.30

3.0

2.0

39.36

37.79

g/l

—

Secondary malignant neoplasm of other and unspecified sites, excluding all cancers (controls excluding all cancers)

273

2611

1.05

0.30

2.8

1.5

35.61

37.63

g/l

5.68

235

2203

Cauda equina syndrome

102

1.28

0.30

2.3

1.7

34.92

38.17

g/l

1.26

Other specified/unspecified diseases of inner ear

1.26

0.30

1.9

2.1

42.03

36.93

g/l

—

Benign neoplasm: Connective and other soft tissue of trunk, unspecified

1.26

0.29

1.1

2.3

34.71

37.83

g/l

—

Struck by thrown, projected or falling objec

344

1.14

0.29

1.2

2.6

39.47

38.20

g/l

0.71

306

Benign neoplasm: Skin of upper limb, including shoulder

148

1.22

0.29

4.4

1.4

40.08

38.27

g/l

1.87

127

Unspecified renal colic

1.24

0.29

2.4

1.1

39.30

38.72

g/l

—

Preparation and fitting of bite rail to mouth

121

1133

1.07

0.28

2.6

2.3

39.67

38.24

g/l

2.48

112

1003

Carcinoma in situ of breast, lobular

1.33

0.28

5.3

2.2

39.35

38.08

g/l

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS